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Chapter 1 
General introduction 
Milena Mechkarska 
“I don’t see no p’ints about that frog that’s any better’n any other frog.” 
Mark Twain, 1867, The Celebrated Jumping Frog of Calaveras County 
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Worldwide spread of infections caused by multidrug resistant bacteria  
A global problem is rapidly evolving and expanding to the point of posing a serious 
threat to public health. This is the emergence of pathogenic bacteria and fungi resistant to 
commonly used antibiotics, which cause increased morbidity and mortality, and impact 
heavily on healthcare costs (Livermore, 2009). 
Antibiotic resistance is a type of drug resistance in which a microorganism is able to 
survive exposure to an antibiotic. Antibiotics have been considered to be the single most 
significant discovery in medicine. However, even at the early stage after their discovery, 
antibiotic resistance had already begun to emerge (Rammelcamp and Maxon, 1942). 
Bacteria are either non-responsive or resistant to the action of antibiotics by a range of 
different mechanisms (Fig. 1). 
Fig. 1. Bacterial resistance mechanisms to antibiotics. (1) Enzymatic degradation as a result of 
production of proteases; (2) Target alteration such as composition of the membrane, LPS or 
intracellular molecules; (3) Reduction of permeability by changing trans-membrane potential or 
modification of membrane fluidity; (4) Over-expression of efflux pumps causing immediate export; 
(5) Protection of intracellular target; (6) Overproduction of target; and (7) Bypassing the action on 
target. Key: enzyme (proteases)       ; antibiotic       ; intracellular target  ; protection          ; 
alteration of target      . Kindly provided by Prof. T. Pal (2012). 
E 
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Resistance can arise either by mutations of bacterial genes, or even more frequently by 
horizontal gene transfer. Antibiotic resistance genes may be mobilized between the same or 
even different species by plasmids or transposons or acquired by natural competence for 
transformation by exogenous DNA. Thus, a gene for antibiotic resistance that evolves via 
natural selection may be shared in or across the population(s). The resistant bacteria are 
classified into multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-
resistant (PDR) categories (Magiorakos et al., 2012). MDR is defined as acquired non-
susceptibility to at least one agent in three or more antimicrobial categories, XDR is 
defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial 
categories (i.e. bacterial isolates remain susceptible to only one or two categories) and PDR 
is defined as non-susceptibility to all agents in all antimicrobial categories (Magiorakos et 
al., 2012). The genes for resistance to antibiotics, like the antibiotics themselves, are 
ancient (Donadio et al., 2010). Although there were low levels of pre-existing antibiotic-
resistant bacteria (Nelson, 2009; Caldwell and Lindberg, 2011), the major factor in 
development and selection of MDR strains and in sharing of resistance between bacterial 
species is the widespread use of antibiotics (Hawkey and Jones, 2009). Examples of the 
misuse of antibiotics include their sales over the counter without a prescription; 
inappropriate prescription by doctors; addition to livestock feed; and unsound practices in 
the pharmaceutical manufacturing industry involving release of new antibiotics despite the 
fact that resistant strains have already been documented. The problem is made worse by the 
increasing trend for regional and international travel among human populations (Cohen, 
1992; Tomasz, 1994; Swartz, 1997). This makes the emergence of antibiotic resistance “the 
most eloquent example of Darwin’s principle of evolution” (Livermore, 2009). 
One of the major drug-resistant human pathogens is a strain of the Gram-positive 
aerobic, non-motile coccus: Staphylococcus aureus. This microorganism is carried by 
approximately one third of the human population. It causes local infections by colonizing 
mucous membranes and skin which can, in later stages, develop into systemic infections, 
such as bacteremia and sepsis in both adults and children. The second group of infections is 
toxin- and superantigen-mediated diseases (Kurlenda and Grinholc, 2012; and references 
therein). S. aureus possesses a wide spectrum of virulence factors (Feng et al., 2008; Plata 
et al., 2009) that enable it to bypass the barriers of the host defence system and it can 
survive hostile environmental conditions due to its extraordinary versatility and adaptability 
to antibiotic pressure (Lowy, 1998; Lowy, 2003). 
The development of antibiotic resistance by S. aureus is summarized in Fig. 2. 
S. aureus was one of the first bacteria in which penicillin resistance was found 
(Rammelcamp and Maxon, 1942) and the specific role of penicillinase was subsequently 
identified (Kirby, 1944; Bondi and Dietz, 1945). This necessitated the clinical use of 
penicillinase-resistant derivatives such as methicillin as the antibiotics of choice. However, 
reports describing the emergence of methicillin-resistant S. aureus (MRSA) quickly 
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followed (Jevons, 1961). Since then, MRSA has become endemic in many countries and 
poses a significant problem worldwide (Kreiswirth et al., 1993). The subsequent usage of 
newer classes of antibiotics also quickly caused appearance of resistant S. aureus strains 
(Bozdogan et al., 2003). Thus, apart from being resistant to all β-lactam antibiotics, MRSA 
may not be responsive to macrolides, clindamycin, fluoroquinolones, tetracycline and 
gentamicin (Feng et al., 2008). 
Fig. 2. Timeline for the introduction of antibiotics into medical practice. The history of the emergence 
of methicillin-resistant S. aureus (MRSA) with the subsequent change in epidemiology of MRSA 
infections is presented in parallel. CA – community-acquired; HA – hospital-acquired. Kindly 
provided by Dr. A. Sonnevend (2012). 
The epidemiology of infections caused by MRSA is rapidly changing. Originally, 
MRSA was associated predominantly with hospital-acquired infections (HA-MRSA) 
(Chambers and Deleo, 2009; Rosenthal et al., 2010); however, in the past 10 years, 
community-acquired MRSA (CA-MRSA) has become prevalent. CA-MRSA infections 
occur in otherwise healthy people who have not been recently hospitalized or had a medical 
procedure (e.g. dialysis, surgery, catheter) and usually involve skin infections, such as 
abscesses, boils, and other pus-filled lesions. Frequently though, CA-MRSA is responsible 
for rapidly progressive, fatal diseases, including necrotizing pneumonia, severe sepsis and 
necrotizing fasciitis (Boyle-Vavra and Daum, 2007; Woodford and Livermore, 2009). 
Although effective new types of antibiotics against multidrug-resistant Gram-positive 
bacteria such as MRSA have been introduced or are in clinical trials (Kurlenda and 
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Grinholc, 2012), the situation regarding new treatment options for infections produced by 
MDR Gram-negative pathogens such as extended-spectrum β-lactamase (ESBL)-producing 
Enterobacteriaceae (primarily Escherichia coli and Klebsiella pneumoniae), Pseudomonas 
aeruginosa and Acinetobacter baumannii is less encouraging (Giamarellou and Poulakou, 
2009). In general, drug-resistant Gram-negative bacteria threaten mainly hospitalized 
patients whose immune systems are weak. These bacteria can survive for a long time on 
surfaces in the hospital and enter the body through wounds, catheters and ventilators. 
Pulmonary infections, particularly hospital-acquired pneumonia, caused by these 
carbapenemase-producing bacteria that are resistant to all β-lactam antibiotics are 
particularly difficult to treat (Kollef, 2010). Gram-negative bacteria have a great ability for 
exchanging genetic material among strains of the same species and even among different 
species. 
The most common mechanism of resistance among E. coli, K. pneumoniae, and other 
Enterobacteriaceae is through the production of β-lactamases which, depending on the 
enzyme, inactivate a wide range of β-lactam antibiotics (Jacoby and Munoz-Price, 2005). 
The ESBLs are a heterogeneous group of β-lactamase enzymes that are mostly encoded by 
plasmid-bourne genes and hydrolyse the majority of β-lactam antibiotics with the exception 
of carbapenems. ESBLs now number 532 distinct enzymes and convey varying degrees of 
resistance to cephalosporins, penicillins, β-lactamase inhibitors, and monobactams (Jacoby 
and Munoz-Price, 2005; Bhavnani et al., 2006). The prevalence of ESBL-producing strains 
varies by geography (particularly in urban areas), type of hospital, and patient age. 
Importantly, there have been reports of ESBL-producing strains that also produce 
carbapenemases [K. pneumoniae carbapenemase (KPC), metallo-β-lactamase (VIM type 
and NDM1 type) and oxacillinase (OXA) carbapenemases] (Bradford et al., 2004) and thus 
became resistant to all β-lactam antibiotics. 
One of the emerging multidrug resistant HA- and CA-pathogens is A. baumannii, 
which was long thought to be relatively avirulent (Talbot et al., 2006). It is an increasingly 
common cause of ventilator-associated pneumonia. This microorganism has rapidly 
developed resistance to currently available antimicrobials via a wide range of mechanisms, 
including production of aminoglycoside-modifying enzymes, ESBLs, carbapenemases, and 
through changes in outer membrane proteins, penicillin-binding proteins, and 
topoisomerases (Gales et al., 2001; Bonomo and Szabo, 2006). It is not surprising, 
therefore, that Acinetobacter spp. have emerged as an important pathogen in the hospital 
settings and even in war zones. In many regions it is common to find strains of 
Acinetobacter spp. that are resistant to all aminoglycosides, cephalosporins, and 
fluoroquinolones (Landman et al., 2002; Vila and Pachón, 2008). During the last decade, 
MDR A. baumanii (MDRAB) have emerged to become a major phenotype in hospitals 
worldwide with a high mortality rate (Dijkshoorn et al., 2007; Peleg et al., 2008). 
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P. aeruginosa is a highly prevalent, opportunistic, invasive Gram-negative pathogen 
that is responsible for a wide range of severe HA-infections, including pneumonia, urinary 
tract infections, and bacteremia (Talbot et al., 2006). Importantly, this pathogen is 
intrinsically susceptible to only a limited number of antibacterial agents because of the low 
permeability of its cell wall (Lambert, 2002). Consequently, infections are often difficult to 
treat and may be life-threatening, particularly if the causative strain is drug resistant. In 
addition to its intrinsic resistance, P. aeruginosa has also acquired resistance via multiple 
mechanisms, including production of β-lactamases and carbapenemases, upregulation of 
multidrug efflux pumps, and cell wall mutations leading to a reduction in porin channels 
(Lambert, 2002). Recent studies have shown that phenotypic resistance associated with 
biofilm formation or the emergence of small-colony-variants may be important in the 
response of P. aeruginosa populations to antibiotic treatments (Cornelis, 2008; 
McCollister, 2011).  
Another important opportunistic human pathogen, an inhabitant of the oral cavity and 
the gastrointestinal and the genitourinary tracts of most healthy people, is Candida 
albicans. This microorganism is a polymorphic fungus, which transitions from budding 
yeast, pseudohyphae to true hyphae (Whiteway and Bachewich, 2007). The major virulence 
factors of C. albicans are proteinase secretion, hyphal formation, and adhesion and 
phenotype switching between two distinct types of cells, white and opaque (Yang, 2003). 
This switching of phenotypes contributes to a better adaptation of C. albicans to new host 
niches (Soll, 1988). White cells are much more virulent than opaque cells after intravenous 
infection. In a healthy host, C. albicans persists in equilibrium with the host’s microflora 
(McCallum, 2010). However, it can cause serious disseminated infections in critically ill or 
immunocompromised patients (Eggiman et al., 2003). Although resistance of C. albicans 
towards antifungal agents is less frequent than in many other species, an increasing number 
of resistant strains are emerging (Slutsky et al., 1985; Soll, 2002). 
In the past decade, the situation regarding antimicrobial resistance has worsened 
significantly. Increasing numbers of patients with immune deficiencies, such as HIV 
infection or receiving immunosuppressive therapy for cancers and organ transplants, mean 
that there is an ever increasing population at risk of invasive bacterial and fungal infection. 
In view of the successful spread and the notable virulence capacity of the MDR, XDR and 
PDR pathogens combined with their antibiotic resistance, novel treatment approaches are 
urgently required in order to control the infections.  
Innate immunity and antimicrobial peptides (AMPs) 
Innate immunity is the initial response of a host in defending against pathogen invasion 
(Janeway and Medzhitov, 2002; Beutler, 2004). The key features of an innate immune 
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response are that it is non-specific (broad-spectrum), rapid (often within minutes to hours) 
and conserved in its pattern of recognition, meaning that this system responds to pathogens 
in a generic way. Innate immunity can be constitutively expressed or be inducible and is 
characterized by mechanisms that adapt on an evolutionary timescale, rather than over a 
single lifespan. 
One of the central components of the innate immune response is the production of 
antimicrobial peptides (AMPs). AMPs are host-defense effector molecules present in 
virtually all life forms, including vertebrates, invertebrates, and plants (Zasloff, 2002), 
emphasizing their evolutionary importance in host defense. 
General characteristics of AMPs 
AMPs are typically small molecules generally composed of 8 - 50 amino acid residues, 
mostly in the usual L configuration, with a net positive charge of +2 to +6 (reviewed in 
Pukala et al., 2006; Hancock and Sahl, 2006; Conlon, 2011). They are cationic due to a 
high percentage of the basic amino acids, arginine, lysine, and histidine (Hancock and 
Diamond, 2000; Boman, 1998; Boman, 2003). Typically, more than 50% of an AMP’s 
amino acids are hydrophobic (Scott and Hancock, 2000). 
Structures of AMPs 
Although exceptions exist, the AMPs can be divided into three major classes based on 
their three dimensional structure (Boman, 2003): 
i) cationic peptides with and without cysteine amino acids that adopt an amphipathic 
ii) peptides with three disulfide bonds adopting a flat β-sheet conformation;
iii) peptides with a high percentage of certain amino acids particularly proline, 
arginine and tryptophane.
The α-helical peptides are the most common in nature and the most intensively studied 
of the three classes. 
Interaction of α-helical AMPs with biological membranes 
AMPs target the cell membranes and their action ultimately leads to bacterial death 
(Matsuzaki et al., 1989; Williams et al., 1990; Matsuzaki et al., 1991; Grant et al., 1992; 
Vaz Gomez et al., 1993; Blazyk et al., 2001; Yeaman and Yount, 2003). Membranes are the 
fundaments maintaining life through compartmentalization of cells and homeostasis. The 
α–helical conformation; 
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lipid headgroups vary in size, charge, and polarity and their composition constitutes the 
most important difference between eukaryotic and prokaryotic membranes (Fahy et al., 
2005) (Fig. 3). 
Fig. 3. Asymmetric lipid composition of cytoplasmic membranes from several bacteria compared 
with that of human erythrocytes. Membrane constituents ranging from anionic (left) to zwitterionic or 
neutral (right) are cardiolipin (CL), glycerophosphoglycerol (PG), glycerophosphoethanolamine (PE), 
glycerophosphocholine (PC), sphingomyelin (SM) and sterols (cholesterol or ergesterol) (ST). Key: 
open, E. coli; horizontal hatching, S. aureus; shaded, B. subtilis; checkered, C. albicans; solid, human 
erythrocyte (from Yeaman and Yount, 2003). 
Prokaryotic cytoplasmic membranes contain a high proportion of anionic lipids, such 
as glycerophosphoglycerols and cardiolipins, whereas these lipids are rarely found in 
mammalian cytoplasmic membranes. On the other hand, eukaryotic membranes possess a 
high proportion of zwitterionic lipids like glycerophosphoethanolamines, 
glycerophosphocholines, sphingomyelin (or ceramide phosphocholines) and the sterol 
lipids which are important for the dynamics and integrity of the lipid layers (de Almeida et 
al., 2003; Koronkiewicz and Kalinowski, 2004). 
The mode of action of AMPs on membranes is dictated by their physicochemical 
properties, mainly their cationic and amphipathic nature (Fig. 4) (Chapter 8), as well as by 
the intrinsic characteristics of the pathogens (Fig. 5). 
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Fig. 4. Interrelationship among structural determinants in AMPs. The activity and selectivity of the 
peptides on phospholipid membranes originates from several interdependent physicochemical 
parameters such as charge (cationicity), conformation (α-helicity), amphipathicity and hydrophobicity 
(modified from Yeaman and Yount, 2003). 
Two membrane architectures prevail in bacteria (Fig. 5, step 1). In Gram-negative 
bacteria, an outer membrane, rich in PG, lipopolysaccharide (LPS) and magnesium ions 
(Mg2+) is followed by a 2 nm thick peptidoglycan wall that protects the cytoplasmic 
membrane. In Gram-positive bacteria, the cytoplasmic membrane is directly surrounded by 
a 20 to 40 nm thick peptidoglycan wall featuring anionic lipoteichoic acid groups that 
provide a negatively charged surface. The relevant target of AMPs is the cytoplasmic 
membrane (Fig. 5, step 3). 
Bacterial membranes are characterized by a highly asymmetric lipid charge 
distribution generating a transmembrane potential. This electrical potential is necessary for 
several energy-dependent catalytic and transport processes. Thus, the presence of large 
inside-negative transmembrane potentials in respiring prokaryotic cells but not in 
erythrocytes (Matsuzaki et al., 1995a) leads to selective electrostatic interactions between 
bacterial membranes and AMPs. 
The AMPs are usually unstructured in an aqueous environment but adopt a stable 
α-helical conformation upon contact with the lipid bilayer. At low concentrations the AMPs 
lie on the membrane surface. It has been reported that under certain conditions, the AMPs 
can aggregate or assemble together even before binding to the membrane (Urrutia et al., 
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1989). After reaching a “threshold” concentration of peptide (Fig. 5, step 4), defects in the 
membrane structure appear and leakage occurs through the membrane in different manners 
according to three models: 
Fig. 5. Proposed mechanisms of action for α-helical AMPs on Gram-negative (G-) and Gram-positive 
(G+) bacteria: peptide insertion and membrane permeability models. Kindly provided by Prof. A. 
Tossi, University of Trieste, Italy.  
The barrel-stave pore model (Fig. 5, step 5a): This was the first mechanism proposed 
to explain killing of bacteria by AMPs (Ehrenstein and Lehar, 1977). Initially, the AMPs 
accumulate as monomers alongside the bacterial surface. When concentration is increased, 
the peptide assembly changes its orientation to transmembrane thus forming a classical 
pore. The tightly packed peptide assembly forms a barrel-like structure spanning the 
membrane, in which the hydrophobic regions of the inserted peptides align with the lipid 
core region of the bilayer and the hydrophilic peptide regions constitute the pore lining. 
Progressively, new AMPs are recruited and, through a process of self-aggregation, the pore 
size increases. 
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The carpet model (Fig. 5, steps 5c and 5d): This model was proposed on the basis of 
studies with dermaseptin S (a cationic amphipathic α-helical frog peptide from 
Phyllomedusa sauvagei) (Pouny et al., 1992). Locally, AMPs accumulate on the lipid 
bilayer surface, in an orientation that is parallel to the membrane during the process. When 
a high peptide concentration is attained, the membrane is weakened by unfavorable 
energetic influences and thinning of the membranes occurs. The AMPs then re-orient and 
form peptide aggregates that intercalate into the membrane and disrupt it by producing 
micelles in a detergent like manner. 
The toroidal wormhole model (Fig. 5, step 5b): This mechanism combines components 
of the barrel-stave (Fig. 5, steps 5c and 5d) and carpet models (Fig. 5, step 5a) (Hancock 
and Chapple, 1999). The AMPs assemble with intercalated anionic lipid headgroups to 
compensate for the charge repulsion (Wieprecht et al., 2000) and form pores (Duclohier, 
1994; Matsuzaki et al., 1995b; Ludtke et al., 1996). The direct involvement of lipids in the 
pore structure leads to a toroidal-shaped hole. The pores have a larger radius than the 
classical pore (Fig. 5, step 5a). As a consequence of this pore formation, the peptides 
enhance the lipid translocation rate (Matsuzaki et al., 1996). This can dissipate the electric 
potential and uncouple the respiration of cells (Westerhoff et al., 1989; Wieprecht et al., 
2000; Glaser et al., 2005). 
Although disruption of membrane integrity is the principal mechanism of action of 
AMPs, some members can cross the cell membrane without causing damage to the lipid 
bilayer (Fig. 5, step 6). For example, AMPs rich in arginine, such as buforin II isolated 
from Bufo bufo gargarizans (Park et al., 1996), are reported to translocate across both the 
cellular and nuclear membranes (Futaki et al., 2001). Once inside the cell, the AMPs can 
bind to DNA and RNA targets resulting in inhibition of cell-wall synthesis and enzymatic 
activity (Fig. 5, step 7) (Brogden, 2005). 
The AMPs, due to their markedly different and highly destructive mode of action, are 
usually active against microorganisms that are resistant to currently licensed antibiotics. 
The plethora of cationic AMPs is a consequence of a co-evolution between host organisms 
and microbes which has shaped the diversity of the AMPs (Peschel and Sahl, 2006). 
Despite the fact that bacteria have had a huge time-span to adapt to their killing 
mechanisms, the development of resistance against AMPs has been shown to be a much 
slower process than against conventional antibiotics (Ge et al., 1999; Perron et al., 2006). 
Since the primary target of AMPs is the cell membrane, the pathogen would have to 
redesign its whole cell membrane – a very lengthy process – in order to develop a 
resistance against their action. Therefore, it is very unlikely for a resistance phenomenon to 
arise rapidly. 
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AMPs in frogs 
Anurans (frogs and toads) are confined, for at least part of their life cycle, to a warm 
and moist environment that is conductive to the growth of potentially harmful bacteria and 
fungi. Therefore, these animals have evolved innate defenses to protect the skin of the 
organism from invasion by pathogenic microorganisms. Frogs have the full complement of 
the immune systems found in higher vertebrates including both adaptive and innate 
immunity (Du Pasquier et al., 1989; Woodhams et al., 2007). They are poikilothermic 
organisms whose internal temperature relies heavily upon the temperature of their 
environment. In addition to being activated too slowly to provide sufficient protection for 
infections in the skin (Simmaco et al., 1998), the adaptive immune system of frogs is 
temperature-dependent and suppressed if temperature decreases. Similarly, humoral innate 
immunity, including complement mediated effects, is also temperature-dependent (Green 
and Cohen, 1977; Simmaco et al., 1998). Therefore, the specialized innate immune 
defenses of skin (being relatively temperature-independent) are essential in protecting the 
frogs against various pathogens. Because it is the first to respond, the innate immune 
system plays a key role in the host’s ability to avoid the progression of a potential pathogen 
from a threat to an infection (Scott and Hancock, 2000). 
Innate immune defenses in amphibians include: pattern-recognition receptors (PRRs), 
AMPs (Simmaco et al., 1998; Rollins-Smith et al., 2005), a complement lytic system 
(Green and Cohen, 1977), cytokines and various types of cells, such as phagocytic 
macrophages, dendritic cells and granulocytes (Manning and Horton, 1982), natural killer 
cells (NK cells) (Horton et al., 1996), neutrophils, eosinophils, mast cells, basophils and 
epithelial cells (Hancock and Diamond, 2000) (Fig. 6). 
Fig. 6. Components of the innate immunity in amphibians. 
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In general, AMPs are encoded by single genes or homologous gene families. These 
gene families are located in clustered arrangements in the genome and mapped to syntenic 
(co-localized genetic loci) chromosomal regions, which suggests co-evolution of different 
subclasses of AMPs (Scott and Hancock, 2000; Bals, 2000). The expression of the AMPs 
during amphibian development correlates with metamorphic changes and is induced by 
thyroid hormone treatment (Reilly et al., 1994; Ohnuma et al., 2006). AMPs are generally 
found in cells of the granular glands in adult frog skin (Fig. 7) (Hoffmann et al., 1983a; 
Hoffmann et al., 1983b), and sometimes in the mucosa of the gastrointestinal tract (Moore 
et al., 1991; Wang et al., 1998). Larval skin is devoid of granular glands able to synthesize 
and secrete AMPs and there is no evidence for the expression of AMPs during pre and pro-
metamorphic stages (Pollet, 2010). Afterwards, these glands develop rapidly and become 
functional at the climax of metamorphosis. 
Fig. 7. Stimulated amphibian granular glands secrete AMPs. Dermal granular glands are surrounded 
by myoepithelial cells that contract upon stimulation of local α-adrenergic nerve terminals, causing 
secretion of protective AMPs through a gland duct onto the epidermal surface. (A) Schematic 
depiction of an amphibian dermal granular gland filled in with AMP granules (depicted in pink); 
(B) A hematoxylin and eosin stained skin section of X. laevis 24h after injection with amphibian 
phosphate buffer saline with active secretion of one granular gland (G) and two mucus glands (M) 
through gland ducts (indicated by solid and open arrows, respectively). The scale bar is equivalent to 
500 µm (Gammill et al., 2012). 
Adult frogs have two types of skin glands that are located in the dermis: granular and 
mucus glands (Duellman and Trueb, 1986; Stebbins and Cohen, 1995; Shepherd et al., 
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1998). Both types of glands may occur in aggregations, or as macroglands visible as raised 
areas of skin, described variously as parotid glands or dorsolateral folds in some species 
(Duellman and Trueb, 1986; Tyler, 1987). Many frog species lack these aggregations, and 
in these species glands are distributed evenly throughout the integument (Duellman and 
Trueb, 1986; Steinborner et al., 1997). The mucus glands are mainly responsible for 
secreting components to keep the skin continuously moist (Duellman and Trueb, 1986; 
Stebbins and Cohen, 1995), which is vital for efficient respiration and thermoregulation. 
The granular glands are large multinucleated granule-filled cells, surrounded by myocytes 
and innervated by sympathetic fibers (Simmaco et al., 1998). They are the main anatomical 
structures in which a variety of biologically-active AMPs are stored (Duellman and Trueb, 
1986; Erspamer, 1994; Shepherd et al., 1998). 
AMPs from the different frog families are synthesized as large precursor peptides 
(prepropeptides). All have a common “signal-spacer-bioactive peptide” organization with a 
conserved signal peptide followed by acidic spacer sequences flanking the AMPs 
sequences (Vanhoye et al., 2003). After synthesis, the signal sequence is removed from the 
precursor peptides by an endoprotease. Adrenergic stimulation of myocytes, such as by 
electrical excitation, administration of norepinephrine, injury, predation, handling or other 
stressors (Tyler et al., 1992; Rollins-Smith et al., 2002; Woodhams, 2003), causes 
compression of the peptide-containing serous cells. The cells discharge the contents of the 
storage vesicles by a holocrine-like mechanism involving the rupture of the glands (Moore 
et al., 1992; Flucher et al., 1986). 
As a result, secretions contain not only AMPs but also cytosolic components and intact 
polyadenylated mRNAs encoding the peptides (Chen et al., 2003). Within 15-30 minutes, 
the peptides are cleaved and deactivated on the skin surface (Resnick et al., 1991; 
Steinborner et al., 1997; Bowie et al., 1999). This is assumed to be a means of 
detoxification in order to prevent self-injury, as AMPs are also cytotoxic at higher 
concentrations. Some microorganisms, which are an abundant component of the skin 
microbiota of healthy frogs such as Proteus mirabilis and Aeromonas hydrophilia, secrete 
proteolytic enzymes that inhibit the antimicrobial activity by degrading the skin peptides 
(Schadich, 2009; Schadich and Cole, 2009). After depletion of the granular glands, the 
deposits of skin peptides may be restored within 6 days to 2 weeks (Erspamer, 1994; 
Rollins-Smith et al., 2005). 
Distribution of AMPs in different frog families 
In the Anuran Defense Peptide Database, the AMPs constitute the most common class 
based on the classification of peptides by biological function (Novkovic et al., 2012). 
AMPs have been isolated from skin secretions and/or skin extracts from frog species 
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belonging to both the primitive Archeobatrachia and the more highly-derived Neobatrachia 
(Pukala at el., 2006; Conlon, 2011) (Fig. 8). 
However, not all frogs synthesize and release cytotoxic peptides into their skin 
secretions (Conlon, 2010) making the distribution of dermal AMPs among anuran families 
sporadic. In some species the production of AMPs is seasonal and influenced by thyroid 
hormone status (Ohnuma et al., 2006), and may be either stimulated by exposure to bacteria 
(Matutte et al., 2000) or inhibited by environmental factors such as contact with pesticides 
(Davidson et al., 2007). 
Fig. 8. Phylogeny of anuran amphibians (modified from Konig et al., 2012). 
Among the more ancient Archeobatrachia, α-helical peptides with antimicrobial 
activity have been identified in species belonging to the families Leiopelmatidae, Alytidae, 
Bombinatoridae, and Pipidae (Table 1), but are not present in those species examined to 
date that belong to the families Pelobatidae and Scaphiopodidae (Conlon et al., 2009; 
Conlon, 2011). 
Leiopelmatidae
Rhinophrynidae
Alytidae
Bombinatoridae
Pelodytidae
Scaphiopodidae
Pelobatidae
Megophryidae
Pipidae
Archeobatrachia 
Neobatrachia 
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Table 1. Examples of AMPs from skin secretions of frogs of the Archaeobatrachia. 
Family Genus Species Peptides  
Leiopelmatidae Ascaphus Ascaphus truei ascaphins 
Alytidae Alytes Alytes obstetricans alyteserins 
Bombinatoridae Bombina Bombina bombina bombinins 
Pipidae Xenopus Xenopus laevis 
magainins* 
PGLa* 
CPF* 
XPF* 
*- described in section 6 
A similar sporadic distribution of AMPs is found in the more highly derived 
Neobatrachia. Species, belonging to the six families Discoglossidae, Hyperoliidae, Hylidae, 
Myobatrachidae, Ranidae, and Leptodactylidae release AMPs into their skin secretions. 
However, AMPs have not been detected in those species analysed to date belonging to the 
families Bufonidae, Ceratophyridae, Eleutherodactylidae, Microhylidae, Pyxicephalidae 
and Rhacophoridae in the Neobatrachia (Conlon et al., 2009; Conlon, 2011). 
Frogs of the Pipidae family 
Pipid frogs are indisputably basal, belonging to the phylogenetically more ancient 
Archaeobatrachia (Cannatella and de Sa, 1993) (Fig. 8) but show multiple adaptations 
befitting their habitat – webbed feet, flattened body, and a lateral line organ system, visible 
as stitches on the body, to detect wave motion in water (Cannatella and Trueb, 1988). The 
frogs in the family Pipidae are exclusively aquatic. However, they need to rise to the 
surface to breathe air because they have lungs and not gills. Pipids are called clawed frogs, 
because they are the only amphibians to have actual claws. Pipid frogs have powerful legs 
for swimming and lunging after food and also use the claws on their feet to tear pieces of 
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large food. These frogs lack a tongue and vocal cords, instead having bony rods in the 
larynx that help produce clicking sound in a radically different way from the other frogs 
(Rabb, 1960; Yager, 1996). 
The extant clawed frogs of the family Pipidae comprise five genera. Pipa is found in 
South America with the other four genera Hymenochirus, Pseudhymenochirus, Silurana, 
and Xenopus in sub-Saharan Africa. They are proposed to have diverged approximately 
100 million years ago (MYA) (Cannatella and de Sa, 1993; Roelants et al., 2007). 
Pipa, Pseudhymenochirus and Hymenochirus are united in the sub-family Pipinae. 
There are 7 species in genus Pipa, a single species in the genus Pseudhymenochirus – 
P. merlini, and 4 species – H. boettgeri, H. boulengeri, H. curtipes and H. feae in genus 
Hymenochirus. The number of chromosomes in Pipinae varies (2n = 20 for P. carvalhoi; 
2n = 30 for P. parva and 2n = 24 for H. boettgeri) (Canatella and Trueb, 1988; Cannatella 
and de Sa, 1993). 
Silurana and Xenopus are united in the subfamily Xenopodinae that is monophyletic 
based upon nucleotide sequences of the mitochondrial genes. However, the use of two 
genera “underscores trenchant biological and historical differences between the two clades” 
(Evans et al., 2004). The cytogenetics and evolutionary history of this taxon are complex 
(de Sa and Hillis, 1990; Kobel and Du Pasquier, 1991; Kobel et al., 1996; Evans, 2008). 
The species distribution can best be explained if it is assumed that two different modes of 
speciation have acted on the Xenopodinae (Fig. 9). One is bifurcating speciation such as 
allopatric speciation when two populations of an ancestral species become geographically 
separated (de Queiroz, 1998). The other one is reticulate sympatric speciation involving 
genome duplication by allopolyploidization, in which genetic combination between two 
ancestral species results in a descendant with the full complement of chromosomes from 
both ancestors (Kobel, 1996). 
Fig. 9. Modes of speciation acting on subfamily Xenopodinae (Conlon et al., 2012).
Ancestor 1
Ancestor 2
Allopolyploid descendant 
Ancestor
Descendant 1
Descendant 2
Bifurcating speciation
Speciation by allopolyploidization
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An evolutionary scenario is proposed in which a diploid ancestor diverged into 
Silurana and Xenopus between 53 and 64 MYA (Fig. 10).  
Fig. 10. An evolutionary scenario for subfamily Xenopodinae, including species with different ploidy 
level (2n). The diploid Xenopus species (2n = 18) has either disappeared or has not yet been 
discovered (indicated by X). The figure is based upon the results of comparisons of the nucleotide 
sequences of mitochondrial genes provided by Evans et al. (2004). 
The genus Silurana comprise at least three extant species – S. tropicalis has retained 
diploid status with chromosome number 2n = 20, whereas more recent polyploidization 
events have produced S. epitropicalis and at least two other incompletely characterised 
tetraploid species with 2n = 40 chromosomes (Tymowska, 1991; Tymowska and Fischberg, 
1982). Between 21 and 41 MYA, a genome duplication event in the Xenopus lineage 
produced the ancestor of all the extant tetraploid Xenopus species with 2n = 36 
chromosomes (Fig. 10). These species have been divided further into three groups on the 
basis of their morphology, advertisement calls, and proposed evolutionary history (Evans, 
2008; Evans et al., 2004; Tobias et al., 2011): the laevis group includes X. laevis, X. gilli,  
X. largeni, X. petersii, and X. victorianus; the muelleri group includes X. muelleri,  
X. borealis and X. clivii; and the fraseri group includes X. fraseri and X. pygmaeus. It 
would appear that the original Xenopus diploid species (2n = 18) has either disappeared or 
has not yet been discovered (Fig. 10). 
At least two further allopolyploidization events produced two groups octoploid frogs 
comprising 7 species and in a similar fashion, genetic combination between the octoploid 
(2n = 72) and the tetraploid species produced the 2 dodecaploid (2n = 108) species 
(Fig. 11). 
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Fig. 11. A simplified schematic representation of the origin of the octoploid and dodecaploid species 
in the genus Xenopus. The figure is based upon the results of comparisons of the nucleotide sequences 
of mitochondrial genes provided by Evans et al. (2004) (Conlon et al., 2012). 
AMPs in X. laevis 
X. laevis was the first species in which amphibian AMPs were unambiguously 
identified (Zasloff, 1987). These AMPs provide a basis for comparison of the amino acid 
sequences of novel AMPs isolated from other species belonging to Pipidae family 
(Table 2). 
Table 2. Peptides isolated from X. laevis. 
Peptide name Peptide sequence 
Magainin 1 
Magainin 2 
PGLa 
CPF-1 
XPF-1 
GIGKFLHSAGKFGKAFVGEIMKS 
GIGKFLHSAKKFGKAFVGEIMNS 
GMASKAGAIAGKIAKVALKALa 
GLASFLGKALKAGLKIGAHLLGGAPQQ 
GWASKIGQTLGKIAKVGLQGLMQPK 
C-terminal α-amidation is denoted by a
Allopolyploidization
X. longipes 
2n = 108
Tetraploid 3 
Tetraploid 4 
Octoploid
ancestor II 
X. itombwensis 
X. lenduensis 
X. vestitus 
X. wittei 
2n = 72 
Allopolyploidization
X. ruwenzoriensis 
2n = 108
Tetraploid 1 
Tetraploid 2 
Octoploid
ancestor I 
X. amieti 
X. andrei 
X. boumbaensis 
2n = 72 
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The AMP genes in X. laevis display the stereotypical structure “signal-spacer-bioactive 
peptide” with a partially conserved 20 amino acid signal peptide (Hunt and Barker, 1988; 
Konig and Bininda-Emonds, 2011) (Fig. 12). 
Magainin MFKGLFICSLIAVICANALP 
XPF-1  MYKGIFLCVLLAVICANSLA 
PGLa  MYKQIFLCLIIAALCATIMA 
Fig. 12. Alignment of the AMP signal peptides in X. laevis. The shaded residues have been conserved 
in the three signal peptides. 
The prepropeptide for PGLa is one of the simplest comprising only 64 amino acids. In 
contrast, the genes for magainin- and caerulin-precursor in X. laevis show tandem repeats 
of the spacer-peptide subunits, a notable feature for many archaeobatrachian AMP genes 
(Zasloff, 1987; Hunt and Barker, 1988; Gibson et al., 1991). The significant structural 
similarity in the N-terminal pro-regions of the precursor, as well as the repeats of the 
spacer-peptide segments, suggests that the AMPs in X. laevis may have evolved from a 
common ancestral gene by a series of duplication events and exon shuffling (Hunt and 
Barker, 1988; Kuchler et al., 1989). 
Magainins  
The name magainin comes from Hebrew word magain which means “a shield”. The 
magainin prepropeptide is predicted to be 303 residues long. It contains one magainin 1 
sequence and five magainin 2 sequences flanked by almost identical acidic spacers 
(Fig. 13). The two closely related peptides – magainin 1 and 2, differ by two residues at 
positions 10 and 22 (Table 2) and exhibit a net charge of +4 at neutral pH (Zasloff, 1987; 
Giovannini et al, 1987). Biophysical studies have shown that these peptides are 
unstructured in solution, form an antiparallel dimer of amphipathic helices upon binding to 
the bacterial cell membrane, and disrupt the membrane via toroidal-type pore formation 
(described in Chapter 1, Interaction of α-helical AMPs with biological membranes; Fig. 5, 
step 5b) (Matsuzaki, 1999). 
Both magainin 1 and 2 have low haemolytic activity, inhibit growth of numerous 
species of bacteria and fungi and induce osmotic lysis of protozoa (Zasloff, 1987). Amino 
acid deletions in the N-terminal region (residues 1-14) result in the complete loss of 
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antimicrobial activity (Cuervo et al., 1988). In contrast, analogues with deletions in the C-
terminal region (Ala-15, Cly-18 or Clu-19) have equal or even increased antimicrobial 
activity.  
MFKGLFICSLIAVICANALPQPEASA 26 
 DEDMDEREVRGIGKFLHSAGKFGKAFVGEIMKSKRDAEAVGPEAFA 72 
DEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFA 128 
 DEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFA 174 
 DEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFA 210 
 DEDFDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFA 256 
 DEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVDDRRWVE 303 
Fig. 13. Prepropetide sequence for magainin 1 and 2 peptides deduced from X. laevis skin cDNA 
library. Magainin 1 peptide is underlined. Spacers with almost identical sequences are flanking the 
sequences of the magainin 1 (one copy) and magainin 2 (five copies) depicted in bold (Terry et al., 
1988). 
Because magainins were among the first amphibian AMPs to be identified, there has 
been considerable research associated with their structure and mechanism of action. Thus, 
magainin 2 shows potent in vitro activity against E. coli (Zasloff et al., 1988) and S. aureus 
(Giacometti et al., 2000), and is also active, but at higher concentrations, against 
P. aeruginosa (Zasloff et al., 1988; Giacometti et al., 2000). Synthetic analogues have been 
developed in order to maximize the antimicrobial effects and minimize cytotoxicity. An 
extensive structure-activity investigation on magainin 2 resulted in the development of the 
22 amino-acid, lysine-containing, linear analogue MSI-78 or pexiganan acetate with broad-
spectrum antibacterial activity against Gram-positive and Gram-negative, anaerobic and 
aerobic bacteria but low cytotoxicity to mammalian cells (Ge et al., 1999). The bactericidal 
activity of pexiganan against aerobes and anaerobes is equivalent to that of ofloxacin 
(Fuchs et al., 1998). In addition, it is active against some clinical isolates of the 
opportunistic yeast pathogen C. albicans. Pexiganan showed distinct promise as a topical 
anti-infective agent for treatment of infected foot ulcers in diabetic patients and as a 
possible treatment for impetigo (Ge et al., 1999; Lipsky et al., 2008) but did not receive 
FDA approval. 
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Peptidyl-glycine-leucine-amide (PGLa) 
Initially, peptidyl-tyrosine-leucine-amide (PYLa) was predicted from the screening of 
a X. laevis skin cDNA library for clones encoding the precursor of caerulein (Hoffmann et 
al., 1983a). It was furthermore shown that in total polyadenylated mRNA isolated from 
X. laevis, the PYL precursor mRNA is one of the most abundant components (Hoffman et 
al., 1983b). It was concluded that PYLa could form a membrane-active amphipathic helix 
similar to peptides with bacteriostatic, cytotoxic and/or lytic properties. However, the 
natural counterpart of PYLa named PGLa was isolated two years later from skin secretions 
of X. laevis by the same group (Andreu et al., 1985). PGLa is a 21-residue peptide, lacking 
the N-terminal tripeptide of PYLa, with a net charge of +5 at neutral pH because of four 
lysine residues and the amino group at the N-terminal glycine (Table 2). It also has an 
amidated C-terminus that provides resistance to the action of carboxypeptidases (Lohner 
and Prossnigg, 2009). Biophysical studies indicate that PGLa is unstructured in aqueous 
solution but is predominantly α-helical in the presence of negatively-charged lipid bilayers 
or micelles (Jackson et al., 1992; Latal et al., 1997; Bechinger et al., 1998). 
PGLa exhibits broad spectrum of antimicrobial activity against Gram-positive and 
Gram-negative bacteria, fungi and protozoa but has minimal toxicity against eukaryotic 
cells (Bevins and Zasloff, 1990). In particular, PGLa shows potent in vitro activity against 
E. coli, S. aureus, and S. pyogenes, and is also active, but at higher concentrations, against 
P. aeruginosa, Saccharomyces cerevisiae, and C. albicans  (Soravia et al., 1988). PGLa 
forms heterodimers with magainin 2 resulting in synergistic membrane disruption and 
antimicrobial activities (Westerhoff et al., 1995; Matsuzaki et al., 1998). Interestingly, 
PGLa adopts different orientations in the bacterial cell membrane, from a surface aligned 
monomeric state, via tilted dimers to an upright inserted state (described in Chapter 1, 
Interaction of α-helical AMPs with biological membranes), depending on peptide 
concentration and interactions with magainin 2 (Tremouilhac et al., 2006a; Tremouilhac et 
al., 2006b). 
Xenopsin precursor fragment (XPF) 
The octapeptide xenopsin and the related XPF are bioactive peptides derived from a 
processing of a single precursor molecule (Gibson et al., 1986) (Table 2). The precursor 
protein contains xenopsin at the COOH terminus (Sures and Crippa, 1984). Both 
components can be isolated from extracts of X. laevis skin (Araki et al., 1973), as well as 
from specific granular cells in the lower esophagus and stomach. Xenopsin-like 
immunoreactivity, but not XPF, was also detected in tall, thin cells of the duodenum and in 
club-shaped cells of the large intestine (Sadler et al., 1992). XPF exhibits antimicrobial 
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activities against Gram-positive and Gram-negative bacteria comparable to those of the 
magainins (Soravia et al., 1988). 
Caerulein-precursor fragment (CPF) 
Caerulein is a decapeptide whose amino acid sequence shows a close resemblance to 
the C-terminal bioactive sites of the mammalian gastrointestinal hormone cholecystokinin 
(CCK). It was originally isolated from the skin of the Australian frog Litoria caerulea, 
formerly Hyla caerulea (Anastasi et al., 1967). Caerulein-related peptides have been 
identified in the skins of X. laevis as well as in multiple species in the families Hylidae, 
Leptodactylidae, Hyperoliidae, and Ranidae (Bowie and Tyler, 2006). Although the amino 
acid sequence at N-terminal region of the caeruleins is variable, most of the peptides 
contain a C-terminal sequence that is common to the mammalian peptides CCK and gastrin 
(Gly-Trp-Met-Asp-Phe.NH2) and so exert similar biological effects (Erspamer and 
Melchiorri, 1983). It has been proposed that the genes encoding caeruleins in Xenopus and 
Litoria arose independently with the former arising from a duplication of the CCK gene and 
the latter from a duplication of the gastrin gene (Roelants et al., 2010). As with 
proxenopsin, the biosynthetic precursor of caerulein contains the additional bioactive 
peptide CPF. The structure of a CPF was predicted in cloning experiments using a cDNA 
library from X. laevis skin (Wakabayashi et al., 1985) (Table 2). Subsequent cDNA cloning 
studies demonstrated that the X. laevis genome contains multiple caerulein/CPF genes, 
containing one, three, or four copies of caerulein (Richter et al., 1986; Gibson et al., 1986; 
Giovannini et al., 1987). The antimicrobial activity of CPF has not been studied in detail. 
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Research aim, objectives and thesis outline 
Until recently, the diploid frog S. tropicalis (Ali et al., 2001), the tetraploid frog 
X. laevis (Zasloff, 1987; Giovannini et al., 1987), and the octoploid frog X. amieti (Conlon 
et al., 2010) were the only representatives of the Pipidae family from which dermal AMPs 
had been isolated and characterized. The aim of this thesis was to isolate systematically, 
purify and characterize AMPs with therapeutic potential from skin secretions of species of 
African clawed frogs with different level of polyploidy belonging to the Pipidae family. 
The specific objectives of the study were: 
 To isolate and purify AMPs from skin secretions of various polyploid frog species
from the Pipidae family.
 To determine the structures of the newly discovered AMPs by automated Edman
degradation combined with mass spectrometry and amino acid composition
analysis.
 To characterize the in vitro activity of the purified AMPs against various reference
strains and clinical isolates of a range of microorganisms.
 To investigate the possible application of the AMPs as classification tools to study
the taxonomic relation of different frog species and genera.
 To analyse whether genome duplications affect the multiplicity of the AMPs in the
skin secretions.
 To determine the extent to which interspecies hybridization affects the number of
the AMPs in skin secretions from hybrid frogs.
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The following species have been studied: 
African clawed frogs 
Pipidae 
Pipinae Xenopodinae sub-family 
order 
family 
Anura 
genus Hymenochirus Xenopus Silurana 
2n = 36 2n = 20 2n = 72 2n = 40 ploidy 
“S. new  
tetraploid 1”  
H. boettgeri X. andrei X. clivii 
X. borealis 
species X. muelleri 
West 
X. muelleri
X. muelleri 
x 
X. laevis 
interspecies 
hybrid 
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The isolation and structural characterization of AMPs in norepinephrine-stimulated 
skin secretions of X. borealis and X. clivii is described in Chapter 2 and Chapter 3 
respectively. Additionally, the effect of the purified peptides on the growth and viability of 
reference strains of clinically relevant microorganisms was investigated. 
Chapter 4 presents results from a comparative analysis of skin secretions from the 
incompletely characterized “Silurana  new tetraploid 1” and the octoploid  X. andrei. The 
primary structures and physicochemical properties of the AMPs are determined and the 
antimicrobial activities are tested against a range of microorganisms. The multiplicity of 
AMPs in each species was compared to those described in Chapters 2 and 3, and in 
X. laevis. 
A comparative study of the AMPs in skin secretions from two discrete populations of 
X. muelleri is presented in Chapter 5. The antimicrobial potential of the newly identified 
peptides was evaluated using reference bacterial strains. In addition, a comparison of the 
primary sequences of the AMPs sets was performed to clarify the taxonomic relationship 
between the two frog populations. 
The AMP profile from Hymenochirus boettgeri, a species in the subfamily Pipinae, 
was studied in Chapter 6. A novel family of five structurally-related peptides, termed the 
hymenochirins, is described and their antimicrobial activities were determined against a 
range of reference strains of microorganisms. 
The study in Chapter 7 was focused on F1 hybrid X. laevis x X. muelleri frogs. The 
AMP profile in skin secretions from female hybrid frogs is compared with the 
corresponding profiles from both parent species X. laevis and X. muelleri (Chapter 5) in 
order to determine whether hybridization affects AMP multiplicity. 
This thesis is completed by a general discussion (Chapter 8) of the results reported in 
Chapters 2-7. The potential of the newly characterised AMPs as candidates for 
development into therapeutic agents, as well as their application as reliable markers to 
elucidate the evolutionary relations among frogs from different genera and species is 
outlined. In addition, the fate of the duplicated AMPs genes is discussed. Moreover, the 
suitability of the interspecies hybrids as a model to study the mode of inheritance of the 
AMPs genes is described. 
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ABSTRACT 
Nine peptides with differential growth inhibitory activity against Escherichia coli and 
Staphylococcus aureus were isolated from norepinephrine-stimulated skin secretions of the 
tetraploid frog Xenopus borealis Parker, 1936 (Pipidae). Structural characterization of the 
peptides demonstrated that they were orthologous to magainin-2 (1 peptide), peptide 
glycine-leucine-amide, PGLa (2 peptides), caerulein-precursor fragments, CPF (4 peptides) 
and xenopsin-precursor fragments, XPF (2 peptides), previously isolated from X. laevis and 
X. amieti. In addition a second magainin-related peptide 
(G**KFLHSAGKFGKAFLGEVMIG) containing a two amino acid residue deletion 
compared with magainin-2 was identified that had only weak antimicrobial activity. The 
peptide with the greatest potential for development into a therapeutically valuable anti-
infective agent was CPF-B1 (GLGSLLGKAFKIGLKTV GKMMGGAPREQ) with 
MIC = 5 µM against E.coli, MIC = 5 µM against S. aureus, and MIC = 25 µM against 
Candida albicans, and low hemolytic activity against human erythrocytes 
(LC50 >200 µM). This peptide was also the most abundant antimicrobial peptide in the 
skin secretions. CPF-B1 was active against clinical isolates of the nosocomial 
pathogens, methicillin-resistant S. aureus (MRSA) and multidrug-resistant Acinetobacter 
baumannii (MDRAB) with MIC values in the range 4 - 8 µM. 
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1. Introduction
The emergence of pathogenic strains of bacteria and fungi with resistance to commonly
used antibiotics has necessitated a search for new types of antimicrobial agents (Norrby et 
al., 2005; Livermore, 2009). Peptides with broad spectrum antimicrobial activity 
synthesized in granular glands in the skin of several, although by no means all, species of 
Anura (frogs and toads) represent a source of potential therapeutically valuable anti-
infective drugs (Rinaldi, 2002; Conlon et al., 2007). Despite the fact that the African clawed 
frog Xenopus laevis was the first amphibian species in which such peptides were identified 
(Zasloff, 1987), relatively little work has been done to exploit other species belonging to the 
family Pipidae as a source of  pharmaceutically useful antimicrobial compounds. Analysis 
of  X. laevis skin secretions has led to the isolation and characterization of magainin-1 and -
2, peptides that are encoded by the same gene (Giovannini et al., 1987; Zasloff, 1987) and 
multiple antimicrobial peptides with varying potencies and specificities that are derived 
from the post-translational processing of the biosynthetic precursors of, caerulein, xenopsin, 
and peptide glycine-leucine-amide (Gibson et al., 1986; Richter et al., 1986; Soravia et al., 
1988; James et al., 1994) . A comparison of the amino acid sequences of the biosynthetic 
precursors of procaerulein, promagainin, and proxenopsin, deduced from the nucleotide 
sequences of cDNAs, reveals significant structural similarity in the N-terminal regions of 
the precursors suggesting that the peptides may have evolved from a common ancestral 
gene by a series of duplication events (Hunt and Barker, 1988; Kuchler et al., 1989). In 
common with the vast majority of frog skin antimicrobial peptides, all the active 
components isolated from X. laevis have the propensity to form an amphipathic -helical 
conformation over at least part of their structures in a membrane-mimetic solvent such as 
50% trifluoroethanol-water or in the presence of an anionic phospholipid vesicle (Powers 
and Hancock, 2003). 
The clawed frogs comprise 32 species distributed in five genera (Hymenochirus, Pipa, 
Pseudhymenochirus, Silurana, and Xenopus) within the family Pipidae (Frost, 2010). The 
taxonomic status of Silurana is controversial as cladistic analyses based upon nucleotide 
sequences of mitochondrial genes strongly support the monophyly of Xenopus + Silurana 
but it was pointed out that the use of two genera "underscores trenchant biological and 
historical differences between the two clades" (Evans et al., 2004). The genus Xenopus 
currently contains 18 species although several additional, as yet unnamed, species have 
been reported (Evans et al., 2004). The cytogenetics of the African clawed frogs is complex 
(Kobel and Du Pasquier, 1991). S. tropicalis with 2n = 20 chromosomes is the only diploid 
species (de Sa and Hillis, 1990). A putative whole genome duplication within the Silurana 
lineage has given rise to the tetraploid species S. epitropicalis (Tymowska and Fischberg, 
1982), and a duplication within the Xenopus lineage has produced tetraploid  species that 
include X. laevis and Xenopus borealis with 2n = 36 chromosomes (Evans et al., 2004). At 
least one further genome duplication event within the tetraploid lineage has given rise to 
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octoploid species that include X. amieti, and further independent polyploidizations 
involving the combination of tetraploid and octaploid genomes have produced the 
dodecaploid species X. ruwenzoriensis and X. longipes (2n = 108) (Evans et al., 2004). 
In addition to X. laevis, antimicrobial peptides have been isolated only from 
S. tropicalis (Ali et al., 2001) and X. amieti (Conlon et al., 2010). Consequently, the aim of 
the present study was to identify novel peptides with therapeutic potential as anti-infective 
agents and to gain insight into the molecular evolution of the diverse array of Xenopus 
antimicrobial peptides by isolating and characterizing the components that are present in 
norepinephrine-stimulated skin secretions of the Marsabit clawed frog X. borealis (also 
known as the Kenya clawed frog). X. borealis is widely distributed in central and northern 
Kenya and northern Tanzania and may also be found in Uganda. It is an aquatic species 
whose natural habitats are high altitude (above 1500 m) freshwater ponds and slow-flowing 
streams in grasslands and pasturelands. It is currently listed as a species of least concern in 
the IUCN Red List of Threatened Species (Tinsley et al., 2004). 
The nomenclature used for designating the antimicrobial peptides identified in this 
study is that used previously for peptides from X. laevis (James et al., 1994) and X. amieti 
(Conlon et al., 2010). The magainin, peptide glycine-leucine amide (PGLa), caerulein-
precursor fragment (CPF), and xenopsin-precursor fragment (XPF) peptide families are 
recognized. The species origin is denoted by B and paralogs are differentiated by numerals 
e.g. CPF-B1 and CPF-B2. 
2. Experimental
2.1. Collection of skin secretions 
All procedures with live animals were approved by the Animal Research Ethics 
committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators.  Adult specimens of X. borealis (n = 2; male 23 g, female 33 g) were supplied 
by Xenopus Express Inc. (Brooksville, FL, USA). The frogs were collected in Kenya 
(220N, 3759E). Each animal was injected at two sites in the dorsal lymph sac with 
norepinephrine bitartrate (40 nmol/g body mass) and immersed in water for 15 min. The 
solution containing the secretions was acidified with trifluoroacetic acid (TFA) (final 
concentration 1% v/v) and stored at -20o C. The pooled solution was passed at a flow rate of 
2 mL/min through 8 Sep-Pak C-18 cartridges (Waters Associates, Milford, MA, USA) 
connected in series. Bound material was eluted with acetonitrile/water/ TFA (70.0:29.9:0.1, 
v/v/v; 10 mL) and freeze-dried. 
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2.2.  Antimicrobial assays 
Reference strains of Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 
25922), and Candida albicans (ATCC 90028) were purchased from the American Type 
Culture Collection (Rockville, MD, USA). Six strains of methicillin-resistant S. aureus 
(MRSA) strains and five multi-drug resistant Acinetobacter baumannii (MDRAB) strains 
were isolated from patients at four different hospitals in Abu Dhabi Emirate. The origin, 
spectrum of resistance to antibiotics, and the clonal lineage of the strains have been 
described previously (Pál et al., 2006; Conlon et al., 2009). 
Purification of the peptides was monitored by incubating lyophilized aliquots of 
chromatographic effluent in Mueller-Hinton broth (50 L) with an inoculum (50 L of 
106 colony forming units/mL) from a log-phase culture of reference strains of S. aureus and 
E. coli in 96-well microtiter cell-culture plates for 18 h at 37 oC in a humidified atmosphere 
of air. Incubations with C. albicans were carried out in RPMI 1640 medium for 48 h at 
35 oC with an inoculum of 5 x 104 CFU/mL. After incubation, the absorbance at 630 nm of 
each well was determined using a microtiter plate reader. Minimum inhibitory 
concentration (MIC) of the peptides was measured in the concentration range of 
3 - 200 μM by standard double dilution methods (Clinical and Laboratory Standards 
Institute, 2008a,b) and was taken as the lowest concentration of peptide where no visible 
growth was observed. This value was confirmed by measurement of absorbance at 630 nm. 
In order to monitor the validity and reproducibility of the assays, incubations with bacteria 
were carried out in parallel with increasing concentrations of ampicillin and incubations 
with C. albicans with amphotericin as previously described (Conlon et al., 2007, 2010). 
Hemolytic activity against human erythrocytes taken from a healthy donor was 
measured as previously described (Conlon et al., 2010). The LC50 value was taken as the 
mean concentration of peptide producing 50% hemolysis in two independent experiments. 
2.3. Peptide purification 
The skin secretions, after partial purification on Sep-Pak cartridges, were redissolved in 
0.1% (v/v) TFA/water (4 mL) and injected onto a (2.2 x 25-cm) Vydac 218TP1022 (C-18) 
reversed-phase HPLC column (Grace, Deerfield, IL, USA) equilibrated with 0.1% (v/v) 
TFA/water at a flow rate of 6.0 mL/min. The concentration of acetonitrile in the eluting 
solvent was raised to 21% (v/v) over 10 min and to 63% (v/v) over 60 min using linear 
gradients. Absorbance was monitored at 214 nm and 280 nm and fractions (1 min) were 
collected. The abilities of freeze-dried aliquots (50 L) of the fractions to inhibit the growth 
of S. aureus and E. coli were determined as described in the previous section. Fractions 
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associated with antimicrobial activity were successively chromatographed on a (1 x 25-cm) 
Vydac 214TP510 (C-4) column, a (1 x 25-cm) Vydac 208TP510 (C-8) column, and a 
(1 x 25-cm) 238EV510 Everest (C-18) column. The concentration of acetonitrile in the 
eluting solvent was raised from 21% to 56% over 50 min and the flow rate was 2.0 mL/min. 
2.4. Structural characterization 
The primary structures of the peptides were determined by automated Edman 
degradation using an Applied Biosystems model 494 Procise sequenator (Foster City, CA, 
USA). MALDI-TOF mass spectrometry was carried out using a Voyager DE-PRO 
instrument (Applied Biosystems) that was operated in reflector mode with delayed 
extraction and the accelerating voltage in the ion source was 20 kV. The instrument was 
calibrated with peptides of known molecular mass in the 2- 4 kDa range. The accuracy of 
mass determinations was  0.02%. Amino acid composition analyses were performed by 
the University of Nebraska Medical Center Protein Structure Core Facility (Omaha, NE, 
USA). 
3. Results
3.1. Purification of the peptides 
The pooled skin secretions from X. borealis, after partial purification on Sep-Pak C-18 
cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column (Fig. 1). The prominent peaks designated 1-8 were collected and subjected to 
further purification. Under the conditions of assay, peaks 1-4 and 8 were associated with the 
ability to inhibit the growth of E. coli only whereas peaks 5-7 inhibited the growth of both 
E. coli and S. aureus. Subsequent structural analysis demonstrated that peak 1 contained 
magainin-B1, peak 2: magainin-B2, peak 3: XPF-B1, peak 4: XPF-B2, peak 5: PGLa-B1, 
peak 6: a mixture of CPF-B1, CPF-B2, and PGLa-B2, peak 7: CPF-B3, and peak 8 
CPF-B4. 
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Fig. 1. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from 
X. borealis, after partial purification on Sep-Pak cartridges. The peaks designated 1-8 displayed 
varying degrees of antimicrobial activity and were purified further. The dashed line shows the 
concentration of acetonitrile in the eluting solvent. 
The peptides were purified to near homogeneity, as assessed by a symmetrical peak 
shape and mass spectrometry, by further chromatography on semipreparative Vydac C-4, 
Vydac C-8, and Everest C-18 columns. The methodology is illustrated by the partial 
separation of CPF-B1, CPF-B2, and PGLa-B2 on a Vydac C-4 column (Fig. 2A), followed 
by purification to near homogeneity of CPF-B1 by successive chromatographies on a 
Vydac C-8 column (Fig. 2B) and an Everest C-18 column (Fig. 2C). 
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Fig. 2. Purification to near homogeneity of CPF-B1 on semipreparative (a) Vydac C-4, (b) Vydac 
C-8, and (c) Everest C-18 columns. The arrowheads show where peak collection began and ended. In 
panel A, peak 1 contains CPF-B1, peak 2 contains PGLa-B2, and peak 3 contains CPF-B3. In panels 
B and C, the peak containing CPF-B1 is denoted by the symbol +. 
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The approximate final yields of purified peptides (nmol) were magainin-B1 120, 
magainin-B2 590, XPF-B1 25, XPF-B2 80, PGLa-B1 35, PGLa-B2 510, CPF-B1 720, 
CPF-B2 20, CPF-B3 55, and CPF-B4 35. 
3.2. Structural characterization 
The primary structures of the antimicrobial peptides isolated from X. borealis skin 
secretions were established by automated Edman degradation. As the C-terminal regions of 
the magainin-B1, PGLa-B1, PGLa-B2, and CPF-B4 are strongly hydrophobic, it was not 
possible to determine their C-terminal amino acid residue because of wash-out from the 
sequencer disk. However, this ambiguity was resolved by determining the amino acid 
compositions of the peptides and their complete primary structures are shown in Fig. 3. 
MALDI-TOF mass spectrometry was used to confirm the proposed structures and to 
demonstrate that PGLa-B1 and PGLa-B2 are C-terminally α-amidated. 
M+Hobs M+Hcalc
Magainin-B1 GKFLHSAGKFGKAFLGEVMIG 2194.0 2194.2
Magainin-B2 GIGKFLHSAGKFGKAFLGEVMKS 2409.5 2409.3
XPF-B1  GFKQFVHSMGKFGKAFVGEIINPK 2666.7 2666.4
XPF-B2  GWASKIGTQLGKMAKVGLKEFVQS 2563.6 2563.4 
PGLa-B1  GMASKAGTIAGKIAKTAIKLAL.NH2 2113.1 2113.3 
PGLa-B2  GMASKAGSIVGKIAKIALGAL.NH2 1955.2 1955.2
CPF-B1  GLGSLLGKAFKIGLKTVGKMMGGAPREQ 2844.5 2844.6 
CPF-B2  GLGSLLGKAFKIGLKTVGKMMGGAPR 2587.6 2587.5 
CPF-B3 GLGSLLGSLFKFIPKLLPSIQQ 2356.2 2356.4
CPF-B4 GLLTNVLGFLKKAGKGVLSGLLPL 2408.2 2408.5
Fig. 3. Amino acid sequences, observed molecular masses (Mr obs), and calculated molecular masses 
(Mr calc) of the antimicrobial peptides isolated from skin secretions of X. borealis. 
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3.3. Antimicrobial activities 
The abilities of the most abundant of the peptides in the X. borealis skin secretions to 
inhibit the growth of reference strains of the Gram-positive bacterium S. aureus, the Gram-
negative bacterium E. coli, and the opportunistic yeast pathogen C. albicans  are compared 
in Table 1. The MIC values for CPF-B1 against clinical isolates of MRSA and MDRAB 
were within the range 4-8 µM for all strains tested. Magainin-B2, PGLa-B2, and CPF-B1 
displayed very low hemolytic activity (LC50 > 200 µM) against human erythrocytes. There 
was insufficient pure material to determine the antimicrobial activities of PGLa-B1, 
CPF-B2, CPF-B3, CPF-B4, and XPF-B1. 
Table 1. Minimum inhibitory concentrations against microorganisms and hemolytic 
activity against human erythrocytes (HC50) of the endogenous peptides isolated from skin 
secretions of X. borealis 
E. coli  S.aureus  C. albicans  HC50
Magainin‐B1  >100  >100  ND  ND 
Magainin‐B2  50  >100  100  >200 (0%) 
PGLa‐B2  25  50  25  >200 (27%) 
CPF‐B1  5  5  25  >200 (18%) 
XPF‐B2  100  25  ND  ND 
Data are expressed as µM. The values in parentheses represent the % hemolysis at 200 µM. 
4. Discussion
The present study has identified ten peptides with varying degrees of antimicrobial
activity in norepinephrine-stimulated skin secretions of the tetraploid frog X. borealis. As 
shown in Fig. 4, a comparison of their primary structures reveals that they represent 
orthologs of previously described peptides (magainin, PGLa, CPF, and XPF) isolated from 
the diploid frog S. tropicalis (Ali et al., 2001), the tetraploid frog X. laevis (Gibson et al., 
1986; James et al., 1994), and the octoploid frog X. amieti (Conlon et al., 2010). It is 
unclear whether CPF-B2, which is identical to residues (1 -26) of CPB-B1, represents an 
alternative post-translational processing product of the CPB-B1 precursor arising from 
cleavage at Arg26 or, less probably, is the product of a separate gene. In addition, a peptide 
(magainin-B1) was isolated in relatively low yield that is clearly a member of the magainin 
family on the basis of structural similarity but contains a two amino acid residue (Ile2-Gly3) 
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deletion compared with magainin-B2 (Fig. 3). This peptide had only very weak 
antimicrobial activity (MIC > 100 µM against E. coli and S. aureus). A Schiffer-
Edmundson wheel (1967) representation of the magainin-B1 structure (not shown) 
demonstrates that the peptide retains the propensity to form an amphipathic α-helix so that 
the reduced antibacterial activity is probably a consequence of the decreased positive 
charge on the peptide produced by the substitution of the Lys22 residue in magainin-B2 by 
Ile (Fig. 3). Studies with analogs of magainin-2 have demonstrated that increasing the 
positive charge on the peptide resulted in an increase in antimicrobial activity until a limit 
was reached, whereupon further increases in cationicity did not result in any further 
increase in activity (Bessalle et al., 1992; Dathe et al., 2001). 
Evolutionary pressure to conserve the primary structures of the antimicrobial peptides 
from the clawed frogs has not been particularly strong (Fig. 4). 
Magainin-related peptides 
X. borealis G**KFLHSAGKFGKAFLGEVMIG 
X. borealis GIGKFLHSAGKFGKAFLGEVMKS 
X. amieti  GIKEFAHSLGKFGKAFVGGILNQ 
X. amieti  GVSKILHSAGKFGKAFLGEIMKS 
X. laevis  GIGKFLHSAGKFGKAFVGEIMKS 
X. laevis GIGKFLHSAKKFGKAFVGEIMNS 
PGLa-related peptides 
X. borealis GMASKAGTIAGKIAKTAIKLALa 
X. borealis GMASKAGSIVGKIAKIAL*GALa 
X. amieti  GMASKAGSVLGKVAKVALKAALa 
X. amieti  GMASTAGSVLGKLAKAVAIGALa 
X. laevis  GMASKAGAIAGKIAKVALK*ALa 
S. tropicalis GMATKAGTALGKVAKAVIGAALa 
Procaerulein-derived peptides 
X. borealis GLLTNVLGFLKKAGKGVLSGLLPL 
X. amieti  GL*GSVLGKILKMGANLLGGAPKGA 
X. amieti  GL*GSVLGKALKIGANLLa 
X. amieti  GL*GSLVGNALRIGAKLLa 
S. tropicalis GLLGPLLKIAAKVGSNLLa 
S. tropicalis GFLGSLLKTGLKVGSNLLa 
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X. borealis GL*GSLLGKAFKIGLKTVGKMMGGAPREQ 
X. borealis GLGSLLGSLF*KFIPK******LLPSIQQ 
X. laevis  GLASFLGKAL*KAGLK*IGAHLLGGAPQQ 
X. laevis GFASFLGKAL*KAALK*IGANMLGGTPQQ 
X. laevis GFGSFLGKAL*KAALK*IGANALGGSPQQ 
X. laevis GLASLLGKAL*KAGLK*IGTHFLGGAPQQ 
S. tropicalis GFLGPLLKLAAKGVAK**VIPHLIPSRQQ 
Proxenopsin-derived peptides 
X. borealis GFKQFVH*SMGKFGKAFVGEIINPK 
X. borealis GWASKIGTQLGKMAKVGLKEFVQS 
X. amieti  GWASKIAQTLGKMAKVGLQELIQPK 
X. laevis  GWASKIGQTLGKIAKVGLQGLMQPK 
X. laevis  GWASKIGQTLGKIAKVGLKELIQPK 
S. tropicalis GLASTLGSFLGKFAKGGAQAFLQPK 
Fig. 4. A comparison of the primary structures of the antimicrobial peptides from X. borealis with 
orthologous peptides from the octoploid frog X. amieti, the tetraploid frog X. laevis, and the diploid 
frog S. tropicalis.  Structural similarity is emphasized by the shading. (*) denotes a residue deletion 
and (a) indicates that the peptide is C-terminally -amidated. 
In peptides belonging to the magainin family from the four species studied to-date, 
10 out of 23 amino acids are invariant and in the case of peptides from the PGLa family, 
11 out of 22 residues are invariant. In contrast, sequences of the procaerulein- and 
proxenopsin-related peptides are highly variable. Only 5 residues out of 24 are conserved in 
the XPF family. A comparison of the primary structures of the CPF family peptides 
suggests that they divide naturally into two sub-groups but only 3 amino acids in the first 
group and 5 amino acids in the second group are invariant, even after deletions have been 
introduced into some sequences in order to maximize structural similarity. 
The most abundant antimicrobial peptide in the X. borealis skin secretions was the 
component with the greatest potential for development into a therapeutically valuable anti-
infective agent. CPF-B1 showed potent, broad spectrum growth-inhibitory activity against 
reference strains of Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria, and 
against the opportunistic yeast pathogen C. albicans but only very low hemolytic activity 
against human erythrocytes (Table 1). In addition, the peptide displayed high potency 
(MIC = 4 - 8 µM) against isolates of two groups of clinically important pathogens for 
which antibiotic resistance has become a serious problem, notably methicillin-resistant 
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Staphylococcus aureus (MRSA) and multidrug-resistant Acinetobacter baumannii 
(MDRAB). During the last decade, MRSA (Chambers and Deleo, 2009) and MDRAB 
(Dijkshoorn et al., 2007; Peleg et al., 2008) have emerged to become a major phenotype in 
hospitals worldwide with a high rate of mortality. More recently, new strains of the 
pathogens have emerged in the community, causing infections in young, otherwise healthy, 
people (Gootz and Marra, 2008; Cooke and Brown, 2010; Deleo et al., 2010). In addition to 
-lactam resistance, MRSA strains may exhibit multi-drug resistance including non-
susceptibility to quinolones, macrolides and sulfonamides (Garau et al., 2009). Similarly, 
among strains causing nosocomial outbreaks, resistance of MDRAB to fluoroquinolones, 
aminoglycosides, sulphonamides, third-generation cephalosporins and even carbapenems is 
common (Vila and  Pachón, 2008). Treatments of MDRAB with alternative drugs such as 
polymyxins, particularly colistin (polymyxin E), and the glycylcycline, tigecycline are far 
from optimal due to concerns with nephrotoxicity regarding colistin and the bacteriostatic 
nature of tigecycline (Karageorgopoulos and Falagas, 2008). There is clearly a need for 
new anti-infective agents to which these pathogens have not been exposed and CPF-B1 
represents a promising candidate. 
A major obstacle to the development of peptide-based anti-infective drugs, particularly 
if they are to be administered systemically, is their short half-lives in the circulation (Zhang 
and Falla, 2010). However, peptides applied to infected skin or skin lesions in the form of 
sprays or ointments can penetrate into the stratum corneum to kill microorganisms. 
MRSA is a serious problem in infections of the superficial epidermis such as impetigo 
in infants and children (Geria and Schwartz, 2010) and in colonization of surface lesions 
such as the foot ulcers of diabetic patients (Bowling et al., 2009). Similarly, MDRAB 
infection of wounds, particularly associated with natural disasters and conflicts in war 
zones, is becoming increasingly common and can lead to necrotizing lesions that do not 
heal (Sebeny et al., 2008). The high potency of CPF-B1 against MRSA and MDRAB 
together with its low toxicity suggests that topical applications of the peptide may have a 
role to play as a treatment option in combating skin infections caused by these pathogens 
and in therapeutic regimes to promote wound healing. 
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ABSTRACT 
Five peptides with antimicrobial activity were isolated from norepinephrine-stimulated skin 
secretions of the tetraploid frog Xenopus clivii Peracca, 1898 (Pipidae). Characterization of 
the peptides demonstrated that they are structurally similar to magainins (2 peptides), 
caerulein-precursor fragments, CPF (2 peptides), and xenopsin-precursor fragments, 
XPF (1 peptide) that have been previously isolated from other species of the genus 
Xenopus. The magainins and the XPF peptide were active only against the Gram-negative 
microorganism Escherichia coli whereas the CPF peptides were also active against 
the Gram-positive Staphylococcus aureus. The most abundant antimicrobial peptide in 
the secretions, CPF-C1 (GFGSLLGKALRLG ANVL.NH2) inhibited the growth of the 
Gram-negative bacteria Acinetobacter baumannii, Klebsiella pneumoniae, and 
Pseudomonas aeruginosa  (MIC ≤ 25 µM)  suggesting potential for development into an 
anti-infective agent for use against these emerging antibiotic-resistant pathogens. 
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1. Introduction
The skin secretions of many species of frogs contain biologically active peptides with
the potential for development into pharmaceutically useful compounds (Clarke, 1997). The 
family Pipidae is composed of 32 species in 5 genera (Hymenochirus, Pipa, 
Pseudhymenochirus, Silurana, and Xenopus) (Frost, 2010). All are found in Africa except 
for members of the genus Pipa which are found in South America. The genus Xenopus 
(commonly known as African clawed frogs) currently contains 18 species although several 
additional, as yet unnamed, species have been reported (Evans et al., 2004). Examples of 
therapeutically valuable peptides that have been isolated from skin secretions of the 
extensively studied species X. laevis include caerulein, used to restore peristalsis in 
intestinal paralysis after abdominal surgery and as a diagnostic aid in x-ray examination of 
the gallbladder and small bowel (Vincent et al., 1982), and xenopsin, shown to inhibit 
vascular leakage after tissue injury (Gao and Wei, 1993). 
Analysis of X. laevis skin secretions has led to the isolation and characterization of a 
range of peptides with growth inhibitory activity against bacterial and fungal pathogens. 
These include magainin-1 and -2, encoded by the same gene (Giovannini et al., 1987; 
Zasloff, 1987), and multiple antimicrobial peptides that are derived from the post-
translational processing of the biosynthetic precursors of caerulein (Gibson et al., 1986; 
Richter et al., 1986), xenopsin (Gibson et al., 1986; Soravia et al., 1988), and peptide 
glycine-leucine-amide (Andreu et al., 1985). Although magainin-2 has only modest 
antimicrobial potency, a lysine-substituted C-terminally α-amidated analog, termed 
pexiganan, has shown potential as a topical anti-infective agent for the treatment of infected 
foot ulcers in diabetic patients and as a possible treatment for impetigo (Lipsky et al., 2008; 
Gottler and Ramamoorthy, 2009). 
Despite the fact that X. laevis was the first amphibian species in which cutaneous 
antimicrobial peptides were unambiguously identified (Zasloff, 1987), frogs of the Pipidae 
family have not been extensively studied as a source of potential anti-infective agents. 
Besides X. laevis, antimicrobial peptides have been isolated only from the diploid frog 
Silurana tropicalis (formerly Xenopus tropicalis) (Ali et al., 2001), the tetraploid frog 
X. borealis (Mechkarska et al., 2010), and the octoploid frog X. amieti (Conlon et al., 
2010b). Consequently, the aim of the present study was to identify novel peptides with 
therapeutic potential in norepinephrine-stimulated skin secretions of the Eritrea clawed frog 
Xenopus clivii (also known as Peracca’s clawed frog). Structural characterization of these 
peptides allows insight into the molecular evolution of the diverse array of Xenopus 
antimicrobial peptides. X. clivii is a tetraploid frog (chromosome number 2n = 36) with a 
distribution centered on the Ethiopian plateau that is also found in northwestern Kenya and 
adjacent Sudan (Frost, 2010). It is a wholly aquatic species whose wide-ranging natural 
habitats are relatively high altitude (820 - 2745 m elevation), still and slow-flowing 
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permanent water bodies in montane forest and grassland, Acacia woodland and savannah. It 
is a resilient species and is currently listed as a species of least concern in the IUCN Red 
List of Threatened Species (Measey et al., 2004). Although still relatively abundant, 
populations have declined due to habitat loss. 
The nomenclature used for designating the antimicrobial peptides identified in this 
study is that used previously for peptides from X. laevis (James et al., 1994), X. amieti 
(Conlon et al., 2010b), and X. borealis (Mechkarska et al., 2010). The magainin, caerulein-
precursor fragment (CPF), and xenopsin-precursor fragment (XPF) peptide families are 
recognized. The species origin is denoted by C and paralogs are differentiated by numerals 
e.g. CPF-C1 and CPF-C2. 
2. Experimental
2.1. Collection of skin secretions 
All procedures with live animals were approved by the Animal Research Ethics 
committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators. Two specimens of X. clivii (male 41 g, female 15 g) were supplied by 
Xenopus Express Inc. (Brooksville, FL, USA). The animals were collected in Ethiopia 
(0902N, 3842E). Each animal was injected at two sites in the dorsal lymph sac with 
norepinephrine bitartrate (40 nmol/g body mass) and immersed in water (100 ml) for 
15 min at room temperature. The solution containing the secretions was acidified with 
trifluoroacetic acid (TFA) (final concentration 1% v/v) and stored at -20 oC. The pooled 
solution was passed at a flow rate of 2 mL/min through 6 Sep-Pak C-18 cartridges (Waters 
Associates, Milford, MA, USA) connected in series. The bound material was eluted with 
acetonitrile/water/TFA (70.0:29.9:0.1, v/v/v; 10 mL) and freeze-dried.  
2.2. Antimicrobial and hemolytic assays 
Reference strains of Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 
25726), Klebsiella pneumoniae (ATCC 700603), and Pseudomonas aeruginosa (ATCC 
27853) were purchased from the American Type Culture Collection (Rockville, MD, USA). 
The Euroclone I NM8 strain of Acinetobacter baumannii has been described previously 
(Conlon et al., 2010a). Purification of the peptides was monitored by incubating lyophilized 
aliquots of chromatographic effluent in Mueller-Hinton broth (50 L) with an inoculum 
(50 L of 106 colony forming units/mL) from a log-phase culture of reference strains of 
S. aureus and E. coli in 96-well microtiter cell-culture plates for 18 h at 37 oC in a 
humidified atmosphere of air. After incubation, the absorbance at 630 nm of each well was 
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determined using a microtiter plate reader. Minimum inhibitory concentration (MIC) of the 
peptides was measured in the concentration range of 3 - 100 μM by a standard double 
dilution method (Clinical and Laboratory Standards Institute, 2008) and was taken as the 
lowest concentration of peptide where no visible growth was observed. This value was 
confirmed by measurement of absorbance at 630 nm. In order to monitor the validity and 
reproducibility of the assays, incubations were carried out in parallel with increasing 
concentrations of antibiotics (ampicillin for S. aureus, E. coli, and A. baumannii, and 
ciprofloxacin for K. pneumoniae and P. aeruginosa) as previously described (Mechkarska 
et al., 2010). 
Hemolytic activity against human erythrocytes taken from a healthy donor was 
measured as previously described (Conlon et al., 2010b). The LC50 value was taken as the 
mean concentration of peptide producing 50% hemolysis in two incubations. 
2.3. Peptide purification 
The skin secretions, after partial purification on Sep-Pak cartridges, were redissolved in 
0.1% (v/v) TFA/water (4 mL) and injected onto a (2.2 x 25-cm) Vydac 218TP1022 (C-18) 
reversed-phase HPLC column (Grace, Deerfield, IL, USA) equilibrated with 0.1% (v/v) 
TFA/water at a flow rate of 6.0 mL/min. The concentration of acetonitrile in the eluting 
solvent was raised to 21% (v/v) over 10 min and to 63% (v/v) over 60 min using linear 
gradients. Absorbance was monitored at 214 nm and 280 nm and fractions (1 min) were 
collected. The abilities of freeze-dried aliquots (50 L) of the fractions to inhibit the growth 
of S. aureus and E. coli were determined as described in the previous section. Fractions 
associated with antimicrobial activity were successively chromatographed on (1 x 25-cm) 
Vydac 214TP510 (C-4) and (1 x 25-cm) Vydac 208TP510 (C-8) columns. The 
concentration of acetonitrile in the eluting solvent was raised from 21% to 56% over 50 min 
and the flow rate was 2.0 mL/min. 
2.4. Structural characterization 
The primary structures of the peptides were determined by automated Edman 
degradation using an Applied Biosystems model 492 Procise sequenator (Foster City, CA, 
USA). MALDI-TOF mass spectrometry was carried out using a Voyager DE-PRO 
instrument (Applied Biosystems) that was operated in reflector mode with delayed 
extraction and the accelerating voltage in the ion source was 20 kV. The instrument was 
calibrated with peptides of known molecular mass in the 2 - 4 kDa range. The accuracy of 
mass determinations was  0.02%. 
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2.5. Secondary structure prediction 
Prediction of secondary structure and determination of helicity per residue for the 
peptides were performed using the AGADIR program (Muñoz and Serrano 1994). 
AGADIR is a prediction algorithm based on the helix/coil transition theory which predicts 
the helical behaviour of monomeric peptides. Calculations were performed at pH 7 and 
298 K. A minimum percentage of 1% helicity/residue was considered to predict the 
presence of a helix. 
3. Results
3.1. Purification of the peptides 
The pooled skin secretions from X. clivii, after partial purification on Sep-Pak C-18 
cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column (Fig. 1). 
Fig. 1. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from X. clivii, 
after partial purification on Sep-Pak cartridges. The fractions designated by the horizontal bar 
inhibited the growth of E. coli and S.aureus and were purified further. The dashed line shows the 
concentration of acetonitrile in the eluting solvent. 
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Compared with chromatograms from the related species X. amieti (Conlon et al., 
2010b) and X. borealis (Mechkarska et al., 2010) generated under the same conditions, the 
resolution was poor and relatively broad peaks were obtained. The fractions with retention 
times between 39 and 51 min (denoted by the bar in Fig. 1) contained peptides that 
inhibited the growth of both E. coli and S. aureus. These fractions were individually 
subjected to further purification on a semipreparative Vydac C-4 column and those 
components with growth-inhibitory activity were purified to near homogeneity, as assessed 
by a symmetrical peak shape and mass spectrometry, by a final chromatography on a 
semipreparative Vydac C-8 column. The methodology is illustrated by the purification of 
CPF-C1 (Fig. 2). The approximate final yields of purified peptides (nmol) were magainin-
C1 330, magainin-C2 290, XPF-C1 195, CPF-C1 760, and CPF-C2 255. 
Fig. 2. Purification to near homogeneity of CPF-C1 on semipreparative (A) Vydac C-4, and 
(B) Vydac C-8 columns. The arrowheads show where peak collection began and ended. The peak 
containing CPF-C1 is denoted by the symbol + and inhibited the growth of both E. coli and S. aureus. 
3.2. Structural characterization 
The primary structures of the antimicrobial peptides isolated from X. clivii skin 
secretions were established by automated Edman degradation and are shown in Fig. 3. 
MALDI-TOF mass spectrometry was used to confirm the proposed structures and to 
demonstrate that CPF-C1 is C-terminally α-amidated. 
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M+Hobs M+Hcalc 
Magainin-C1 GVGKFLHSAKKFGQALASEIMKS 2433.4 2433.3
Magainin-C2 GVGKFLHSAKKFGQALVSEIMKS 2461.5 2461.4 
XPF-C1  GWASKIGQALGKVAKVGLQQFIQPK  2651.7 2651.5 
CPF-C1  GFGSLLGKALRLGANVL.NH2 1684.0 1684.0 
CPF-C2  GLGSLLGKALKFGLKAAGKFMGGEPQQ 2702.5 2702.5 
Fig. 3. Amino acid sequences, observed molecular masses (M+H obs), and calculated molecular 
masses (M+H calc) of the antimicrobial peptides isolated from skin secretions of X. clivii. 
3.3. Antimicrobial activities 
The abilities of the peptides in the X. clivii skin secretions to inhibit the growth of 
reference strains of the Gram-positive bacterium S. aureus and the Gram-negative 
bacterium E. coli are compared in Table 1. Only CPF-C1 displayed appreciable hemolytic 
activity against human erythrocytes (LC50 = 140 µM) at concentrations up to 200 µM 
(Table 1). 
Table 1. Minimum inhibitory concentrations against microorganisms and hemolytic 
activity against human erythrocytes (LC50) of the endogenous peptides isolated from skin 
secretions of X. clivii. 
Peptide E. coli S. aureus LC50 
Magainin-C1 100 >100 >200
Magainin-C2 50 >100 >200
XPF-C1 12.5 >100 ND
CPF-C1 6  6 140
CPF-C2 25  25 >200
Data are expressed as µM. ND: not determined. 
The MIC values for CPF-C1 and the orthologous peptides CPF-AM1 from X. amieti 
(Conlon et al., 2010b) and XT-7 from S. tropicalis (Ali et al., 2001) against reference 
strains of A. baumannii, K. pneumoniae, and P. aeruginosa are shown in Table 2. 
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Table 2. Minimum inhibitory concentrations of peptides belonging to the CPF family 
against reference strains of Gram-negative bacteria 
Peptide K. pneumoniae P. aeruginosa A. baumannii 
CPF-C1 25 25 3
CPF-AM1 25 25 6
Peptide XT-7 50 50 12.5 
Data are expressed as µM. 
4. Discussion
The present study has identified five peptides with varying degrees of antimicrobial
activity in norepinephrine-stimulated skin secretions of the tetraploid frog X. clivii. As 
shown in Fig. 4, a comparison of their primary structures reveals that they represent 
orthologs of previously described peptides (magainin, CPF, and XPF) isolated from the 
diploid frog S. tropicalis (Ali et al., 2001), the tetraploid frogs X. laevis (Gibson et al., 
1986; James et al., 1994) and X. borealis (Mechkarska et al., 2010), and the octoploid frog 
X. amieti (Conlon et al., 2010b). 
Application of the AGADIR algorithm to predict helical content of peptides indicates 
that magainin-C1 has only a weak propensity to adopt an α-helical conformation between 
residues 13 and 18 (% helicity/residue between 1.0 and 1.40) and the substitution Ala17  
Val in magainin-C2 results in a further destabilization of the helix. Similarly, XPF-C1 is 
predicted to adopt a α-helical conformation between residues 6 and 16 but the value for the 
% helicity per residue is also low (between 1.0 and 1.6). It has been shown using model 
peptides that a stabilized amphipathic α-helical conformation is an absolute requirement for 
cytolytic activity against Gram-positive bacteria whereas the structural requirements for 
activity against Gram-negative bacteria are less stringent (Giangaspero et al., 2001; Powers 
and Hancock, 2003). Provided that cationicity and hydrophobicity are maintained, peptides 
with impaired helicity are still active. Consistent with this hypothesis, the magainin 
peptides and XPF-C1 were active against the Gram-negative E. coli but showed only very 
weak activity against the Gram-positive S. aureus. 
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Magainin-related peptides 
X. clivii-C1 GVGKFLHSAKKFGQALASEIMKS
X. clivii-C2 GVGKFLHSAKKFGQALVSEIMKS 
X. borealis-B1 G**KFLHSAGKFGKAFLGEVMIG 
X. borealis-B2 GIGKFLHSAGKFGKAFLGEVMKS 
X. amieti-AM1 GIKEFAHSLGKFGKAFVGGILNQ 
X. amieti-AM2 GVSKILHSAGKFGKAFLGEIMKS 
X. laevis-1 GIGKFLHSAGKFGKAFVGEIMKS
X. laevis-2 GIGKFLHSAKKFGKAFVGEIMNS
Procaerulein-derived peptides 
X. clivii-C1 GF*GSLLGKALRLGANVLa
X. borealis-B4 GLLTNVLGFLKKAGKGVLSGLLPL 
X. amieti-AM1 GL*GSVLGKALKIGANLL.NH2 
X. amieti-AM2 GIGSALAKAAKLVAGIV.NH2 
X. amieti-AM3 GL*GSVLGKILKMGANLLGGAPKGA 
X. amieti-AM4 GL*GSLVGNALRIGAKLLa 
S. tropicalis XT-6 GFLGSLLKTGLKVGSNLLa 
S. tropicalis XT-7 GLLGPLLKIAAKVGSNLLa 
X. clivii-C2 GLGSLLGKAL*KFGLKAAGKFM*GGEPQQ
X. borealis-B1 GLGSLLGKAF*KIGLKTVGKMMGGAPREQ 
X. borealis-B2 GLGSLLGKAF*KIGLKTVGKMMGGAPR 
X. borealis-B3 GLGSLLGSLF*KFIPK******LLPSIQQ 
X. laevis 1  GLASFLGKAL*KAGLK*IGAHLLGGAPQQ 
X. laevis 2  GFASFLGKAL*KAALK*IGANMLGGTPQQ 
X. laevis 3  GFGSFLGKAL*KAALK*IGANALGGSPQQ 
X. laevis 4 GLASLLGKAL*KAGLK*IGTHFLGGAPQQ 
S. tropicalis XT-1 GFLGPLLKLAAKGVAK**VIPHLIPSRQQ 
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Proxenopsin-derived peptides 
X. clivii-C1 GWASKIGQALGKVAKVGLQQFIQPK 
X. borealis-B1 GFKQFVH*SMGKFGKAFVGEIINPK 
X. borealis-B2 GWASKIGTQLGKMAKVGLKEFVQS 
X. amieti-AM1 GWASKIAQTLGKMAKVGLQELIQPK 
X. laevis 1  GWASKIGQTLGKIAKVGLQGLMQPK 
X. laevis 2  GWASKIGQTLGKIAKVGLKELIQPK 
X. tropicalis XT-2 GVWSTVLGGLKKFAKGGLEAIVNPK 
S. tropicalis XT-3 GLASTLGSFLGKFAKGGAQAFLQPK 
S. tropicalis XT-4 GVFLDALKKF***AKGGMNAVLNPK 
Fig. 4. A comparison of the primary structures of the antimicrobial peptides from X. clivii with 
orthologous peptides from the octoploid frog X. amieti, the tetraploid frogs X. laevis and X. borealis, 
and the diploid frog S. tropicalis.  Conservation of amino acid residues is emphasized by the shading. 
In order to maximize sequence similarity, residue deletions denoted by (*) have been introduced in 
some sequences. (a) indicates that the peptide is C-terminally -amidated. 
In contrast, the CPF family peptides showed broad-spectrum activity and the most 
abundant antimicrobial peptide in the X. clivii skin secretions, CPF-C1 was also the most 
potent in inhibiting the growth of bacteria (MIC = 6 µM against both E. coli and S. aureus) 
(Table 1). The AGADIR algorithm predicts that CPF-C1 has a high probability of adopting 
a stable α-helical conformation between residues 4 and 14 (% helicity/residue between 1.0 
and 4.2). Similarly, CPF-C2 has a high probability of adopting a stable α-helical 
conformation between residues 2 and 18 (% helicity/residue between 1.0 and 5.8). The 
higher potency of the arginine-containing CPF-C1 is probably a consequence of its 
increased cationicity (isoelectric point of 11.49 compared with 10.55 for CPF-C2). Previous 
studies with a range of naturally occurring and model peptides (reviewed in Conlon et al., 
2007) have shown that an increase in peptide cationicity promotes interaction with the 
negatively charged bacterial cell membrane and so increases antimicrobial potency. On the 
other hand, similar studies using naturally occurring (Dathe et al., 1997) and model peptides 
(Stark et al., 2002) have shown that increasing overall hydrophobicity increases hemolytic 
activity. The calculated mean hydrophobicities of the peptides based upon the 
hydrophobicity scales for amino acids of Kyte and Doolittle (1982) are +15.3 for CPF-C1 
and +0.6 for CPF-C2. Thus, the increased hemolytic activity of CPF-C1 (LC50 = 140 µM) 
compared with CPF-C2 (LC50 > 200 µM) is consistent with its appreciably greater 
hydrophobicity. 
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The study supports an earlier conclusion (Mechkarska et al., 2010) that evolutionary 
pressure to conserve the primary structures of the antimicrobial peptides from the clawed 
frogs has not been strong (Fig. 4). In peptides belonging to the magainin family from the 
four species studied to-date, only 7 out of 23 amino acids are invariant and conservation of 
amino acid sequence in peptides of the CPF and XPF families is even less. A comparison of 
the primary structures of peptides of the CPF family peptides suggests that they divide 
naturally into two sub-groups but, even after deletions have been introduced into some 
sequences in order to maximize structural similarity, only the N-terminal glycine residue in 
the first group and 5 amino acids in the second group are invariant. Nevertheless, amino 
acid substitutions are almost always conservative and Schiffer-Edmundson (1967) helical 
wheel representations of the structures indicate that the amphipathic character of the 
peptides has been maintained (data not shown). 
Antimicrobial peptides belonging to the peptide glycine-leucine-amide family have 
been isolated from skin secretions of X. laevis (PGLa), X. amieti (PGLa-AM1 and  
PGLa-AM2), X. borealis (PGLa-B1 and PGLa-B2), and S. tropicalis (peptide XT-5) 
[reviewed in (Mechkarska et al., 2010)] but an ortholog was not identified in the X. clivii 
secretions. Similarly, as shown in Fig. 4, three XPF paralogs (XT-2, XT-3, and XT-4) were 
identified in skin secretions of the diploid frog S. tropicalis (Ali et al., 2001) whereas only 
one XPF peptide was identified in the X. clivii secretions. One possibility is that more 
peptides belonging to these families are present in the X. clivii secretions but their activity is 
so low that they have escaped detection. Alternatively, the gene(s) encoding the peptides 
have been deleted from the X. clivii genome during the course of evolution. This 
explanation is consistent with the conclusion of a previous study with the octoploid frog  
X. amieti that nonfunctionalization, involving deletion of a duplicated gene or its 
degeneration to a pseudogene, is the most common outcome following polyploidization 
events in the Xenopus/Silurana genera (Conlon et al., 2010b). 
Extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria are 
becoming increasingly prevalent and their antibiotic resistance necessitates novel 
therapeutic intervention. Bacteria which express ESBL genes have the capacity to 
hydrolyse a broad spectrum of β-lactam antibiotics, including carbapenems (Bush, 2010). 
Treatment of patients with bacterial infections caused by such multi-resistant pathogens is 
challenging as antibiotic options are becoming increasingly limited. Although some 
effective new types of antibiotics against multidrug-resistant Gram-positive bacteria, such 
as methicillin-resistant S. aureus (MRSA), have been introduced or are in clinical trials, the 
situation regarding new treatment options for infections produced by emerging multidrug-
resistant Gram-negative pathogens such as A. baumannii, K. pneumoniae, and P.aeruginosa 
is less encouraging (Norrby et al., 2005; Livermore, 2009). The present study has 
demonstrated CPF-C1 and other members of the CPF family [CPF-AM1 from X. amieti 
(Conlon et al., 2010b) and XT-7 from S. tropicalis (Ali et al., 2001)] show relatively potent 
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growth-inhibitory activities against reference strains of these Gram-negative bacteria. 
Future studies will investigate their effectiveness against ESBL-producing clinical isolates. 
Previous work from the laboratory has demonstrated the feasibility of using peptides 
against ESBL-producing pathogens (Eley et al., 2008). The frog skin peptide, ascaphin-8 
and its lysine-substituted analogs were effective against a range of clinical isolates of 
ESBL- producing strains of E. coli and K. pneumoniae. Like ascaphin-8, CPF-C1 shows 
moderate hemolytic activity against human erythrocytes (LC50 = 140 µM) which limits its 
applications for systemic use but a strategy has been developed for design of analogs of 
naturally occurring frog skin antimicrobial peptides that retain activity against 
microorganisms but are non-hemolytic (Conlon et al., 2007). For example, the LC50 value 
against human erythrocytes for the potent analog [Lys10]ascaphin-8 was > 500 µM 
compared with 55 µM for the native peptide (Eley et al., 2008). Future studies will 
investigate structure-activity relationships for CPF-C1 with a view to the design of non-
toxic analogs with enhanced potency against microorganisms. 
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ABSTRACT 
A putative genome duplication event within the Silurana lineage has given rise to the 
tetraploid frog S. paratropicalis and a second polyploidization within the Xenopus lineage 
has produced the octoploid frog X. andrei. Peptidomic analysis of norepinephrine-
stimulated skin secretions of S. paratropicalis and X. andrei led to identification of multiple 
peptides with growth-inhibitory activity against Escherichia coli and Staphylococcus 
aureus. Structural characterization demonstrated that the S. paratropicalis components 
comprised three peptides belonging to the caerulein-precursor fragment family (CPF-SP1, 
- SP2 and -SP3), two peptides from the xenopsin-precursor fragment family (XPF-SP1 and 
-SP2), and one peptide orthologous to peptide glycine-leucine-amide (PGLa-SP1). The 
CPF peptides showed potent, broad-spectrum antimicrobial activity. The X. andrei 
components comprised two peptides from the magainin family, (magainin-AN1 and -AN2), 
two from the XPF family (XPF-AN1 and -AN2), two from the PGLa family (PGLa-AN1 
and -AN2), and one caerulein-precursor fragment (CPF-AN1). The primary structures of 
these peptides indicate a close phylogenetic relationship between X. andrei and the 
octoploid frog X. amieti. Under the same experimental conditions, seven orthologous 
antimicrobial peptides were previously isolated from the diploid frog S. tropicalis, nine 
from the tetraploid frog X. borealis, and five from the tetraploid frog X. clivii. The data 
indicate, therefore, that nonfunctionalization (gene deletion) has been the most common 
fate of duplicated antimicrobial peptide genes following polyploidization events in the 
Silurana and Xenopus lineages. 
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1. Introduction
The clawed frogs comprise at least 33 species distributed in five genera Hymenochirus,
Pipa, Pseudhymenochirus, Silurana, and Xenopus within the family Pipidae (Frost, 2011). 
The genus Xenopus has a complex evolutionary history and its members have undergone at 
least one polyploidization event such that all species share either a tetraploid (2n = 36) 
karyotype or euploid multiples (2n = 72 or 2n = 108) (Kobel and Du Pasquier, 1991). 
Although several additional, as yet unnamed, species have been reported (Evans et al., 
2004; Evans et al., 2008), a single polyploidization event in an ancestral Xenopus species 
has generated eight well characterized tetraploid species (X. borealis, X. clivii, X. fraseri, 
X. gilli, X. laevis, X. largeni, X. muelleri, X. pygmaeus)  (Evans, 2008; Frost, 2011; Evans 
et al., 2011). The taxonomic status of X. laevis petersii and X. laevis victorianus as separate 
species is unclear (Frost, 2011). Subsequent independent genome duplication events have 
given rise to at least seven octoploid species with 2n = 72 (X. amieti, X.andrei, 
X. boumbaensis, X. itombwensis, X. lenduensis, X. vestitus, and X. wittei) (Evans et al., 
2005). Two further independent polyploidizations involving the combination of tetraploid 
and octoploid genomes have produced the dodecaploid species X. ruwenzoriensis and  
X. longipes (2n = 108) (Evans et al., 2005; Du Pasquier et al., 2009). Allopolyploidization, 
in which two species hybridize and the descendant inherits the complete genome of both 
ancestors, is considered to be the principal mode of genome duplication in the Xenopus 
genus (Kobel, 1996). 
The taxonomic status of Silurana is controversial. Traditionally, the single diploid 
species that has retained the ancestral chromosome number for pipid frogs of 2n = 20 was 
termed Xenopus tropicalis but the species has now been reclassified in the genus Silurana 
(Cannatella and Trueb, 1988). Cladistic analysis based upon nucleotide sequences of 
mitochondrial genes strongly supports the monophyly of Xenopus + Silurana which are 
united in the Xenopodinae (de Sá and Hillis, 1990) but the use of two genera "underscores 
trenchant biological and historical differences between the two clades" (Evans et al., 
2004). A putative genome duplication event within the Silurana lineage has given 
rise to S. epitropicalis and S. paratropicalis with 2n = 40 as well as at least two 
further unnamed tetraploid species (Tymowska, 1991; Tymowska and Fischberg, 1982). 
The difference in chromosome number (36 and 40) in the two tetraploid lineages suggests 
that divergence of Xenopus from Silurana predates the polyploidization event that 
occurred between 21 and 41 million years ago in a putative diploid (2n = 18) Xenopus 
ancestor (Kobel, 1996; Evans, 2007).
Peptides with antimicrobial activity are present in skin secretions of many, although by 
no means all, species of Anura (frogs and toads) and have excited interest as a source of 
potential therapeutically valuable anti-infective drugs (Zhang and Falla, 2010) and for the 
insight that they provide into the evolutionary history of the species (Conlon, in press). 
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Skin secretions of X. laevis have proved to be a rich source of such peptides. Following the 
initial discovery of the magainins (Giovanni et al., 1987; Zasloff, 1987), multiple 
antimicrobal peptides derived from the post-translational processing of the biosynthetic 
precursors of caerulein, xenopsin, and peptide glycine-leucine-amide (PGLa) have been 
described [reviewed in (Mechkarska et al., 2010)]. A comparison of the nucleotide 
sequences of cDNAs encoding the biosynthetic precursors of procaerulein, promagainin, 
and proxenopsin reveals significant structural similarity in the signal peptide and 
N-terminal regions of the precursors suggesting that the peptides may have evolved from a 
common ancestral gene by a series of duplication events (Hunt and Barker, 1988). These 
studies with X. laevis have since been extended to include the characterization of the 
antimicrobial peptides present in skin secretions of S. tropicalis (Ali et al., 2001), X. amieti 
(Conlon et al., 2010), X. borealis (Mechkarska et al., 2010), and X. clivii (Conlon et al., 
2011). 
The Gabon clawed frog Silurana paratropicalis is closely related to, but less well 
characterized than, the Cameroon clawed frog S. epitropicalis with which it is sympatric. 
Both species occur in the Congo Basin encompassing Gabon, Cameroon, western 
Democratic Republic of Congo and extreme northeastern Angola (Frost, 2011). 
S. paratropicalis was first recognized as tetraploid (2n = 40) by Tymowska (1991) who 
referred to the species as Xenopus nova VII. Although morphologically very similar, 
S. paratropicalis, S. epitropicalis, and S. tropicalis may be distinguished on the basis of 
their mating calls. Andre’s clawed frog Xenopus amieti is widely distributed in coastal 
Cameroon, northern Gabon and western Central African Republic and probably occurs in 
Equatorial Guinea and the Republic of Congo (Frost, 2011). Its natural habitats are shady 
swamps and small ponds in lowland forest. The species is adaptable and its population 
stable. Its IUCN Red List status is ‘Least Concern’ but numbers in certain areas have 
declined due to harvesting for human consumption (Tinsley and Measey, 2004). 
The present study is part of an on-going program of peptidomic analysis using 
MALDI-TOF mass spectrometry coupled with reversed-phase HLPC that aims to gain 
insight into the diversity and evolutionary history of Silurana and Xenopus host-defense 
peptides. There is no universally accepted nomenclature for designating antimicrobial 
peptides from frogs of the Pipidae family and so the peptides described in this study are 
classified according to the terminology used previously for peptides from X. laevis,  
X. borealis, and X. clivii (Conlon et al., 2011). The magainin, peptide glycine-leucine-
amide (PGLa), caerulein-precursor fragment (CPF), and xenopsin-precursor fragment 
(XPF) peptide families are recognized. The species origin is denoted by SP 
(S. paratropicalis) or AN (X. andrei) and paralogs are differentiated by numerals e.g. 
magainin-AN1 and magainin-AN2. To maintain consistency, the peptides from 
X. tropicalis that were originally termed XT-1, XT-6, and XT-7 (Ali et al., 2001) are now 
termed CPF-ST1, CPF-ST2, and CPF-ST-3 respectively, the peptides XT-2, XT-3, and 
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XT-4 are now termed XPF-ST1, XPF-ST2, and XPF-ST3 respectively, and XT-5 is now 
termed PGLa-ST1. 
2. Materials and methods
2.1. Collection of skin secretions 
All experiments with live animals were approved by the Animal Research Ethics 
committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators. Adult S. paratropicalis (n = 2; male 8 g, female 18 g) were collected in 
Cameroon (0248 N, 1108E). Adult X. andrei (n = 2; male 15 g, female 22 g) were 
collected in Cameroon (0304 N, 0958E). Both species were supplied by Xenopus 
Express Inc. (Brooksville, FL, USA). Each animal was injected at two sites in the dorsal 
lymph sac with norepinephrine bitartrate (80 nmole per g body weight) and immersed in 
water for 15 min. The solution containing the secretions was acidified with trifluoroacetic 
acid (TFA) (final concentration 1% v/v) and stored at -20o C. The pooled solutions from 
each species were separately passed at a flow rate of 2 mL/min through 6 Sep-Pak C-18
cartridges (Waters Associates, Milford, MA, USA) connected in series. Bound material was 
eluted with acetonitrile/water/ TFA (70.0:29.9:0.1, v/v/v) and freeze-dried. 
2.2. Antimicrobial assays 
Purification of the peptides was monitored by incubating lyophilized aliquots of 
chromatographic effluent in Mueller-Hinton broth (50 l) with an inoculum (50 L of 
106 colony forming units/mL) from a log-phase culture of reference strains of 
Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 25726) in 96-well 
microtiter cell-culture plates for 18 h at 37 oC in a humidified atmosphere of air. After 
incubation, the absorbance at 630 nm of each well was determined using a microtiter plate 
reader. In order to monitor the validity and reproducibility of the assays, incubations with 
bacteria were carried out in parallel with increasing concentrations of ampicillin. Minimum 
inhibitory concentrations (MIC) of the peptides  against reference strains of S. aureus 
(ATCC 25923), E. coli (ATCC 25726), Klebsiella pneumoniae (ATCC 700603), 
Pseudomonas aeruginosa (ATCC 27853), and Candida albicans (ATCC 90028), and a 
clinical isolate of Acinetobacter baumannii (Euroclone I NM8 strain) were measured in the 
concentration range of 3 - 100 μM by standard double dilution methods (Clinical 
Laboratory Standards Institute, 2008a,b) and were taken as the lowest concentration of 
peptide where no visible growth was observed. The values were confirmed by measurement 
of absorbance at 630 nm. In order to monitor the validity and reproducibility of the assays, 
incubations were carried out in parallel with increasing concentrations of antibiotics 
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(ampicillin for S. aureus and E. coli; ciprofloxacin for K. pneumoniae and P. aeruginosa; 
and amphotericin for C. albicans) as previously described (Mechkarska et al., 2010). 
2.3. Peptide purification 
The lyophilized skin secretions from both species, after partial purification on Sep-Pak 
cartridges, were redissolved in 0.1% (v/v) TFA/water (4 mL) and separately injected onto a 
(2.2 x 25 cm) Vydac 218TP1022 (C-18) reversed-phase HPLC column (Grace, Deerfield, 
IL, USA) equilibrated with 0.1% (v/v) TFA/water at a flow rate of 6.0 mL/min. The 
concentration of acetonitrile in the eluting solvent was raised to 21% (v/v) over 10 min and 
to 63% (v/v) over 60 min using linear gradients. Absorbance was monitored at 214 nm and 
280 nm and fractions (1 min) were collected. The abilities of freeze-dried aliquots (50 L) 
of the fractions to inhibit the growth of S. aureus and E. coli were determined as described 
in the previous section. Fractions associated with antimicrobial activity were successively 
chromatographed on a (1 x 25 cm) Vydac 214TP510 (C-4) column and a (1 x 25 cm) 
Vydac 208TP510 (C-8) column. The concentration of acetonitrile in the eluting solvent was 
raised from 21% to 56% over 50 min and the flow rate was 2.0 mL/min. 
2.4. Structural characterization 
The primary structures of the peptides were determined by automated Edman 
degradation using an Applied Biosystems model 494 Procise sequenator (Foster City, CA, 
USA). MALDI-TOF mass spectrometry was carried out using a Voyager DE-PRO 
instrument (Applied Biosystems) that was operated in reflector mode with delayed 
extraction and the accelerating voltage in the ion source was 20 kV. The instrument was 
calibrated with peptides of known molecular mass in the 2 - 4 kDa range. The accuracy of 
mass determinations was  0.02%. 
2.5. Secondary structure prediction 
Prediction of secondary structure and determination of helicity per residue for the 
peptides were performed using the AGADIR program (Muñoz and Serrano 1994). 
AGADIR is a prediction algorithm based on the helix/coil transition theory which predicts 
the helical behaviour of monomeric peptides. Calculations were performed at pH 7 and 
278 K. A minimum percentage of 1% helicity/residue was considered to predict the 
presence of a helix. Calculated mean hydrophobicities of the peptides were based upon the 
hydrophobicity scales for amino acids of Kyte and Doolittle (1982). 
 C
hapter  4
89 
3. Results
3.1 Purification of the peptides from S. paratropicalis 
The pooled skin secretions from S. paratropicalis, after partial purification on Sep-Pak 
C-18 cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column (Fig. 1). 
Fig. 1. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from 
S. paratropicalis, after partial purification on Sep-Pak cartridges. The fractions designated by the bar 
displayed growth inhibitory activity against E. coli and S. aureus and were purified further. The 
dashed line shows the concentration of acetonitrile in the eluting solvent. Only absorbance at 214 nm 
is shown. 
The fractions with retention times between 44 and 57 min (denoted by the bar in 
Fig. 1) contained peptides that inhibited to varying degrees the growth of either E. coli or 
S. aureus. 
These fractions were individually subjected to further purification on a semipreparative 
Vydac C-4 column and those components with growth-inhibitory activity were purified to 
near homogeneity (> 98% purity), as assessed by a symmetrical peak shape and mass 
spectrometry, by a final chromatography on a semipreparative Vydac C-8 column. The 
methodology is illustrated by the purification of the most abundant peptide in the 
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secretions, CPF-SP3 by sequential chromatography on the Vydac C-4 column (Fig. 2A) 
and Vydac C-8 column (Fig. 2B).The approximate final yields of purified peptides (nmol) 
were CPF-SP1 320, CPF-SP2 235, CPF-SP3 775, XPF-SP1 155, XPF-SP2 190, and PGLa-
SP1 230. 
Fig. 2. Purification to near homogeneity of CPF-SP3 from S. paratropicalis on semipreparative (A) 
Vydac C-4, and (B) Vydac C-8 columns. The arrowheads show where peak collection began and 
ended. The peak denoted by the cross inhibited the growth of E. coli and S. aureus. 
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3.2. Purification of the peptides from X. andrei 
The pooled skin secretions from X. andrei, after partial purification on Sep-Pak C-18 
cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column under the same conditions used for purification of the S. paratropicalis peptides 
(Fig. 3). 
Fig. 3. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from X. andrei, 
after partial purification on Sep-Pak cartridges. The fractions designated  displayed growth inhibitory 
activity against E. coli and S. aureus and were purified further. The dashed line shows the 
concentration of acetonitrile in the eluting solvent. 
Consistent with previous studies with skin secretions from X. clivii (Conlon et al., 
2011) and with the S. paratropicalis secretions (Fig. 1), the resolution on this column was 
poor and relatively broad peaks were obtained. The fractions with retention times between 
39 and 51 min (denoted by the bar in Fig. 3) contained peptides with antimicrobial activity. 
These fractions were individually subjected to further purification on a semipreparative 
Vydac C-4 column and those components with growth-inhibitory activity were purified to 
near homogeneity, as assessed by a symmetrical peak shape and mass spectrometry, by a 
final chromatography on a semipreparative Vydac C-8 column. Chromatography on these 
columns resulted in sharp, well-defined peaks. The approximate final yields of purified 
peptides (nmol) were magainin-AN1 25, magainin-AN2 370, PGLa-AN1 20, 
PGLa-AN2 85, CPF-AN1 20, XPF-AN1 70, and XPF-AN2 15. 
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3.3. Structural characterization 
The primary structures of the antimicrobial peptides isolated from S. paratropicalis 
and X. andrei skin secretions were established by automated Edman degradation and are 
shown in Fig. 4. MALDI-TOF mass spectrometry was used to confirm the proposed 
structures and to demonstrate that CPF-SP3, PGLa-SP1, CPF-AN1, PGLa-AN1 and 
PGLa-AN2 are C-terminally α-amidated. 
Mrobs Mrcalc 
S. paratropicalis 
XPF-SP1 GFWSSALEGLKKFAKGGLEALTNPK 2649.7 2648.4
XPF-SP2 GLASTIGSLLGKFAKGGAQAFLQPK 2460.3 2459.4
PGLa-SP1 GMATKAGTALGKVAKAVIGAAL.NH2 1997.3 1997.2 
CPF-SP1 GFLGPLLKLGLKGVAKVLPHLIPSRQQ 2878.9 2878.8 
CPF-SP2 GFLGPLLKLGLKGAAKLLPQLLPSRQQ 2857.5 2856.8 
CPF-SP3 GFLGSLLKTGLKVGSNLL.NH2 1815.4 1815.1 
X. andrei 
Magainin-AN1 GIKEFAHSLGKFGKAFVGGILNQ 2417.3 2417.4 
Magainin-AN2 GVSKILHSAGKFGKAFLGEIMKS 2404.9 2404.4 
XPF-AN1 GWASKIGQTLGKMAKVGLQELIQPK 2680.6 2680.5
XPF-AN2 GWVSKIGQTLGKMAKVGLQELIQPK 2708.4 2708.5
PGLa-AN1 GMASKAGSVLGKVAKVALKAAL.NH2 2068.2 2068.2 
PGLa-AN2 GMASKAGSVLGKLAKVAIGAL.NH2 1940.2 1940.2 
CPF-AN1 GFASVLGKALKLGANLL.NH2 1669.9 1670.0 
Fig. 4. Amino acid sequences, observed molecular masses (Mr obs), and calculated molecular masses 
(Mr calc) of the antimicrobial peptides isolated from skin secretions of S. paratropicalis and 
X. andrei. The calculated masses of CPF-SP3, PGLa-SP1, CPF-AN1, PGLa-AN1 and PGLa-AN2 
assume that the peptides are C-terminally α-amidated. 
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3.4. Antimicrobial activities 
The abilities of the purified peptides in the S. paratropicalis skin secretions to inhibit 
the growth of a range of clinically relevant bacteria are compared in Table 1. In view of the 
low amounts of purified peptides obtained, it was not possible to determine the growth 
inhibitory potencies of all the X. andrei peptides but limited data were obtained for the 
more abundant magainin-AN2, XPF-AN1, PGLa-AN2. 
Table 1. Minimum inhibitory concentrations (M) against microorganisms of the 
endogenous peptides isolated from skin secretions of Silurana paratropicalis and 
Xenopus andrei 
E. coli S. aureus A. baumannii K. pneumoniae P. aeruginosa C. albicans 
CPF-SP1 25 6 12.5 25 6 25
CPF-SP2 50 6 6 50 25 12.5 
CPF-SP3 50 25 6 50 50 50 
XPF-SP1 50 >100 12.5 >50 ND ND 
XPF-SP2 100 >100 25 >50 ND >50 
PGLa-SP1 100 >100 25 >50 ND 50 
Magainin-AN2 100 >100 ND 100 200 ND 
XPF-AN1 50 50 ND ND ND ND 
PGLa-AN2 25 100 ND ND ND ND 
Data are expressed as µM. ND: not determined 
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4. Discussion
This study has described the purification and characterization of six peptides with
varying degrees of antimicrobial activity in norepinephrine-stimulated skin secretions of 
the tetraploid frog S. paratropicalis and seven antimicrobial peptides in skin secretions of 
the octoploid frog X. andrei. As shown in Figs. 5 and 6, a comparison of their primary 
structures reveals that they represent orthologs of previously described dermal peptides 
(magainin, PGLa, CPF, and XPF) isolated from the octoploid frog X. amieti (Conlon et al., 
2010) and the tetraploid frogs X. laevis (Gibson et al., 1986), X. borealis (Mechkarska et 
al., 2010), and X. clivii (Conlon et al., 2011). 
Procaerulein-derived peptides 
S. paratropicalis CPF-SP1 GFLGPLLKLGLKGVAKVLPHLIPSRQQ 
S. paratropicalis CPF-SP2 GFLGPLLKLGLKGAAKLLPQLLPSRQQ 
S. tropicalis CPF-ST1  GFLGPLLKLAAKGVAKVIPHLIPSRQQ 
S. paratropicalis CPF-SP3 GFLGSLLKTGLKVGSNLL.NH2 
S. tropicalis CPF-ST2  GFLGSLLKTGLKVGSNLL.NH2
S. tropicalis CPF-ST3  GLLGPLLKIAAKVGSNLL.NH2
Proxenopsin-derived peptides 
S. paratropicalis XPF-SP1 GFWSSALEGLKKFAKGGLEALTNPK 
S. paratropicalis XPF-SP2 GLASTIGSLLGKFAKGGAQAFLQPK 
S. tropicalis XPF-ST1  GVWSTVLGGLKKFAKGGLEAIVNPK 
S. tropicalis XPF-ST2  GLASTLGSFLGKFAKGGAQAFLQPK 
S. tropicalis XPF-ST3 GVFLDALKKF***AKGGMNAVLNPK 
PGLa-related peptides 
S. paratropicalis PGLa-SP1 GMATKAGTALGKVAKAVIGAAL.NH2 
S. tropicalis PGLa-ST1  GMATKAGTALGKVAKAVIGAAL.NH2
Fig. 5. A comparison of the primary structures of the antimicrobial peptides from the tetraploid frog, 
S. paratropicalis with orthologous peptides from the diploid frog S. tropicalis. (*) denotes a residue 
deletion. 
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Magainin-related peptides 
X. andrei-AN1 GIKEFAHSLGKFGKAFVGGILNQ 
X. andrei-AN2 GVSKILHSAGKFGKAFLGEIMKS
X. amieti-AM1 GIKEFAHSLGKFGKAFVGGILNQ 
X. amieti-AM2 GVSKILHSAGKFGKAFLGEIMKS
X. clivii-C1 GVGKFLHSAKKFGQALASEIMKS
X. clivii-C2 GVGKFLHSAKKFGQALVSEIMKS
X. borealis-B1 G**KFLHSAGKFGKAFLGEVMIG 
X. borealis-B2 GIGKFLHSAGKFGKAFLGEVMKS 
X. laevis-1 GIGKFLHSAGKFGKAFVGEIMKS
X. laevis-2 GIGKFLHSAKKFGKAFVGEIMNS
Procaerulein-derived peptides 
X. andrei-AN1 GFASVLGKALKLGANLL.NH2
X. amieti-AM1 GLGSVLGKALKIGANLL.NH2 
X. amieti-AM2 GIGSALAKAAKLVAGIV.NH2 
X. amieti-AM4 GLGSLVGNALRIGAKLL.NH2 
X. clivii-C1 GFGSL*GKALRLGANVL.NH2
X. amieti-AM3 GLGSVLGKILKMGANLLGGAPKGA 
X. clivii-C2 GLGSLLGKALKFGLKAAGKFM*GGEPQQ
X. borealis-B1 GLGSLLGKAFKIGLKTVGKMMGGAPREQ 
X. borealis-B2 GLGSLLGKAFKIGLKTVGKMMGGAPR 
X. borealis-B3 GLGSLLGSLFKFIPK******LLPSIQQ 
X. borealis-B4 GLLTNVLGFLKKAGKGVLSGLLPL 
X. laevis 1 GLASFLGKALKAGLK*IGAHLLGGAPQQ
X. laevis 2 GFASFLGKALKAALK*IGANMLGGTPQQ
X. laevis 3 GFGSFLGKALKAALK*IGANALGGSPQQ
X. laevis 4 GLASLLGKALKAGLK*IGTHFLGGAPQQ
Proxenopsin-derived peptides 
X. andrei-AN1 GWASKIGQTLGKMAKVGLQELIQPK 
X. andrei-AN2 GWVSKIGQTLGKMAKVGLQELIQPK 
X. amieti-AM1 GWASKIAQTLGKMAKVGLQELIQPK 
X. clivii-C1 GWASKIGQALGKVAKVGLQQFIQPK
X. borealis-B1 GFKQFVH*SMGKFGKAFVGEIINPK 
X. borealis-B2 GWASKIGTQLGKMAKVGLKEFVQS 
X. laevis 1 GWASKIGQTLGKIAKVGLQGLMQPK
X. laevis 2 GWASKIGQTLGKIAKVGLKELIQPK
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PGLa-related peptides 
X. andrei-AN1 GMASKAGSVLGKVAKVALKAAL.NH2 
X. andrei-AN2 GMASKAGSVLGKLAKVAI*GAL.NH2
X. amieti-AM1 GMASKAGSVLGKVAKVALKAAL.NH2 
X. amieti-AM2 GMASTAGSVLGKLAKAVAIGAL.NH2 
X. borealis-B1 GMASKAGTIAGKIAKTAIKLAL.NH2 
X. borealis-B2 GMASKAGSIVGKIAKIAL*GAL.NH2 
X. laevis GMASKAGAIAGKIAKVALK*AL.NH2 
Fig. 6. A comparison of the primary structures of the antimicrobial peptides from the octoploid frog 
X. andrei with orthologous peptides from the octoploid frog X. amieti, and the tetraploid frogs, 
X. borealis, X. clivii, and X. laevis. (*) denotes a residue deletion. 
Consistent with previous work with the diploid frog S. tropicalis (Ali et al., 2001), 
peptides orthologous to the magainins were not detected in the S. paratropicalis secretions. 
The distribution of the antimicrobial peptides in the skin secretions of X. andrei is atypical 
(Fig. 7). 
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The potent and broad spectrum CPF antimicrobial peptides are present in high 
abundance and in multiple molecular forms in the secretions of all other species studied 
to-date, including S. paratropicalis, whereas only a single CPF peptide was isolated from 
the X. andrei secretions and this in low yield. 
As well as their potential for development into therapeutically valuable anti-infective 
agents, the antimicrobial peptides in frog skin secretion can provide insight into the 
evolutionary history of closely related species. The primary structures of the Xenopus 
antimicrobial peptides have generally been poorly conserved both within and between 
species (Mechkarska et al., 2010; Conlon et al., 2011). However, the primary structures of 
the PGLa peptides from S. paratropicalis and S. tropicalis are the same and CPF-SP3 is 
identical to CPF-ST2 (Fig. 5) suggesting that the tetraplodization event within the Silurana 
lineage that produced S. paratropicalis was relatively recent. The data in Fig. 6 indicate a 
particularly close phylogenetic relationship between the octoploid frogs, X. andrei and 
X. amieti as the amino acid sequences of the magainins and the PGLa-1 peptides are 
identical. This conclusion is consistent with data from comparisons of nucleotide sequences 
of mitochondrial DNA (Evans et al., 2004; Evans, 2008) and the RAG1 gene (Evans, 
2007). It was proposed that X. amieti, X. andrei, and X. boumbaensis share a common 
octoploid ancestor whereas the octoploid frogs, X. vestitus and X. wittei arose from 
independent polyploidization events. 
The antimicrobial potencies and specificities of the peptides isolated in this study 
varied appreciably (Table 1). CPF-SP1 represents the component with the greatest potential 
for development into a therapeutically valuable anti-infective agent, displaying relatively 
high potency (MIC ≤ 25 µM) against reference strains of the Gram-negative bacteria 
E. coli, A. baumannii, K. pneumonia, and P. aeruginosa. The peptide was also active 
against a reference strain of the Gram-positive S. aureus (MIC = 6 µM) and against the 
opportunistic yeast pathogen C. albicans (MIC = 25 µM). There was insufficient material 
to determine accurately the hemolytic activity of the peptide against human erythrocytes 
but the LC50 value was > 100 µM. The emergence of multidrug-resistant Gram-negative 
pathogens poses a particularly serious threat to public health and the situation regarding 
new treatment options for infections produced by these microorganisms is not encouraging 
(Livermore, 2009). There is clearly an urgent need for new types of antimicrobial agents to 
which the pathogens have not been exposed. 
The observed potencies of the S. paratropicalis peptides correlate moderately well 
with their physicochemical properties (Table 2). The antimicrobial potency of a peptide 
against microorganisms is determined by complex interactions among cationicity, 
hydrophobicity, -helicity and amphipathicity [reviewed in (Conlon et al. 2007)]. Studies 
using model -helical peptides have demonstrated that an increase in cationicity promotes 
interaction with the negatively charged phospholipids in the bacterial cell membrane and 
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thereby increases antimicrobial activity. Consistent with this observation, CPF-SP1 and 
CPF-SP2 with a molecular charge of +4 at pH 7 and a predicted -helical domain between 
residues 5 - 11, are more potent than CPF-SP3 which has a charge of +3 and a low 
propensity to adopt a -helical conformation. 
Table 2. Physicochemical properties of the antimicrobial peptides isolated from skin 
secretions of Silurana paratropicalis and Xenopus andrei 
Peptide Mean
hydrophobicity 
Charge  
at pH 7 
α-helical
domain 
CPF-SP1 +10.5 +4 5-11
CPF-SP2 +6.7 +4 5-11
CPF-SP3 +14.6 +3 Non-helical
XPF-SP1 -6.3 +2 5-15,18-22
XPF-SP2 +7.9 +3 6-14
PGLa-SP1 +20.3 +4 9-19
Magainin-AN1 +4.6 +3 Non-helical 
Magainin-AN2 +5.6 +2 Non-helical 
CPF-AM1 +18.1 +3 5-17
XPF-AN1 -5.1 +3 10-16, 18-22
XPF-AN2 -2.7 +3 10-16, 18-22
PGLa-AN1 +18.4 +5 9-18
PGLa-AN2 +20.3 +4 9-18
Mean hydrophobicities (H) of the peptides are calculated using the hydrophobicity scales for amino 
acid residues of Kyte and Doolittle. Predictions of helical domains were made using the AGADIR 
program. 
The low activity of XPF-SP1 is consistent with its lower charge (+2 at pH 7) and low 
mean hydrophobicity. The reduced potency of PGLa-SP1 is more difficult to explain as it 
possesses a charge of +4 at pH 7 and can adopt a stable, amphipathic -helical 
conformation. The peptide is strongly hydrophobic and it is possible that its activity is 
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reduced by low solubility and a tendency to oligomerize. Magainin-2 and PGLa from 
X. laevis act synergistically so that the peptides in combination show more potent growth 
inhibitory activity against E. coli than either peptide tested alone (Westerhoff et al., 1995). 
It is probable, therefore, that the mixture of antimicrobial peptides in the S. paratropicalis 
and X. andrei skin secretions provides greater protection for the animal against pathogenic 
microorganisms in the environment than inferred from data obtained by measuring the MIC 
of each individual peptide. 
Polyploidization events involving duplication of the complete genome, are believed to 
have occurred several times during vertebrate evolution – twice during the very early 
history of the chordates (2R hypothesis) and once in fish immediately before the radiation 
of the teleost lineage (Lundin et al., 2003). Subsequent genome duplications are believed to 
have occurred sporadically in individual species among the Anura but it is only in the 
Xenopodinae that polyploid species predominate (Otto and Whitton, 2000). A duplicated 
gene has three possible evolutionary fates – nonfunctionalization involving deletion of the 
gene or its degeneration to a pseudogene; subfunctionalization in which the mother and 
daughter genes share functionality; and neofunctionalization in which the duplicated gene 
evolves to adopt a new biological role (Lynch and Katju, 2004).  Analysis of large numbers 
of duplicate gene pairs in tetraploid Xenopus and Silurana species has shown that both 
copies of the duplicate gene are subject to strong purifying selection (a greater number of 
synonymous substitutions per site than nonsynonymous substitutions per site) (Chain and 
Evans, 2006; Chain et al., 2008), and it has been estimated that only 23% of the duplicate 
gene copies in X. laevis have been lost following tetraploidization (Hughes and Hughes, 
1993). Consistent with this estimate, electrophoretic analysis of serum proteins from 20 
Silurana/Xenopus species revealed that S. paratropicalis, S. epitropicalis and all tetraploid 
Xenopus species displayed two albumin bands whereas S. tropicalis gave only one (Graf 
and Fischberg, 1986). However, in the case of the octoploid and dodecaploid species, the 
rate of duplicate gene loss following the second and third polyploidization events appears 
to be greater. The serum of the octaploid species X. andrei contained only three albumins 
instead of the expected four and the dodecaploid species X. ruwenzoriensis contained three 
albumins instead of the expected six. A similar high level of gene deletion and/or gene 
silencing in octoploid and dodecaploid species was seen in the case of genes encoding 
RAG1 and RAG2, proteins crucial to the process of somatic rearrangement of DNA in 
adaptive immunity (Evans, 2007) and among major histocompatibility complex genes 
(Sammut et al., 2002; Du Pasquier et al., 2009). Studies of duplicated RAG-1 genes in 
Xenopus and Silurana species have indicated that degeneration of paralogs occurs via 
incorporation of premature stop codons and frameshift mutations (Evans et al., 2005). 
It is not claimed that the antimicrobial peptides isolated from S. paratropicalis and 
X. andrei skin secretions in this study necessarily represent the full complement of 
expressed antimicrobial gene products as components present in low abundance and/or with 
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very weak growth-inhibitory activity may have been missed. However, it is fair to claim 
that the multiplicity of antimicrobial peptides in the skin secretions of the tetraploid species 
S. paratropicalis is not appreciably greater that in the skin secretions of the diploid species 
S. tropicalis (Ali et al., 2001). Similarly, the multiplicity of the peptides in the secretions of 
the octoploid frogs X. andrei and X. amieti (Conlon et al., 2010) is not appreciably different 
from that in the tetraploid species X. borealis (Mechkarska et al., 2010) and X. clivii 
(Conlon et al., 2011) when analyzed using exactly the same experimental protocol. It is 
concluded, therefore, that nonfunctionization is the most common fate of antimicrobial 
peptide genes following the putative genome duplication event in the Silurana lineage and 
the second polyploidization in the Xenopus lineage. The existence of multiple biologically 
active CPF peptides in the S. paratropicalis secretions appears to be a clear example of 
subfunctionalization. In view of the very low antimicrobial potencies of the XPF and PGLa 
peptides in S. paratropicalis, it is tempting to speculate that they are evolving towards a 
new, as yet undetermined function (neofunctionalization). 
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ABSTRACT 
Mueller’s clawed frog Xenopus muelleri (Peters 1844) occupies two non-contiguous ranges 
in east and west Africa. The phylogenetic relationship between the two populations is 
unclear and it has been proposed that the western population represents a separate species. 
Peptidomic analysis of norepinephrine-stimulated skin secretions from X. muelleri from the 
eastern range resulted in the identification of five antimicrobial peptides structurally related 
to the magainins (magainin-M1 and -M2), xenopsin-precursor fragments (XPF-M1) and 
caerulein-precursor fragments (CPF-M1 and -M2) previously found in skin secretions of 
other Xenopus species. A cyclic peptide (WCPPMIPLCSRF.NH2) containing the RFamide 
motif was also isolated that shows limited structural similarity to the tigerinins, previously 
identified only in frogs of the Dicroglossidae family. The components identified in skin 
secretions from X. muelleri from the western range comprised one magainin (magainin-
MW1), one XPF peptide (XPF-MW1), two peptides glycine-leucine amide (PGLa-MW1 
and -MW2), and three CPF peptides (CPF-MW1, -MW2 and -MW3). Comparison of the 
primary structures of these peptides suggest that western population of X. muelleri is more 
closely related to X. borealis than to X. muelleri consistent with its proposed designation as 
a separate species. The CPF peptides showed potent, broad-spectrum activity against 
reference strains of bacteria (MIC 3 - 25 µM), but were hemolytic against human 
erythrocytes. 
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1. Introduction
Peptides with broad-spectrum antibacterial and antifungal activities and with the ability
to permeabilize mammalian cells are found in skin secretions from a variety of species of 
Anura (frogs and toads). It is proposed that they constitute a component of the system of 
innate immunity that defends the animal against invasion by pathogens in the environment 
[3]. Such peptides have attracted interest for their possible clinical applications in treating 
infections produced by antibiotic-resistant microorganisms [39]. With few exceptions, the 
frog skin antimicrobial peptides are cationic and lack stable secondary structure in aqueous 
solutions but have the propensity to form an amphipathic -helix in the environment of a 
phospholipid vesicle or in a membrane-mimetic solvent such as 50% trifluoroethanol-water 
[4,30]. The peptides may be grouped together in families on the basis of limited similarities 
in amino acid sequence and skin secretions from a single species frequently contain 
peptides from different families as well as several members of a particular peptide family. 
Their primary structures are hypervariable and it is rare that orthologous peptides from two 
different species have the same amino acid sequence even when those species are closely 
related phylogenetically. Consequently the antimicrobial peptides in skin secretions may 
serve as valuable phylogenetic markers for gaining insight into the evolutionary history of 
the different frog families [6,7,9]. 
The clawed frogs comprise at least 33 species distributed in five genera Hymenochirus, 
Pipa, Pseudhymenochirus, Silurana, and Xenopus within the family Pipidae [15]. All are 
found in Africa south of the Sahara except for members of the genus Pipa which are found 
in South America. The genera Silurana and Xenopus are united in the Xenopodinae [14] 
and have a complex evolutionary history characterized by both bifurcating and reticulating 
modes of speciation [11]. Allopolyploidization events, in which two species hybridize and 
the descendant inherits the complete genome of both ancestors, have given rise to 
tetraploid, octoploid, and dodecaploid species with only a single species, S. tropicalis 
retaining the diploid status that is thought to be related to the ancestral state existing prior to 
one or more whole genome duplications [12-14,21,22]. The 10 tetraploid Xenopus species 
have been divided into three species groups on the basis of similarities in morphology, 
advertisement calls, and/or nucleotide sequences of mitochondrial genes: the laevis group 
includes X. laevis, X. gilli, X. largeni, X. petersii, and X. victorianus; the muelleri group 
includes X. muelleri, X. borealis and X. clivii; and the fraseri group includes X. fraseri and 
X. pygmaeus [14,16,35]. 
Mueller’s clawed frog Xenopus muelleri Peters, 1844 (also known as Mueller's 
Platanna) is a relatively large aquatic species with females reaching up to 9 cm snout-to-
vent length and males about 20% smaller. It occupies both temporary and permanent ponds, 
and also streams and rivers in the dry season, preferring agricultural and other altered 
habitats and is seldom found in forests. In certain regions, X. muelleri, like X. borealis and 
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X. gilli, is known to hybridize with X. laevis revealing that reproductive isolation is not 
complete [15,25]. In view of its very wide distribution and tolerance of a broad range of 
habitats, its current IUCN (Red List) status is ‘Least Concern’ but numbers in certain areas 
are declining due to loss of habitat and harvesting for human consumption [25]. 
X. muelleri occupies two discontinuous ranges. In the eastern range, X. muelleri is 
found along the East African coastal belt from extreme southern Kenya through Tanzania 
into northwestern border areas of the Republic of South Africa, Botswana and the Caprivi 
region of Nambia [16,18]. In the western range, X. muelleri is widely distributed in a zone 
encompassing Burkina Faso, Cameroon, Côte d'Ivoire, northern Gabon, Nigeria, eastward 
to northeastern Democratic Republic of Congo [16,31]. It has been proposed that the 
western population represents a separate species with only the eastern population retaining 
the current scientific name X. muelleri [26]. For convenience, the western population is 
referred to as X. muelleri West in this article but this is not a recognized species name. The 
aim of the present study was to use peptidomic analysis (reversed-phase HLPC coupled 
with MALDI-TOF mass spectrometry) of norepinephrine-stimulated skin secretions from 
frogs from both ranges to determine whether the two populations should be regarded as 
conspecific. The study is part of a program of investigation with the dual purpose of 
gaining insight into the evolutionary history of the Xenopodinae and identifying 
antimicrobial peptides with the potential for development into therapeutically valuable anti-
infective agents. The investigation complements previous work that has led to the 
characterization of antimicrobial and other peptides in skin secretions from X. amieti [5], 
X. andrei [28], X. borealis [27], and X. clivii [8]. 
There is no universally accepted nomenclature for designating antimicrobial peptides 
from frogs of the Pipidae family and so the peptides described in this study are classified 
according to the terminology used previously for peptides from the Xenopodinae [17]. The 
magainin, peptide glycine-leucine amide (PGLa), caerulein-precursor fragment (CPF), and 
xenopsin-precursor fragment (XPF) peptide families are recognized. The species origin is 
denoted by M for X. muelleri and MW for X. muelleri West. Paralogs are differentiated by 
numerals e.g. magainin-M1 and magainin-M2. 
2. Experimental
2.1. Collection of skin secretions 
All experiments with live animals were approved by the Animal Research Ethics 
committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators. Adult X. muelleri from the eastern range (n = 2; male 43 g, female 43 g) were 
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collected in South Malawi. Adult individuals from the western range (n = 2; male 32 g, 
female 32 g) were collected in Nigeria, near Jos Plateau. Animals from both groups were 
supplied by Xenopus Express Inc. (Brooksville, FL). Each animal was injected via the 
dorsal lymph sac with norepinephrine hydrochloride (40 nmol/g body weight) and placed in 
a solution (100 ml) of distilled water for 15 min. The frog was removed and the collection 
solution was acidified by addition of trifluoroacetic acid (TFA) (1 ml) and immediately 
frozen for shipment to U.A.E. University. The solutions containing the secretions from each 
group were pooled and separately passed at a flow rate of 2 ml/min through 6 Sep-Pak C-18 
cartridges (Waters Associates, Milford, MA) connected in series. Bound material was 
eluted with acetonitrile/water/TFA (70.0:29.9:0.1, v/v/v) and freeze-dried. The material was 
redissolved in 0.1% (v/v) TFA/water (2 ml). 
2.2. Peptide purification 
The pooled skin secretions from each group, after partial purification on Sep-Pak 
cartridges, were injected onto a (1.0 cm x 25 cm) Vydac 218TP510 (C-18) reversed-phase 
HPLC column (Grace, Deerfield, IL) equilibrated with 0.1% (v/v) TFA/water at a flow rate 
of 2.0 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 21% 
(v/v) over 10 min and to 63% (v/v) over 60 min using linear gradients. Absorbance was 
monitored at 214 nm and 280 nm, and fractions (1 min) were collected. Purification of the 
peptides was monitored by incubating lyophilized aliquots of chromatographic effluent 
(100 µl) in Mueller-Hinton broth (50 l) with an inoculum (50 l of 106 colony forming 
units/ml) from a log-phase culture of reference strains of Staphylococcus aureus (ATCC 
25923) and Escherichia coli (ATCC 25726) in 96-well microtiter cell-culture plates for 
18 h at 37oC in a humidified atmosphere of air. After incubation, the absorbance at 630 nm 
of each well was determined using a microtiter plate reader. Fractions associated with 
antimicrobial activity were successively chromatographed on a (1.0 cm x 25 cm) Vydac 
214TP510 (C-4) column and a (1.0 cm x 25 cm) Vydac 208TP510 (C-8) column. The 
concentration of acetonitrile in the eluting solvent was raised from 21% to 56% over 50 min 
and the flow rate was 2.0 ml/min. 
2.3. Structural characterization 
The primary structures of the peptides were determined by automated Edman 
degradation using an Applied Biosystems model 494 Procise sequenator (Foster City, CA). 
MALDI-TOF mass spectrometry was carried out using a Voyager DE-PRO instrument 
(Applied Biosystems) that was operated in reflector mode with delayed extraction and the 
accelerating voltage in the ion source was 20 kV. The instrument was calibrated with 
peptides of known molecular mass in the 2 - 4 kDa range. The accuracy of mass 
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determinations was  0.02%. Amino acid composition analyses were performed by the 
University of Nebraska Medical Center Protein Structure Core Facility (Omaha, NE). 
2.4. Peptide synthesis 
Tigerinin-M1 (WCPPMIPLCSRF.NH2) was supplied in crude form by China Peptides 
Co., Shanghai, China and was purified  to near homogeneity (> 98% purity) by reversed-
phase HPLC on a (2.2 cm x 25 cm) Vydac 218TP1022 (C-18) column.  The concentration 
of acetonitrile in the eluting solvent was raised from 21% to 56% over 60 min and the flow 
rate was 6 ml/min. The structure of the peptide was confirmed by electrospray mass 
spectrometry. 
2.5.  Antimicrobial and hemolytic activities 
Reference strains of microorganisms were purchased from the American Type Culture 
Collection (Rockville, MD). Minimum inhibitory concentrations (MIC) of the purified 
peptides against reference strains of Staphylococcus aureus (ATCC 25923), Escherichia 
coli (ATCC 25726), and Candida albicans (ATCC 90028) were measured in the 
concentration range of 3 - 200 μM by standard microdilution methods [1,2] and were taken 
as the lowest concentration of peptide where no visible growth was observed. The values 
were confirmed by measurement of absorbance at 630 nm. In order to monitor the validity 
and reproducibility of the assays, incubations were carried out in parallel with increasing 
concentrations of antibiotics (ampicillin for S. aureus and E. coli; and amphotericin for 
C. albicans) as previously described [27]. 
Hemolytic activity against human erythrocytes taken from a healthy donor was 
measured as previously described [27]. The LC50 value was taken as the mean 
concentration of peptide producing 50% hemolysis in two incubations. 
2.6. Secondary structure prediction 
Prediction of secondary structure and determination of helicity per residue for the 
peptides were performed using the AGADIR program [29]. AGADIR is a prediction 
algorithm based on the helix/coil transition theory which predicts the helical behaviour of 
monomeric peptides. Calculations were performed at pH 7 and 278 K. A minimum 
percentage of 1% helicity/residue was considered to predict the presence of a helix. 
Calculated mean hydrophobicities of the peptides were based upon the hydrophobicity 
scales for amino acids of Kyte and Doolittle [23]. 
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2.7. Enzymatic assay 
The ability of tigerinin-M1 (100 µM) to inhibit the activity of porcine pancreatic 
elastase (Calbiochem, San Diego, CA) was determined using succinyl-Ala-Ala-Pro-Abu-p-
nitroanilide [Abu = L-α-aminobutyric acid] (Calbiochem) as substrate as described [24]. 
3. Results
3.1. Purification of the peptides from X. muelleri 
The pooled skin secretions from X. muelleri, after partial purification on Sep-Pak C-18 
cartridges, were chromatographed on a Vydac C-18 semipreparative reversed-phase HPLC 
column (Fig. 1). The prominent peaks designated 1 - 6 were collected and subjected to 
further purification. Under the conditions of assay, peak 2 was associated with the ability to 
inhibit the growth of E. coli only whereas peaks 1 and 4 - 6 inhibited the growth of both 
E. coli and S. aureus. 
Fig. 1. Reversed-phase HPLC on a semipreparative Vydac C-18 column of skin secretions from 
X. muelleri after partial purification on Sep-Pak cartridges. The peaks designated 1 - 2 and 4 - 6 
displayed antimicrobial activity and were purified further. Peak 3 contained tigerinin-M1. The dashed 
line shows the concentration of acetonitrile in the eluting solvent. 
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Subsequent structural analysis demonstrated that peak 1 contained magainin-M1, 
peak 2: magainin-M2, peak 3: tigerinin-M1, peak 4: XPF-M1, peak 5: CPF-M1, and 
peak 6: CPF-M2. The peptides were purified to near homogeneity, as assessed by a 
symmetrical peak shape and mass spectrometry, by further chromatography on 
semipreparative Vydac C-4 and Vydac C-8 columns as previously described. The 
approximate final yields of purified peptides (nmol) were magainin-M1 182, 
magainin-M2 20, tigerinin-M1 55, XPF-M1 50, CPF-M1 115, CPF-M2 40. 
3.2. Purification of the peptides from X. muelleri West 
The pooled skin secretions from X. muelleri West, after partial purification on Sep-Pak 
C-18 cartridges, were chromatographed on a Vydac C-18 semipreparative reversed-phase 
HPLC column using the same experimental conditions as for the X. muelleri skin secretions 
(Fig. 2). 
Fig. 2. Reversed-phase HPLC on a semipreparative Vydac C-18 column of skin secretions from 
X. muelleri West after partial purification on Sep-Pak cartridges. The peaks designated 1 - 6 displayed 
antimicrobial activity and were purified further. The dashed line shows the concentration of 
acetonitrile in the eluting solvent. 
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The prominent peaks designated 1 - 6 were collected and subjected to further 
purification. Under the conditions of assay, peaks 1 and 2 were associated with the ability 
to inhibit the growth of E. coli only whereas peaks 3 - 6 inhibited the growth of both E. coli 
and S. aureus. Subsequent structural analysis demonstrated that peak 1 contained magainin-
MW1, peak 2: XPF-MW1, peak 3: PGLa-MW1 and PGLa-MW2, peak 4: CPF-MW1, 
peak 5: CPF-MW2, and peak 6: CPF-MW3. The peptides were purified to near 
homogeneity, as assessed by a symmetrical peak shape and mass spectrometry, by further 
chromatography on semipreparative Vydac C-4 and Vydac C-8 columns. The methodology 
is illustrated by the partial separation of PGLa-MW1 and PGLa-MW2 on a Vydac C-4 
column (Fig. 3A), followed by purification to near homogeneity of PGLa-MW1 by further 
chromatograpy on a Vydac C-8 column (Fig. 3B). 
Fig. 3. (A) Separation of PGLa-MW1  (peak 1) and PGLa-MW2 (peak 2) on a semipreparative Vydac 
C-4 column and (B) purification to near homogeneity of PGLa-MW1 on a semipreparative Vydac C-8 
columns. The arrowheads show where peak collection began and ended and the dashed line shows the 
concentration of acetonitrile in the eluting solvent. 
The approximate final yields of purified peptides (nmol) were magainin-MW1 420, 
XPF-MW1 50, PGLa-MW1 230, PGLa-MW2 50, CPF-MW1 220, CPF-MW2 140 and 
CPF-MW38. 
 C
ha
pt
er
  5
 
116
3.3. Structural characterization 
The primary structures of the antimicrobial peptides isolated from X. muelleri and 
X. muelleri West skin secretions were established by automated Edman degradation and 
their complete primary structures are shown in Fig. 4. 
Xenopus muelleri 
[Mr+H]obs [Mr+H]calc 
Magainin-M1 GIGKFLHSAGKFGKAFIGEIMKS 2423.1 2423.3 
Magainin-M2 GFKQFVHSLGKFGKAFVGEMIKPK 2680.9 2680.5 
Tigerinin-M1 WCPPMIPLCSRF.NH2 1446.6 1446.6 
XPF-M1 GWASKIGQTLGKMAKVGLKDLIQA  2513.8 2513.4 
CPF-M1  GLGSLLGKAFKFGLKTVGKMMAGAPREQ 2892.6 2892.4 
CPF-M2  GLGSLLGKAFKFGLKTVGKMMAGAPREE 2893.6 2893.6 
Xenopus muelleri West 
[Mr+H]obs [Mr+H]calc 
Magainin-MW1 GIGKFLHSAGKFGKAFLGEVMKS 2409.1 2409.3 
XPF-MW1 GWASKIGQTLGKLAKVGLKEFAQS 2518.6 2517.4 
PGLa-MW1 GMASKAGSVLGKITKIALGAL.NH2  1985.4 1985.2 
PGLa-MW2 GMASKAGAIAGKIAKTAIKIAL.NH2  2083.4 2083.3 
CPF-MW1 GLGSLLGKAFKFGLKTVGKMMGGAPREQ  2878.6 2878.6 
CPF-MW2 GLGSLLGKAFKFGLKTVGKMMGGAPREE 2879.8 2879.6 
CPF-MW3 GLGSLLGKAFKFGLKTVGKMMGGAPR  2621.3 2621.5 
Fig. 4. Amino acid sequences, observed molecular masses (Mr obs), and calculated molecular masses 
(Mr calc) of the antimicrobial peptides isolated from skin secretions of X. muelleri and X. muelleri 
West. 
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As there was some ambiguity with regard to identification of the amino acids at the 
very hydrophobic C-terminus of PGLa-MW2, the proposed sequence was confirmed by 
amino acid composition analysis [Found: Thr 1.2 (1), Ser 1.2 (1), Gly 3.5 (4), Ala 7.0 (7), 
Ile 3.5 (4), Leu 1.1 (1), Lys 3.9 (4)  residues/mol peptide]. Figures in parentheses show the 
number of residues predicted from the proposed sequences. MALDI-TOF mass 
spectrometry was used to confirm the proposed structures and to demonstrate that tigerinin-
M1, PGLa-MW1 and PGLa-MW2, are C-terminally α-amidated and tigerinin-M1 exists in 
the cyclic (disulphide-bridged) form. It is probable that CPF-MW3 is a product of the post-
translational processing of CPF-MW1 and/or CPF-MW2 arising from proteolytic cleavage 
at a single arginine residue rather than the product of a separate gene. 
3.4. Antimicrobial and hemolytic activities 
The abilities of the most abundant peptides (> 50 nmol) in the X. muelleri and  
X. muelleri West skin secretions to inhibit the growth of reference strains of the Gram-
positive bacterium S. aureus, the Gram-negative bacterium E. coli, and the opportunistic 
yeast pathogen C. albicans are compared in Table 1. CPF-MW1 (LC50 = 70 µM), 
CPF-MW2 (LC50 = 105 µM), and magainin-M1 (LC50 = 180 µM) showed moderately high 
hemolytic activity against human erythrocytes (Table 1) whereas the hemolytic activities of 
magainin-MW1, tigerinin-M1 and PGLa-MW1 were very low (LC50 > 200 µM). 
Tigerinin-M1 did not display antimicrobial activity and did not inhibit the activity of 
elastase at a concentration of 100 µM. 
Table 1. Minimum inhibitory concentrations (M) against microorganisms and hemolytic 
activity against human erythrocytes of the endogenous peptides isolated from skin 
secretions of X. muelleri and X. muelleri West. 
E. coli S. aureus C. albicans LC50 
Magainin-M1 12.5 50 25 180
CPF-M1 12.5  6 25 ND
Tigerinin-M1 >200 >200 ND >500
Magainin-MW1 50 200 100 200 
PGLa-MW1 12.5  100 50 200 
CPF-MW1 3 6 25 70
CPF-MW2 6 6 ND 105
ND: not determined 
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4. Discussion
This study has described the purification of five peptides with varying degree of
antimicrobial activity in norepinephrine-stimulated skin secretions from the tetraploid frog 
X. muelleri and seven antimicrobial peptides in skin secretions of X. muelleri West. 
Determination of the primary structures of the peptides reveals that they represent orthologs 
of previously described dermal peptides magainin, PGLa, CPF, and XPF isolated from the 
tetraploid frogs X. laevis [17], X. borealis [27], and X. clivii [8] and from the octoploid 
frogs X. amieti [5] and X. andrei [28]. A comparison of the primary structures of these 
peptides from frogs of the X. muelleri species group (Fig. 5) strongly suggests that 
X. muelleri and X. muelleri West are not conspecific thereby providing support for the 
proposal that the latter should eventually be described as a separate species. No orthologous 
peptide from the two populations of X. muelleri has the same amino acid sequence. 
Additionally, the X. muelleri secretions, like those from X. clivii [8], did not contain a PGLa 
peptide whereas the X. muelleri West secretions contained two members of this family. The 
data suggest that X. muelleri West is more closely related to X. borealis than to either 
X. muelleri or X. clivii. In particular, magainin-MW1 from X. muelleri West is identical to 
magainin-B2 from X. borealis and XPF-MW1 shows only two amino acid substitutions 
compared with the ortholog from X. borealis but five substitutions compared with the 
ortholog from X. muelleri (Fig. 5). This conclusion is supported by cladistic analysis based 
upon the nucleotide sequences of mitochondrial DNA that places X. muelleri West 
(described in the article as “X. new tetraploid”) as sister group to X. borealis rather than to 
X. muelleri [14]. 
A disulphide-bridged peptide containing the RFamide motif at its C-terminus was 
isolated from the X. muelleri skin secretions. The peptide lacks antimicrobial or hemolytic 
activity but shows limited structural similarity to peptides of the tigerinin peptide family 
(Fig. 6) and so is provisionally designated tigerinin-M1. The presence of such peptide in 
skin secretions of species belonging to the Xenopodidae has not been reported previously. 
Tigerinin peptides have previously been identified only in Hoplobatrachus tigerinus [32], 
Hoplobatrachus rugulosus (unpublished data), and Fejervarya cancrivora [38] belonging 
to the subfamily Dicroglossinae of the family Dicroglossidae. Despite their low cationicity 
and their inability to adopt a α-helical conformation, the tigerinins from Hoplobatrachus 
and Fejervarya have been reported to display broad-spectrum antimicrobial activity 
[32,38]. However, under the conditions of assay used in this study, the peptide from 
H. rugulosus was not active against either E. coli or S. aureus (unpublished data). The 
biological role of tigerinin-M1, if any, and its evolutionary relationship to other vertebrate 
peptides containing the RFamide motif [34] are unknown. Skin secretions of several species 
of frogs have been shown to contain protease inhibitors [33]. The region of the cysteine-
rich inhibitor of elastase, guamerin, first isolated from the leech Hirudo nipponia [20] 
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contains a Met(P1)-Ile( P1΄) scissile bond. A Met-Ile bond is also found in tigerinin-M1 but 
the peptide did not inhibit porcine pancreatic elastase at a concentration of 100 μM. 
Magainin-related peptides 
X. muelleri West-MW1 GIGKFLHSAGKFGKAFLGEVMKS 
X. muelleri-M1 GIGKFLHSAGKFGKAFIGEIMKS (2)
X. muelleri-M2 GFKQFVHSLGKFGKAFVGEMIKPK (10)
X. borealis-B1 G**KFLHSAGKFGKAFLGEVMIG (4)
X. borealis-B2 GIGKFLHSAGKFGKAFLGEVMKS (0)
X. clivii-C1 GVGKFLHSAKKFGQALASEIMKS (7)
X. clivii-C2 GVGKFLHSAKKFGQALVSEIMKS (7)
Proxenopsin-derived peptides 
X. muelleri West-MW1 GWASKIGQTLGKLAKVGLKEFAQS 
X. muelleri-M1 GWASKIGQTLGKMAKVGLKDLIQA (5)
X. borealis-B2 GWASKIGQTLGKMAKVGLKEFVQS (2)
X. clivii-C1 GWASKIGQALGKVAKVGLQQFIQPK (6)
PGLa-related peptides 
X. muelleri West-MW1 GMASKAGSVLGKITKIAL*GALa 
X. borealis-B2 GMASKAGSIVGKIAKIAL*GALa  (3) 
X. muelleri West-MW2 GMASKAGAIAGKIAKTAIKLALa
X. borealis-B1 GMASKAGTIAGKIAKTAIKLALa  (1) 
Procaerulein-derived peptides 
X. muelleri West-MW1 GLGSLLGKAFKFGLKTVGKMMGGAPREQ 
X. muelleri-M1 GLGSLLGKAFKFGLKTVGKMMAGAPREQ (1) 
X. borealis-B1 GLGSLLGKAFKIGLKTVGKMMGGAPREQ (1) 
X. clivii-C2 GLGSLLGKALKFGLKAAGKFMGGEP*QQ (7)
X. muelleri West-MW2 GLGSLLGKAFKFGLKTVGKMMGGAPREE 
X. muelleri-M2 GLGSLLGKAFKFGLKTVGKMMAGAPREE (1) 
X. muelleri West-MW3 GLGSLLGKAFKFGLKTVGKMMGGAPR 
X. borealis-B2 GLGSLLGKAFKIGLKTVGKMMGGAPR (1) 
Fig. 5. A comparison of the primary structures of the orthologous peptides from X. muelleri West,  
X. muelleri, X. borealis, and X. clivii.  Structural differences are emphasized by the shading and the 
values in parentheses show the number of amino acids that differ from the X. muelleri West sequence. 
(*) Denotes a residue deletion and (a) indicates that the peptide is C-terminally -amidated. 
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Tigerinin-related peptides 
X. muelleri  WCPPMIPL**CSRFa
H. tigerinus 1 FC*TMIPIPRCYa 
H. tigerinus 2 RVC*FAIPLPICHa
H. tigerinus 3 RVC*YAIPLPICYa
H. tigerinus 4 RVC*YAIPLPICa
F. cancrivora RVC*SAIPLPICH 
F. cancrivora RVC*MAIPLPLCH 
H. rugulosus RVC*MAIPLPLCHa
Fig. 6. A comparison of the primary structures of the tigerinin-like peptide from X. muelleri with the 
tigerinins from Hoplobatrachus tigerinus, Hoplobatrachus rugulosus, and Fejervarya cancrivora. 
Structural similarity is emphasized by the shading. (*) Denotes a residue deletion and (a) indicates 
that the peptide is C-terminally -amidated. 
The physicochemical properties (mean hydrophobicity, cationicity, and degree of 
α-helicity) of the peptides isolated in this study are compared in Table 2. The antimicrobial 
activities of frog skin peptides against microorganisms and their cytotoxic activities against 
mammalian cells are determined by complex interactions among cationicity, 
hydrophobicity, -helicity and amphipathicity [4,30]. 
Consistent with previous observations with peptides from related species [5,8,27,28], 
the CPF peptides show the greatest antimicrobial potency (MIC in the range 3 - 25 µM) 
against the Gram-negative E. coli, the Gram-positive S. aureus, and the opportunistic yeast 
pathogen C. albicans. This activity correlates with a high propensity to adopt an extended 
α-helical conformation in a membrane-mimetic solvent (Table 2). The 2-fold decrease in 
potency against E. coli of CPF-MW2 compared with CPF-MW1 may be explained by the 
decrease in cationicity associated with the amino acid substitution Gln28  Glu. Several 
structure-activity studies involving both naturally occurring antimicrobial peptides and 
synthetic model peptides (reviewed in [4]) have shown a correlation between increasing 
cationicity and increased antimicrobial potency until a certain optimal molecular charge is 
reached. However, the therapeutic potential of the CPF peptides as anti-infective agents, 
particularly for systemic use, is limited by their hemolytic activity against human 
erythrocytes (LC50 in the range 70 – 105 µM). 
 C
hapter  5
121
Table 2. Physicochemical properties of the antimicrobial peptides isolated from skin 
secretions of Xenopus muelleri and Xenopus muelleri West 
Peptide Mean 
hydrophobicity 
Charge at 
pH 7 
α-helical domain 
Magainin-M1 +5.3 +3 Non-helical
Magainin-M2 -2.1 +4 Non-helical
Tigerinin-M1 +7.0 +2 Non-helical
XPF-M1 +1.8 +3 10-16
CPF-M1 +1.6 +4 2-11, 14-22
CPF-M2 +1.6 +3 2-11, 14-22
Magainin-MW1 +4.3 +3 Non-helical
XPF-MW1 -2.6 +3 10-18
PGLa-MW1 +18.1 +4 12-19
PGLa-MW2 +18.0 +5 8-22
CPF-MW1 -0.6 +4 2-12, 14-17
CPF-MW2 -0.6 +3 2-11, 14-17
CPF-MW3 +6.4 +5 2-11, 14-17
Mean hydrophobicities (H) of the peptides are calculated using the hydrophobicity scales for amino 
acid residues of Kyte and Doolittle [23]. Predictions of helical domains are made using the AGADIR 
program [29]. 
It is more difficult to account for the greater antimicrobial potency and hemolytic 
activity of magainin-M1 compared with magainin-MW1. Both peptides bear a charge +3 at 
pH 7 but the substitutions Leu17  Ile and Val20  Ile in the X. muelleri West peptide 
result in an increase in mean hydrophobicity. Studies with synthetic analogs of magainin-2 
from X. laevis have shown that increasing overall hydrophobicity enhanced activity against 
Gram-positive bacteria while, at the same time, increasing hemolytic activity [10,36]. 
Although the potency of magainin-MW1 is relatively low, it is known that the magainin 
peptides act synergistically with PGLa so that the peptides in combination show more 
potent growth inhibitory activity against E. coli than either peptide tested alone [37]. 
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Consequently, in the X. muelleri West secretions, magainin-MW1 may act to potentiate the 
activities of PGLa-MW1 and PGLa-MW2 as well as the CPF peptides. 
This study has given further support to the assertion that the amino acid sequences of 
antimicrobial peptides in skin secretions have value in inferring evolutionary relationships 
among frogs. The skin peptide profiles of Australian hylid frogs from the genera Crinia, 
Litoria, and Uperoleia have been used, together with morphological and cognate methods, 
to differentiate between sub-species and even different population clusters of the same 
species [19]. Previous investigations with ranid frogs have used the same methodology 
described in this article to demonstrate that Rana tagoi tagoi and Rana tagoi okiensis are 
probably not conspecific [6] and that the relict leopard frog Lithobates onca and the 
lowland leopard frog Lithobates yavapaiensis, although closely related phylogenetically, 
are separate species [7]. On the other hand, the presence of identical peptides in skin 
secretions from specimens of the Chiricahua leopard frog Lithobates chiricahuensis 
occupying regions in southern Arizona and from morphologically distinct specimens 
occupying the Mogollon Rim of central Arizona suggest that the two populations probably 
do not represent separate species [9]. 
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ABSTRACT 
Skin secretions of frogs from the subfamily Xenopodinae (Xenopus + Silurana) within the 
family Pipidae are a rich source of antimicrobial peptides with therapeutic potential but 
species from the sister taxon Hymenochirus in the subfamily Pipinae (Hymenochirus + 
Pseudhymenochirus + Pipa) have not been investigated. Peptidomic analysis of 
norepinephrine-stimulated skin secretions from two distinct populations of the Congo 
dwarf clawed frog Hymenochirus boettgeri (Tornier, 1896) has led to identification of five 
structurally-related peptides with broad-spectrum antimicrobial activity. Hymenochirin-1B 
(IKLSPETKDNLKKVLKGAIKGAIAVAKMV.NH2) is C-terminally α-amidated whereas 
hymenochirins-2B-5B have the general structure XKIPX2VKDTLKKV 
AKGX2SX2AGAX3.COOH. Hymenochirin-3B (IKIPAVVKDTLKKVAKGVLSAVA 
GALTQ) was the most abundant peptide in the secretions. The hymenochirins show very 
low structural similarity with the antimicrobial peptides isolated from skin secretions of 
Silurana tropicalis and Xenopus laevis consistent with the proposed ancient divergence of 
the Pipinae and Xenopodinae. Synthetic replicates of hymenochirin-1B - 4B inhibit the 
growth of Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and 
Staphylococcus aureus (MIC in the range 10 - 40 µM) and Candida albicans  
(MIC = 80 µM). The peptides display relatively weak hemolytic activity against human 
erythrocytes (LC50 in the range 160 to >300 µM). 
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1. Introduction
The clawed frogs comprise 33 well-characterized species distributed in five genera
Hymenochirus, Pipa, Pseudhymenochirus, Silurana, and Xenopus within the family Pipidae 
[17,18]. All are found in Africa south of the Sahara except for members of the genus Pipa 
which are found in South America. The skins of frogs from the subfamily Xenopodinae 
(Xenopus + Silurana) have proved to be a rich source of host-defense peptides with 
antimicrobial and anti-inflammatory activities (reviewed in [10]). Xenopus laevis was the 
first amphibian species in which cutaneous peptides, the magainins with growth inhibitory 
activity against bacteria and fungi were unambiguously identified [39]. Subsequent analysis 
of X. laevis skin secretions has led to the isolation and characterization of several other 
peptides that show therapeutic potential as anti-infective agents. These include peptide 
glycine-leucine-amide (PGLa) and multiple structurally-related peptides termed caerulein-
precursor fragment (CPF) and xenopsin-precursor fragment (XPF) that are derived from the 
post-translational processing of the biosynthetic precursors of caerulein  and xenopsin 
respectively [21,35]. Peptides that belong to the PGLa family (peptide XT-5), the 
CPF family (peptides XT-1, XT-6, and XT-7), and the XPF family (peptides XT-2, XT-3, 
and XT-4) have been isolated from skin secretions of Silurana tropicalis but peptides 
orthologous to the magainins were not identified [1]. More recently, antimicrobial peptides 
belonging to the magainin, PGLa, CPF, and XPF families have been isolated from 
norepinephrine-stimulated skin secretions from Xenopus amieti [8], Xenopus andrei [29], 
Xenopus borealis [28], Xenopus clivii [9], Xenopus lenduensis [22], Xenopus muelleri [30] 
and an incompletely characterized species from West Africa provisionally designated 
X. muelleri West [30], Xenopus petersii [22], and Xenopus pygmaeus [22]. 
The genus Hymenochirus Boulenger, 1896 comprises four species (H. boettgeri, 
H. boulengeri, H. curtipes, and H. feae) that are found in equatorial Africa [18]. 
H. boettgeri ranges widely through the equatorial forest zone of central Africa from 
southeastern Nigeria and Cameroon south through Gabon to the Mayombe region of 
western Democratic Republic of Congo and the species has been introduced into 
southeastern Florida, USA non-indigenously [38]. The species is aquatic, generally found 
in still, shaded water in lowland rainforest and in pools by slow-flowing rivers [36]. 
H. boettgeri is unusual in that it relies solely on inertial suction to capture prey [4]. It is 
listed as a Species of Least Concern by the International Union for Conservation of Nature 
(IUCN) Red List of Threatened Species in view of its wide distribution. However, it is a 
popular species for the pet trade and numbers have also declined because of habitat 
modification from deforestation [37]. Chyridiomycosis has been reported in a population of 
H. boettgeri that were probably captive bred in Florida [33]. 
Up until this time, no species belonging to the genus Hymenochirus has been 
investigated for the presence of cutaneous host-defense peptides. The present study 
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describes the isolation and the structural and biological characterization of peptides with 
antimicrobial activity from norepinephrine-stimulated skin secretions of two distinct 
populations of the Congo dwarf clawed frog H. boettgeri (Tornier, 1896) that originated in 
the Cameroon and the Democratic Republic of the Congo. 
2. Experimental
2.1. Collection of skin secretions 
All experiments with live animals were approved by the Animal Research Ethics 
Committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators. Two populations of the Congo dwarf clawed frog H. boettgeri were sampled. 
Adult animals from group 1 (n = 4; weights 3.0-5.0 g; 2 female) were kept at the Steinhart 
Aquarium, California Academy of Science, San Francisco, CA and were originally 
collected at a site in the Cameroon. Sub-adult animals from group 2 (n = 4; weights 
0.69-0.74 g; sex not determined) were purchased at a pet store in St Louis, MO, USA and 
were originally collected at a site in the Democratic Republic of Congo. 
Each animal was injected via the dorsal lymph sac with norepinephrine hydrochloride 
(40 nmol/g body weight) and placed in a solution (40 ml) of distilled water for 15 min. The 
frog was removed and the collection solution was acidified by addition of trifluoroacetic 
acid (TFA) (1 ml) and immediately frozen for shipment to U.A.E. University. The solutions 
containing the secretions from both groups were separately pooled and passed at a flow rate 
of 2 ml min-1 through 4 Sep-Pak C-18 cartridges (Waters Associates, Milford, MA, USA) 
connected in series. Bound material was eluted with acetonitrile/water/TFA (70.0:29.9:0.1, 
v/v/v) and freeze-dried. The material was redissolved in 0.1% (v/v) TFA/water (2 ml). 
2.2.  Peptide purification 
The skin secretions from each group of H. boettgeri, after partial purification on Sep-
Pak cartridges, were separately injected onto a preparative (2.2 cm x 25 cm) Vydac 
218TP1022 (C-18) reversed-phase HPLC column (Grace, Deerfield, IL, USA) equilibrated 
with 0.1% (v/v) TFA/water at a flow rate of 6.0 ml min-1. The concentration of acetonitrile 
in the eluting solvent was raised to 21% (v/v) over 10 min and to 63% (v/v) over 60 min 
using linear gradients. Absorbance was monitored at 214 nm and 280 nm, and fractions 
(1 min) were collected. Purification and biological activities of the peptides were monitored 
by incubating lyophilized aliquots of chromatographic effluent (100 µl) in Mueller-Hinton 
broth (50 l) with an inoculum (50 l of 106 colony forming units/ml) from a log-phase 
culture of reference strains of Staphylococcus aureus (ATCC 25923) and Escherichia coli  
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(ATCC 25726) in 96-well microtiter cell-culture plates for 18 h at 37oC in a humidified 
atmosphere of air. After incubation, the absorbance at 630 nm of each well was determined 
using a microtiter plate reader. Fractions associated with antimicrobial activity were 
successively chromatographed on a (1.0 cm x 25 cm) Vydac 214TP510 (C-4) column and a 
(1.0 cm x 25 cm) Vydac 208TP510 (C-8) column. The concentration of acetonitrile in the 
eluting solvent was raised from 21% to 56% over 50 min and the flow rate was 2.0 ml min-1. 
2.3. Structural characterization 
The primary structures of the peptides were determined by automated Edman 
degradation using a model 494 Procise sequenator (Applied Biosystems, Foster City, CA, 
USA). MALDI-TOF mass spectrometry was carried out using a Voyager DE-PRO 
instrument (Applied Biosystems) that was operated in reflector mode with delayed 
extraction and the accelerating voltage in the ion source was 20 kV. The instrument was 
calibrated with peptides of known molecular mass in the 2 - 4 kDa range. The accuracy of 
mass determinations was  0.02%. 
2.4. Peptide synthesis 
Hymenochirins-1B - 5B were supplied in crude form by China Peptides Ltd. 
(Shanghai, China) and GL Biochem Ltd. (Shanghai, China) and were purified to near 
homogeneity (> 98% purity) by reversed-phase HPLC on a (2.2 cm x 25 cm) Vydac 
218TP1022 (C-18) column. The concentration of acetonitrile in the eluting solvent was 
raised from 28% to 56% over 60 min and the flow rate was 6 ml min-1. The identity and 
purity of the peptides was confirmed by electrospray mass spectrometry. Hymenochirin-5B 
was obtained in low yield and was observed to form a viscous gel in concentrated solution. 
2.5. Antimicrobial and hemolytic activities 
Reference strains of microorganisms were purchased from the American Type Culture 
Collection (Rockville, MD). Minimum inhibitory concentrations (MIC) of the synthetic 
hymenochirins against S. aureus (ATCC 25923), E. coli (ATCC 25726), 
Klebsiella pneumoniae (ATCC 700603), Pseudomonas aeruginosa (ATCC 27853), and 
Candida albicans (ATCC 90028) were measured in the concentration range of 2.5 - 160 
μM by standard double dilution methods [5,6] and were taken as the lowest concentration 
of peptide where no visible growth was observed. The values were confirmed by 
measurement of absorbance at 630 nm. A minimum of three independent incubations were 
performed. In order to monitor the validity and reproducibility of the assays, incubations 
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were carried out in parallel with increasing concentrations of antibiotics (ampicillin for  
S. aureus and E. coli, ciprofloxacin for K. pneumoniae and P. aeruginosa, and 
amphotericin for C. albicans) as previously described [28-30]. 
Hemolytic activity against human erythrocytes taken from a healthy donor was 
measured as previously described [28-30]. Peptides were tested in the concentration range 
37.5 - 300 µM. The LC50 value was taken as the mean concentration of peptide producing 
50% hemolysis in three independent incubations. 
 
2.6.  Secondary structure prediction 
Prediction of secondary structure and determination of % helicity per residue for the 
peptides were performed using the AGADIR program [31]. AGADIR is a prediction 
algorithm based on the helix/coil transition theory which predicts the helical behaviour of 
monomeric peptides. Calculations were performed at pH 7 and 278K. A minimum 
percentage of 1% helicity/residue was considered to predict the presence of a helix. 
Calculated mean hydrophobicities of the peptides were based upon the hydrophobicity 
scales for amino acids of Kyte and Doolittle [23]. 
 
3. Results 
3.1. Purification of the peptides 
The pooled skin secretions from the group 1 population of H. boettgeri (Cameroon), 
after partial purification on Sep-Pak C-18 cartridges, were chromatographed on a Vydac  
C-18 preparative reversed-phase HPLC column (Fig. 1). Under the conditions of assay, the 
prominent peaks designated 1 - 5 were associated with the ability to inhibit the growth of 
both E. coli and S. aureus. Subsequent structural analysis demonstrated that these peaks 
contained hymenochirins 1- 5. The peptides were purified to near homogeneity, as assessed 
by a symmetrical peak shape and mass spectrometry, by further chromatography on 
semipreparative Vydac C-4 and Vydac C-8 columns. The methodology is illustrated by 
purification of hymenochirin-3B on C-4 (Fig. 2A) and C-8 (Fig. 2B) columns. The 
approximate final yields of purified peptides (nmol) were hymenochirin-1B (40), 
hymenochirin-2B (55), hymenochirin-3B (425), hymenochirin-4B (90) and  
hymenochirin-5B (65). 
  
C
hapter  6 
133
Fig. 1. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from 
H. boettgeri from the Cameroon (Group 1) after partial purification on Sep-Pak cartridges. Peaks 1-5 
inhibited growth of E. coli and S. aureus and were purified further. The dashed line shows the 
concentration of acetonitrile in the eluting solvent. 
Fig. 2. Purification to near homogeneity of hymenochirin-3B on semipreparative (A) Vydac C-4, and 
(B) Vydac C-8 columns. The arrowheads show where peak collection began and ended. The dashed 
line shows the concentration of acetonitrile in the eluting solvent. 
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The pooled skin secretions from the group 2 population of H. boettgeri (Congo), after 
partial purification on Sep-Pak C-18 cartridges, were chromatographed on a Vydac C-18 
preparative reversed-phase HPLC column under the same condition used for secretions 
from the group 1 population (Fig. 3). The prominent peaks designated 1 - 5 were collected 
and analysed by MALDI-TOF mass spectrometry. 
Fig. 3. Reversed-phase HPLC on a preparative Vydac C-18 column of skin secretions from 
H. boettgeri from the Democratic Republic of the Congo (Group 2) after partial purification on Sep-
Pak cartridges. Peaks 1-5 were analysed by MALDI-TOF mass spectrometry and were purified 
further. The dashed line shows the concentration of acetonitrile in the eluting solvent. 
3.2. Structural characterization 
The primary structures of the antimicrobial peptides isolated from the group 1 
population (Cameroon) of H. boettgeri were established by automated Edman degradation 
and their amino acid sequences are shown in Fig. 4. 
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Cameroon Congo
Mrobs Mrobs Mrcalc 
Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV.NH2 3061.8 3062.4 3061.8 
Hymenochirin-2B LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 2973.5 2973.7 2973.7 
Hymenochirin-3B IKIPAVVKDTLKKVAKGVLSAVAGALTQ 2817.6 2817.9 2817.7 
Hymenochirin-4B IKIPAFVKDTLKKVAKGVISAVAGALTQ 2865.9 2865.5 2865.7 
Hymenochirin-5B IKIPPIVKDTLKKVAKGVLSTIAGALST  2861.0 2860.5 2860.8 
Fig. 4. Amino acid sequences, observed molecular masses (Mr obs), and calculated molecular masses 
(Mr calc) of the antimicrobial peptides isolated from skin secretions of H. boettgeri. 
As there was some ambiguity with regard to identification of the amino acids at the 
hydrophobic C-terminus of  hymenochirin-1B, the proposed sequence was confirmed by 
amino acid composition analysis [Found: Asx 2.1 (2), Clx (1.0), Thr 1.1 (1), Ser 1.1 (1), 
Gly 2.1 (2), Ala 4.0 (4), Val 2.9 (3), Met 1.1 (1), Ile 2.7 (3), Leu 3.0 (3), Lys 6.7 (7), Pro 
1.0 (1) residues/mol peptide]. Figures in parentheses show the number of residues predicted 
from the proposed sequences. The molecular masses of the peptides determined by 
MALDI-TOF mass spectrometry are consistent with their proposed structures and 
demonstrate that only hymenochirin-1B is C-terminally α-amidated. The amino acid 
sequences of hymenochirins from the group 2 population (Congo) were not determined but 
the close similarities in molecular masses (Fig. 4) and retention times on reversed-phase 
HPLC (Figs. 1 and 3) indicate that the peptides from both populations are probably 
identical. 
3.3. Antimicrobial and hemolytic activities 
The abilities of the synthetic hymenochirins to inhibit the growth of reference strains 
of the Gram-positive bacterium S. aureus, the Gram-negative bacteria E. coli,  
K. pneumoniae, and P. aeruginosa, and the opportunistic yeast pathogen C. albicans are 
compared in Table 1. The MIC values for hymenochirin-5B may be artefactually high 
because of the restricted solubility of the peptide in Mueller-Hinton broth and its tendency 
to form a gel in concentrated solution. All peptides displayed relatively low hemolytic 
activities against human erythrocytes (LC50 in the range 160 to > 300 µM). 
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Table 1. Minimum inhibitory concentrations against microorganisms and hemolytic 
activity against human erythrocytes (LC50) of the peptides isolated from skin secretions of 
H. boettgeri. 
Peptide E. coli P. aeruginosa K. pneumoniae S. aureus C. albicans LC50 
Hymenochirin-1B 20 40 20 10 80 225 
Hymenochirin-2B 20 20 20 40 80 >300 
Hymenochirin-3B 20 40 40 40 80 >300 
Hymenochirin-4B 20 20 20 20 80 160 
Hymenochirin-5B 40 ND ND 80 160 ND 
Data are expressed as µM and are derived from a minimum of three independent incubations. ND: not 
determined. 
4. Discussion
The study has described the purification and characterization of five structurally related
antimicrobial peptides from skin secretions of the frog H. boettgeri (Pipidae) belonging to 
two populations from different geographical locations. Skin secretions from a frog from the 
genus Hymenochirus have not been investigated previously. The peptides have been termed 
the hymenochirins and given the suffix B to denote the species. Although the amino acid 
sequences of the peptides from the population originating in the Democratic Republic of 
Congo were not determined, the close similarities in molecular masses and 
chromatographic properties indicate that they are probably identical to the peptides from 
frogs originating in the Cameroon. The work complements previous studies that have led to 
the isolation of antimicrobial peptides from several species from the genera Silurana and 
Xenopus within the family Pipidae (reviewed in [10,22]). Antimicrobial peptides were not 
identified in skin secretions from a representative of the genus Pipa, notably P. pipa [7], 
and the single species (P. merlini) belonging to the genus Pseudhymenochirus has not yet 
been investigated. 
Pipidae is sister-group to the Rhinophrynidae (represented by a single species, the 
Mexican burrowing toad Rhinophrynus dorsalis) [17,18] but phylogenetic relationships 
among the clades within the family are not entirely clear. A study based upon 
morphological characters concluded that Silurana was more closely related to the genera 
Hymenochirus, Pipa, and Pseudhymenochirus than to Xenopus [3]. However, subsequent 
analyses based upon the comparison of the nucleotide sequences of the DNA from 
ribosomal 18S and 28S genes strongly supported the sister-group relationship between 
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Silurana and Xenopus rather than the relationship suggested by morphology [14]. 
Subsequent comparisons of the nucleotide sequences of mitochondrial DNA [15,16] 
provide support for this conclusion and suggest that the divergence of the Xenopodinae 
(Silurana + Xenopus) from the Pipinae (Hymenochirus + Pipa + Pseudhymenochirus) 
predates the divergence of the Pipinae subfamily which occurred at the time of separation 
of Africa and South America (105 - 119 million years ago, MYA) [27]. The origin of the 
Pipidae is at least Late Jurassic (150 MYA) and breakup of Gondwana led to the 
establishment of Pipa in South America and Hymenochirus + Pseudhymenochirus in Africa 
[2]. As shown in Fig. 5, the hymenochirins show only very low structural similarity to the 
magainins from X. laevis [39] and the xenopsin-precursor fragment peptides, the caerulein-
precursor fragment peptides, and the PGLa-related peptides that were isolated from skin 
secretions of S. tropicalis [1] and X. laevis [21]. Amino acid sequence comparisons of 
orthologous antimicrobial peptides from S. tropicalis and a range of Xenopus species 
indicate an appreciably greater degree of sequence similarity (reviewed in [10]). The data 
are thus consistent with the proposed ancient divergence of Hymenochirus from the 
Silurana + Xenopus clade. 
Magainin 
Hymemochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMVa 
Hymenochirin-2B LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 
Hymenochirin-3B IKIPAVVKDTLKKVAKGVLSAVAGALTQ 
Hymenochirin-4B IKIPAFVKDTLKKVAKGVISAVAGALTQ 
Hymenochirin-5B IKIPPIVKDTLKKVAKGVLSTIAGALST 
X. laevis-1  GIGKFLHSAGKFGKAFVGEIMKS
X. laevis-2 GIGKFLHSAKKFGKAFVGEIMNS
XPF 
Hymemochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMVa
Hymenochirin-2B LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 
Hymenochirin-3B IKIPAVVKDTLKKVAKGVLSAVAGALTQ 
Hymenochirin-4B IKIPAFVKDTLKKVAKGVISAVAGALTQ 
Hymenochirin-5B IKIPPIVKDTLKKVAKGVLSTIAGALST 
S. tropicalis XT-2 GVWSTVLGGLKKFAKGGLEAIVNPK 
S. tropicalis XT-3 GLASTLGSFLGKFAKGGAQAFLQPK 
X. laevis-1  GWASKIGQTLGKIAKVGLQGLMQPK
X. laevis-2  GWASKIGQTLGKIAKVGLKELIQPK 
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PGLa 
Hymemochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMVa
Hymenochirin-2B LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 
Hymenochirin-3B IKIPAVVKDTLKKVAKGVLSAVAGALTQ 
Hymenochirin-4B IKIPAFVKDTLKKVAKGVISAVAGALTQ 
Hymenochirin-5B IKIPPIVKDTLKKVAKGVLSTIAGALST 
S. tropicalis XT-5 GMATKAGTALGKVAKAVIGAALa 
X. laevis  GMASKAGAIAGKIAK*VALKALa
CPF 
Hymemochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMVa
Hymenochirin-2B LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 
Hymenochirin-3B IKIPAVVKDTLKKVAKGVLSAVAGALTQ 
Hymenochirin-4B IKIPAFVKDTLKKVAKGVISAVAGALTQ 
Hymenochirin-5B IKIPPIVKDTLKKVAKGVLSTIAGALST 
S. tropicalis XT-1 GFLGPLLKLAAKGVAKVIPHLI*PSRQQ 
X. laevis CPF-1 GLASFLGKAL*KAGLKIGAHLLGGAPQQ 
X. laevis CPF-2 GFASFLGKAL*KAALKIGANMLGGTPQQ 
X. laevis CPF-3 GFGSFLGKAL*KAALKIGANALGGSPQQ 
X. laevis CPF-4 GLASLLGKAL*KAGLKIGTHFLGGAPQQ 
Fig. 5. A comparison of the primary structures of peptides belonging to the magainin, XPF, PGLa, 
and CPF families from Hymenochirus boettgeri, Silurana tropicalis, and Xenopus laevis. a indicates 
that the peptide is C-terminally -amidated. Shading is used to indicate conserved amino acid 
residues. Gaps, denoted by *, are inserted into some sequences to maximize structural similarity. 
The physicochemical properties (grand average of hydrophobicity, cationicity, and 
degree of α-helicity) of the peptides isolated in this study are compared in Table 2. 
Retention time on reversed-phase HPLC has been shown to provide a measure of the 
effective hydrophobicity of a α-helical peptide [36]. However, the observed retention times 
of the hymenochirins do not correlate exactly with calculated hydrophobicity as 
hymenochirin-4B and -5B are eluted from the column with anomalously high retention 
times which may be related to their tendency to self-aggregate. 
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Table 2. Physicochemical properties of the antimicrobial peptides isolated from skin 
secretions of H. boettgeri. 
Peptide GRAVY Charge at pH 7 α-helicity 
Hymenochirin-1B 0.169 +6 5-27
Hymenochirin-2B 0.466 +4 8-16
Hymenochirin-3B 0.689 +4 9-16
Hymenochirin-4B 0.664 +4 7-16
Hymenochirin-5B 0.596 +4 9-16
Grand average of hydropathicity (GRAVY) of the peptides are calculated using the hydrophobicity 
scales for amino acid residues of Kyte and Doolittle [23]. Predictions of helical domains are made 
using the AGADIR program [31]. 
Analysis of the secondary structure of the peptides using the AGADIR program [31] 
indicates that hymenochirins -2B, -3B, -4B, and - 5B have a relatively weak propensity to 
adopt a α-helical conformation in the conserved central region of the molecule (maximum 
percentage helicity/residue = 1.5) whereas hymenochrin-1B is predicted to form a more 
stable (maximum percentage helicity/residue = 20) and extended α-helical domain from 
residues 5 to 27. A Schiffer-Edmundsen wheel representation [34] of N-terminal region of 
hymenochirin-1B illustrates the amphipathic nature of the α-helical conformation with the 
polar Lys2, Glu6, Lys8, Asp9, Lys12, Lys13, and Lys16 segregating on one face of the helix 
and the hydrophobic Leu3, Leu11, Val14, and Leu15 residues on the opposite face (Fig. 6). 
Hymenochirin-1B differs from the other structurally similar hymenochirins by its 
greater cationicity (charge of +6 at pH 7 compared with +4 for hymenochirins -2B, -3B, 
-4B, and -5B) and by its strong propensity to form a stable and extended α-helical 
conformation (Table 2). The antimicrobial activities of peptides against microorganisms 
and their cytotoxic activities against mammalian cells are determined by complex 
interactions among cationicity, hydrophobicity, -helicity and amphipathicity [11,12]. 
Several structure-activity studies involving both naturally occurring antimicrobial peptides 
and synthetic model peptides (reviewed in [12]) have shown a correlation between 
increasing cationicity and increased antimicrobial potency until a certain optimal molecular 
charge is reached. 
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Fig. 6. Schiffer-Edmundson wheel representation of the (1-18) region of hymenochirin-1B 
demonstrating the amphipathic nature of the predicted α-helical conformation. 
The increased growth inhibitory potency of hymenochirin-1B against the Gram-
positive bacterium S. aureus is consistent with the results of these studies. The effects of 
increased cationicity on potency of hymenochirin-1B against Gram-negative bacteria are 
less pronounced (Table 2). It has been shown using model peptides that a stabilized 
amphipathic α-helical conformation is an absolute requirement for cytotoxic activity 
against Gram-positive bacteria whereas the structural requirements for activity against 
Gram-negative bacteria are less stringent [20]. Studies with analogs of the amphipathic 
model α-helical peptide KLALKLALKALKAAKLA.NH2 have shown a positive 
correlation between hemolytic activity and degree of α-helicity [11]. The greater hemolytic 
activity of hymenochirin-1B compared with hymenochirin-2B and -3B is consistent with its 
increased propensity to form a stable α-helix. Hemolytic activity of an amphipathic 
α-helical peptide also increases with hydrophobicity [13,35]. The increased hemolytic 
activity of hymenochirin-4B correlates with its greater effective hydrophobicity as 
determined by retention time on reversed-phase HPLC. There was insufficient material to 
determine the LC50 value of hymenochirin-5B against human erythrocytes. 
The emergence in all regions of the world of strains of pathogenic bacteria and fungi 
with resistance to commonly used antibiotics constitutes a serious threat to public health 
[32]. Although effective new types of antibiotics against multidrug-resistant Gram-positive 
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bacteria such as methicillin-resistant S. aureus (MRSA) have been introduced or are in 
clinical trials, the situation regarding new treatment options for infections produced by 
multidrug-resistant Gram-negative pathogens such as E. coli, P. aeruginosa and 
K. pneumoniae is less encouraging  [26]. Infections caused by these carbapenemase-
producing bacteria that are resistant to all beta-lactam antibiotics are particularly difficult to 
treat [19]. Colistin, the cyclic antibiotic peptide polymyxin E derived from Bacillus 
polymyxa, is used as a “last resort” therapy in the management of infections due to 
multidrug-resistant Gram-negative bacteria [25]. However, not only high nephrotoxicity 
limits its use but resistance to colistin has already been described and increasing use of this 
antibiotic is likely to lead to the emergence of more resistant strains [24]. This situation has 
necessitated a search for novel types of antimicrobial agents, with appropriate toxicological 
and pharmacokinetic properties, to which pan-resistant pathogenic microorganisms have 
not been exposed. Hymenochirins-2B and 3B, although displaying only moderate potency 
against Gram-negative bacteria (MIC in the range 20 - 40 µM), have the advantage over 
many naturally occurring antimicrobial peptides of having very low cytotoxicity against 
human erythrocytes (LC50 > 300 µM). Further structure-activity studies are warranted to 
develop analogs of these peptides with increased activity against drug-resistant pathogenic 
microorganisms that retain low hemolytic activity. 
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ABSTRACT 
Peptidomic analysis was used to compare the distribution of host-defense peptides in 
norepinephrine-stimulated skin secretions from laboratory-generated female F1 hybrids of 
the common clawed frog Xenopus laevis (Daudin, 1802) and Mueller’s clawed frog 
Xenopus muelleri (Peters, 1844) with the corresponding distribution in skin secretions from 
the parent species.  A total of 18 peptides were identified in secretions from the hybrid 
frogs. Eleven peptides (magainin-1, magainin-2, CPF-1, CPF-3, CPF-4, CPF-5, CPF-6, 
CPF-7, XPF-1, XPF-2, and PGLa) were identified in secretions of both the hybrids and 
X. laevis. Four peptides (magainin-M1, XPF-M1, CPF-M1, and tigerinin-M1) were 
previously found in skin secretions of X. muelleri but magainin-M2 and CPF-M2 from 
X. muelleri were not detected. Three previously undescribed peptides (magainin-LM1, 
PGLa-LM1, and CPF-LM1) were purified from the secretions of the hybrid frogs that were 
not detected in secretions from either X. laevis or X. muelleri. Magainin-LM1 differs from 
magainin-2 from X. laevis by a single amino acid substitution (Gly13  Ala) but 
PGLa-LM1 and CPF-LM1 differ appreciably in structure from orthologs in the parent 
species. CPF-LM1 shows potent, broad-spectrum antimicrobial activity and is hemolytic. 
The data indicate that hybridization increases the multiplicity of skin host-defense peptides 
in skin secretions. As the female F1 hybrids are fertile, hybridization may represent an 
adaptive strategy among Xenopus species to increase protection against pathogenic 
microorganisms in the environment. 
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1. Introduction
The clawed frogs of the genus Xenopus within the family Pipidae currently comprise
19 well characterized species although several unnamed species have been reported (Kobel 
et al., 1996; Frost, 2011). All are found in Africa south of the Sahara. The genus has a 
complex evolutionary history involving both bifurcating and reticulating modes of 
speciation (Kobel, 1996; Evans et al., 2004; Evans, 2008). Allopolyploidization events, in 
which two species hybridize and the descendant inherits the complete genome of both 
ancestors, have given rise to tetraploid, octoploid, and dodecaploid species with no extant 
Xenopus species retaining the diploid status that is thought to be related to the ancestral 
state existing prior to one or more whole genome duplications (Kobel and Du Pasquier, 
1991). At this time, the ten tetraploid Xenopus species have been divided into three species 
groups on the basis of similarities in morphology, advertisement calls, and/or nucleotide 
sequences of mitochondrial genes: the laevis group includes X. laevis, X. gilli, X. largeni, 
X. petersii, and X. victorianus; the muelleri group includes X. muelleri, X. borealis, and  
X. clivii; and the fraseri group includes X. fraseri and X. pygmaeus (Kobel et al., 1996; 
Evans et al., 2004). It has been proposed that the seven extant octoploid species arose from 
three distinct allopolyploidization events (Evans, 2008; Evans et al., 2011). Thus, 
X. lenduensis and X. vestitus share a common tetraploid ancestor; X. amieti, X. andrei, and 
X. boumbaensis form a second group; and X. itombwensis and X. wittei constitute a third 
group. Further allopolyploidizations within the second group have given rise to the 
dodecaploid species X. longipes and X. ruwenzoriensis. 
The skins of frogs from the genus Xenopus have proved to be a rich source of host-
defense peptides with antimicrobial and anti-inflammatory activities [reviewed in (Conlon 
et al., 2012)]. The magainins were isolated from X. laevis skin more than 25 years ago, 
(Giovannini et al., 1987; Zasloff, 1987) and analysis of skin secretions from this species led 
to the isolation and characterization of several other peptides that show therapeutic potential 
as anti-infective agents (Zhang and Falla, 2010). These include peptide glycine-leucine-
amide (PGLa) and multiple structurally-related peptides that are derived from the post-
translational processing of the biosynthetic precursors of caerulein [termed caerulein-
precursor fragment (CPF)] and xenopsin [termed xenopsin-precursor fragment (XPF)] 
(Gibson et al., 1986; Soravia et al., 1988). More recently, antimicrobial peptides belonging 
to the magainin, PGLa, CPF, and XPF families have been isolated from norepinephrine-
stimulated skin secretions from X. amieti (Conlon et al., 2010), X. andrei (Mechkarska et 
al., 2011b) , X. borealis (Mechkarska et al., 2010), X. clivii (Conlon et al., 2011), 
X. lenduensis (King et al., 2012), X. muelleri and an incompletely characterized species 
from West Africa provisionally designated X. muelleri West (Mechkarska et al., 2011a), 
X. petersii (King et al., 2012), and X. pygmaeus (King et al., 2012). 
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There have been relatively few reports of natural hybridization between Xenopus 
species in the wild. Extensive interbreeding has been described only for X. laevis and the 
seriously endangered X. gilli (Picker, 1985). Hybrids between X. borealis and 
X. victorianus in western Kenya have also been described (Yager, 1996). Areas of sympatry 
between X. laevis and X. muelleri are few which mitigates against interbreeding but the two 
species were found in the same bodies of water in Mpumalanga province of South Africa 
and natural hybrids were characterized both biochemically and morphologically and from 
their distinctive advertisement calls (Fischer et al., 2000). In contrast, many Xenopus 
species can be hybridized in the laboratory and gametic incompatibilities are generally 
found to be absent (Kobel et al., 1996). In such interspecies crosses, the males are 
consistently sterile and the females are fully or partially fertile. As Xenopus females are 
heterogametic and males are homogametic, it has been pointed out that this genus 
represents an exception to Haldane’s rule that the heterogametic sex typically suffers the 
greater dysfunctional effects of hybridization (Malone et al., 2007). 
The generation of X. laevis x X. muelleri hybrids in the laboratory has been described 
and microarray analysis has been used to study gene expression in the testes of hybrid 
males (Malone et al., 2007) and in the ovary of hybrid females (Malone and Michalak, 
2008). These animals have been made available to the investigators and the aim of the 
present study was to use peptidomic analysis (reversed-phase HLPC coupled with 
electrospray mass spectrometry) to compare the host-defense peptides in norepinephrine-
stimulated skin secretions from female X. laevis x X. muelleri F1 hybrids with the 
corresponding peptides from the parent species. The peptides described in this study are 
classified according to the terminology used previously for peptides from the X. laevis 
(Gibson et al., 1986, Zasloff, 1987). The magainin, PGLa, CPF, and XPF peptide families 
are recognized. The term tigerinin refers to the family of cyclic peptides first identified in 
the Asian frog Hoplobatrachus tigerinus (Sai et al., 2001). Orthologs from X. muelleri are 
designated M and the novel peptides identified in the hybrids are denoted by LM. Paralogs 
are differentiated by numerals e.g. CPF-1 and CPF-2. 
2. Materials and methods
2.1. Collection of skin secretions 
All experiments with live animals were approved by the Animal Research Ethics 
committee of U.A.E. University (Protocol No. A21-09) and were carried out by authorized 
investigators. X. laevis x X. muelleri F1 hybrids were produced as previously described 
(Malone et al., 2007). The female parents were X. laevis originating from the Cape region 
of South Africa and the male parents were X. muelleri originating from the Nkambeni area 
of Swaziland. Female hybrids (n = 3; 5 -6 years old; weights 43 – 48 g) were injected via 
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the dorsal lymph sac with norepinephrine hydrochloride (40 nmol/g body weight) and 
placed in a solution (100 mL) of collecting buffer (50 mM sodium chloride-25 mM sodium 
acetate, pH 7.0)  for 15 min. The frogs were removed and the collection solution was 
acidified by addition of concentrated hydrochloric acid (1 mL) and immediately frozen for 
shipment to U.A.E. University. The solutions containing the secretions from each group 
were pooled and separately passed at a flow rate of 2 mL/min through 6 Sep-Pak C-18
cartridges (Waters Associates, Milford, MA, USA) connected in series. Bound material was 
eluted with acetonitrile/water/trifluoroacetic acid (TFA) (70.0:29.9:0.1, v/v/v) and freeze-
dried. The material was redissolved in 0.1% (v/v) TFA/water (2 mL). 
A single adult female specimen of X. laevis (weight 263 g) was supplied by Xenopus 
Express Inc. (Brooksville, FL, USA) and housed in the vivarium at U.A.E. University. Skin 
secretions were obtained and partially purified on Sep-Pak cartridges using the same 
protocol used for the hybrids. The collection of skin secretions from X. muelleri has been 
described previously (Mechkarska et al., 2011a). 
2.2. Peptide purification 
The pooled skin secretions from the hybrid frogs, after partial purification on Sep-Pak 
cartridges, were injected onto a (2.2 cm x 25 cm) Vydac 218TP1022 (C-18) reversed-phase 
HPLC column (Grace, Deerfield, IL, USA) equilibrated with 0.1% (v/v) TFA/water at a 
flow rate of 6.0 mL/min. The concentration of acetonitrile in the eluting solvent was raised 
to 21% (v/v) over 10 min and to 63% (v/v) over 60 min using linear gradients. Absorbance 
was monitored at 214 nm and 280 nm, and fractions (1 min) were collected. Purification of 
the peptides was monitored by incubating lyophilized aliquots of chromatographic effluent 
(100 µL) in Mueller-Hinton broth (50 L) with an inoculum (50 L of 106 colony forming 
units/mL) from a log-phase culture of reference strains of Staphylococcus aureus (ATCC 
25923) and Escherichia coli (ATCC 25726) in 96-well microtiter cell-culture plates for 
18 h at 37oC in a humidified atmosphere of air. After incubation, the absorbance at 630 nm 
of each well was determined using a microtiter plate reader. Fractions associated with 
antimicrobial activity were successively chromatographed on a (1.0 cm x 25 cm) Vydac 
214TP510 (C-4) column and a (1.0 cm x 25 cm) Vydac 208TP510 (C-8) column. The 
concentration of acetonitrile in the eluting solvent was raised from 21% to 56% over 50 min 
and the flow rate was 2.0 mL/min. 
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Skin secretions from X. laevis (20% of the total amount collected) were subjected to 
the same chromatographic procedures used for purification of the peptides from the hybrid 
frogs. The purification of antimicrobial peptides from X. muelleri skin secretions has been 
described previously (Mechkarska et al., 2011a). 
2.3. Structural characterization 
Electrospray-ionization mass spectrometry was carried out using an Agilent 6310 
Series ion trap mass spectrometer as previously described (Zahid et al., 2011). The polarity 
of the mass spectrometer was set to positive and the scan range was from 200 to 2200 m/z 
with maximum accumulation time of 300 ms. The capillary voltage was set to -3500V, the 
skimmer voltage was 36.3 V and the trap drive was 74.2 V. The flow of drying gas was set 
to 10 l/min, the nebulizer gas pressure was set to 70 psi, and the drying temperature was 
350 °C. The accuracy of mass determinations was ± 0.05%. The primary structures of the 
novel peptides were determined by automated Edman degradation using a model 492 
Procise sequenator (Applied Biosystems, Foster City, CA, USA). 
2.4. Peptide synthesis 
PGLa-LM1 and CPF-LM1 were supplied in crude form by GL Biochem. Ltd. 
(Shanghai, China) and were purified to near homogeneity (> 98% purity) by reversed-phase 
HPLC on a (2.2 cm x 25 cm) Vydac 218TP1022 (C-18) column. The concentration of 
acetonitrile in the eluting solvent was raised from 21% to 56% over 60 min and the flow 
rate was 6 mL/min. The structures of the peptides were confirmed by electrospray mass 
spectrometry. 
2.5. Antimicrobial and hemolytic activities 
Reference strains of microorganisms were purchased from the American Type Culture 
Collection (Rockville, MD, USA). Minimum inhibitory concentrations (MIC) of synthetic 
PGLa-LM1 and CPF-LM1 against reference strains of S. aureus (ATCC 25923), E. coli 
(ATCC 25726), and Candida albicans (ATCC 90028) were measured in the concentration 
range of 3 - 200 μM by standard microdilution methods (Clinical Laboratory Standards 
Institute, 2008a; 2008b) and were taken as the lowest concentration of peptide where no 
visible growth was observed. The values were confirmed by measurement of absorbance at 
630 nm. In order to monitor the validity and reproducibility of the assays, incubations were 
carried out in parallel with increasing concentrations of antibiotics (ampicillin for S. aureus 
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and E. coli; and amphotericin for C. albicans) as previously described (Mechkarska et al., 
2011a). 
Hemolytic activity against human erythrocytes taken from a healthy donor was 
measured as previously described (Mechkarska et al., 2011a). The LC50 value was taken as 
the mean concentration of peptide producing 50% hemolysis in three independent 
incubations. 
3. Results
3.1. Purification of the peptides from X. laevis x X. muelleri hybrids 
The pooled skin secretions from the hybrid frogs, after partial purification on Sep-Pak 
C-18 cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column (Fig. 1). 
Fig. 1. Reversed-phase HPLC on a semipreparative Vydac C-18 column of skin secretions from F1 
X. laevis x X. muelleri hybrids after partial purification on Sep-Pak cartridges. The peaks designated 
1 - 13 displayed varying degrees of antimicrobial activity against E. coli and S. aureus and were 
purified further. The dashed line shows the concentration of acetonitrile in the eluting solvent. 
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The prominent peaks designated 1 - 13 were collected and the masses of the major 
components present in the peaks are shown in Table 1. Subsequent structural analysis 
revealed that peak 1 contained magainin-2, peak 2 magainin-1, peak 3 magainin-M1 + 
PGLa-LM1, peak 4 PGLa, peak 5 magainin-LM1, peak 6 XPF-1 + XPF-M1, 
peak 7 tigerinin-M1 + XPF-2, peak 8 CPF-M1, peak 9 CPF-4 + CPF-5, peak 10 CPF-3 + 
CPF-6, peak 11 CPF-1, peak 12 CPF-LM1, peak 13 CPF-7. Under the conditions of assay, 
material from peaks 1 - 11 inhibited to varying degrees the growth of E. coli and material 
from peaks 2, 3, and 8-10 inhibited growth of S. aureus. The peptides were purified to near 
homogeneity, as assessed by a symmetrical peak shape and mass spectrometry, by further 
chromatography on semipreparative Vydac C-4 and Vydac C-8 columns. 
3.2. Purification of the peptides from X. laevis 
The pooled skin secretions from X. laevis, after partial purification on Sep-Pak C-18 
cartridges, were chromatographed on a Vydac C-18 preparative reversed-phase HPLC 
column using the same experimental conditions as for the skin secretions from the hybrid 
frogs (Fig. 2). 
Fig. 2. Reversed-phase HPLC on a semipreparative Vydac C-18 column of skin secretions from 
X. laevis after partial purification on Sep-Pak cartridges. The peaks designated 1 - 9 displayed varying 
degrees of antimicrobial activity against E. coli and S. aureus and were purified further. The dashed 
line shows the concentration of acetonitrile in the eluting solvent. 
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The prominent peaks designated 1 - 9 were collected and subjected to further 
purification. Under the conditions of assay, material from all peaks inhibited the growth of 
E. coli at least partially and peaks 2, 3, and 6-9 inhibited the growth of S. aureus. The 
masses of the major components present in the peaks are shown in Table 1. Subsequent 
structural analysis demonstrated that peak 1 contained magainin-2, peak 2 magainin-1, peak 
3 PGLa, peak 4 XPF-1, peak 5 XPF-2, peak 6 CPF-4 + CPF-5, peak 7 CPF-3 + CPF-6, 
peak 8 CPF-1, peak 9 CPF-7. The peptides were purified to near homogeneity, as assessed 
by a symmetrical peak shape and mass spectrometry, by further chromatography on 
semipreparative Vydac C-4 and Vydac C-8 columns. 
Purification of antimicrobial peptides (magainin-M1, magainin-M2, XPF-M1, 
CPF-M1, CPF-M2, and tigerinin-M1) from X. muelleri has been described previously 
(Mechkarska et al., 2011a). 
3.3. Structural characterization 
The molecular masses of the purified peptides from X. laevis, X. muelleri, and the 
X. laevis x X. muelleri F1 hybrids are shown in Table 1. 
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Table 1. Molecular masses of the host-defense peptides isolated from skin secretions of 
Xenopus laevis, Xenopus muelleri, and X. laevis x X. muelleri F1 hybrids. 
Peptide  X. laevis  X. 
muelleri 
F1 hybrid 
Magainin‐1 2410.3 2410.3
Magainin‐2 2467.3 2467.4
Magainin‐M1 2424.9 2424.4
Magainin‐M2 2682.3
Magainin‐LM1 2480.4
PGLa  1968.8 1969.0
PGLa‐LM1 1948.0
CPF‐1  2618.6  2617.5
CPF‐3  2602.4 2602.6
CPF‐4  2647.3 2647.4
CPF‐5  2632.3 2632.3
CPF‐6  2586.8 2586.5
CPF‐7  2660.2 2659.6
CPF‐M1  2894.5 2894.1
CPF‐M2  2895.5
CPF‐LM1  2791.0
XPF‐1  2610.6 2610.3
XPF‐2  2664.6 2664.8
XPF‐M1  2515.1 2514.5 
Tigerinin‐M1 1446.6 1446.7
The primary structures of the peptides from the F1 hybrids are shown in Fig. 3. This 
list includes both peptides that have been previously identified and characterized in 
X. laevis and X. muelleri and newly discovered peptides present in skin secretions of the 
hybrid frogs that are not present in skin secretions of the parent species. The data indicate 
that magainin-1, magainin-2, CPF-1, CPF-3, CPF-4, CPF-5, CPF-6, CPF-7, XPF-1, XPF-2, 
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and PGLa are present in skin secretions of both the hybrids and X. laevis. Magainin-M1, 
XPF-M1, CPF-M1, and tigerinin-M1 are present in skin secretions of both the hybrids and 
X. muelleri. Magainin-M2 and CPF-M2, present in skin secretions of X. muelleri, were not 
detected in secretions from the hybrids. Magainin-LM1, PGLa-LM1, and CPF-LM1 are 
present in the secretions of the hybrid frogs but were not detected in secretions from either 
X. laevis or X. muelleri. 
[Mr+H]obs [Mr+H]calc 
Magainin-1 GIGKFLHSAGKFGKAFVGEIMKS 2410.3 2410.9
Magainin-2 GIGKFLHSAKKFGKAFVGEIMNS 2467.4 2467.9 
Magainin-M1 GIGKFLHSAGKFGKAFIGEIMKS 2424.4 2424.9
Magainin-LM1 GIGKFLHSAKKFAKAFVGEIMNS 2480.4 2480.3
PGLa  GMASKAGAIAGKIAKVALKAL.NH2 1969.0 1969.5 
PGLa-LM1 GMASKAGSVAGKIAKFALGAL.NH2 1948.0  1948.4 
CPF-1  GLASFLGKALKAGLKIGAHLLGGAPQQ 2617.5 2618.2 
CPF-3  GFGSFLGKALKAALKIGANALGGSPQQ 2602.6 2603.1 
CPF-4  GLASLLGKALKAGLKIGTHFLGGAPQQ 2647.4 2648.2 
CPF-5  GFGSFLGKALKTALKIGANALGGSPQQ 2632.3 2633.1 
CPF-6  GFASFLGKALKAALKIGANMLGGAPQQ 2659.6 2659.4 
CPF-7  GFGSFLGKALKAALKIGANALGGAPQQ 2586.5 2585.5 
CPF-M1  GLGSLLGKAFKFGLKTVGKMMAGAPREQ 2894.1 2894.5 
CPF-LM1 GFGSFLGSLFKTGLKIIPKLLPSIQQ 2791.0 2789.6
XPF-1  GWASKIGQTLGKIAKVGLQGLMQPK 2610.3 2611.2 
XPF-2 GWASKIGQTLGKIAKVGLKELIQPK 2664.8 2665.3
XPF-M1 GWASKIGQTLGKMAKVGLKDLIQA 2514.5 2515.0
Tigerinin-M1 WCPPMIPLCSRF.NH2 1446.7 1446.7
Fig. 3. Amino acid sequences, observed average molecular masses (Mr obs), and calculated average 
molecular masses (Mr calc) of the antimicrobial peptides isolated from skin secretions of the X. laevis 
x X. muelleri hybrids. 
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3.4. Antimicrobial activity 
The MIC values for synthetic PGLa-LM1 and CPF-LM1 against reference strains of 
the Gram-positive bacterium S. aureus, the Gram-negative bacterium E. coli, and the 
opportunistic yeast pathogen C. albicans, together with their hemolytic activities against 
human erythrocytes, are shown in Table 2. 
Table 2. Minimum inhibitory concentrations (M) against microorganisms and hemolytic 
activity against human erythrocytes (M) of synthetic replicates of PGLa-LM1 and 
CPF-LM1 from X. laevis x X. muelleri F1 hybrids. 
E. coli  S. aureus  C. albicans  HC50
PGLa‐LM1  80  80  160  >500 
CPF‐LM1  20  5  40  30 
4. Discussion
This study has described the purification of 18 peptides with varying degree of 
antimicrobial activity in norepinephrine-stimulated skin secretions from female X. laevis x 
X. muelleri F1 hybrids. Characterization of the peptides by mass spectrometry and Edman 
degradation reveals that they represent orthologs of the previously described host-defense 
peptides magainin, PGLa, CPF, and XPF, first identified in X. laevis (Gibson et al., 1986; 
Zasloff, 1987) and tigerinin, first identified in the Asian frog H. tigerinus (Sai et al., 2001) 
and subsequently in X. muelleri (Mechkarska et al., 2011a). The data indicate that the 
hybrid is expressing genes derived from both parent species so that the multiplicity of the 
antimicrobial peptides in the skin secretions of the hybrid is greater than in either parent 
species. As shown in Table 1, all the antimicrobial peptides identified in the X. laevis 
secretions are also present in the secretions of the hybrid. Four out of six peptides identified 
in the skin secretions of X. muelleri were found in the secretions of the hybrid but two 
peptides (magainin-M2 and CPF-M2) were not detected. In addition, three previously 
undescribed peptides (magainin-LM1, PGLa-LM1, and CPF-LM1) were purified from the 
secretions of the hybrid frogs that were not detected in secretions from either X. laevis or 
X. muelleri (Fig. 4). 
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Magainin 
Hybrid‐LM1 GIGKFLHSAKKFAKAFVGEIMNS 
X. laevis‐1 GIGKFLHSAGKFGKAFVGEIMKS 
X. laevis‐2 GIGKFLHSAKKFGKAFVGEIMNS 
X. muelleri‐M1    GIGKFLHSAGKFGKAFIGEIMKS 
X. muelleri‐M2    GFKQFVHSLGKFGKAFVGEMIKPK 
PGLa 
Hybrid‐LM1 GMASKAGSVAGKIAKFALGAL.NH2 
X. laevis GMASKAGAIAGKIAKVALKAL.NH2 
CPF 
Hybrid‐LM1 GFGSFLGSLFKTGLKI*IPKLL*PSIQQ 
X. laevis‐1 GLASFLGKALKAGLKI*GAHLLGGAPQQ 
X. laevis‐2 GFASFLGKALKAALKI*GANMLGGTPQQ 
X. laevis‐3 GFGSFLGKALKAALKI*GANALGGSPQQ 
X. laevis‐4 GLASL LGKALKAGLKI*GTHFLGGAPQQ 
X. laevis‐5 GFGSFLGKALKTALKI*GANALGGSPQQ 
X. laevis‐6 GFASFLGKALKAALKI*GANMLGGAPQQ 
X. laevis‐7 GFGSFLGKALKAALKI*GANALGGAPQQ 
X. muelleri‐M1    GLGSLLGKAFKFGLKTVGKMMAGAPREQ 
X. muelleri‐M2    GLGSLLGKAFKFGLKTVGKMMAGAPREE 
Fig. 4. A comparison of the primary structures of the novel peptides magainin-LM1, PGLa-LM1, and 
CPF-LM1 identified in skin secretions of the hybrid with orthologous peptides from X. laevis and 
X. muelleri. The shaded residues indicate amino acid differences. Residue deletions (denoted by *) 
have been introduced into some sequences to maximize structural similarity. 
 C
ha
pt
er
  7
 
160
The data complement, and are consistent with, the results of an earlier study which 
investigated the distribution of host-defense peptides in the skin secretions of F1 hybrid 
treefrogs produced in captivity from female Litoria splendida and male Litoria caerulea 
(Pukala et al., 2006). The skin secretions contained peptides common to only one parent 
together with peptides synthesized by both parental species and four peptides (caerins 1.10, 
2.6, 2.7, and 5.1) found only in secretions of the hybrid but not in either parental species. 
The authors speculated that the appearance of these novel peptides is a result of “some form 
of altered regulation of expression in the hybrid genetic background”. Firm support for this 
assertion is provided by a comprehensive analysis using microarray technology of gene 
expression in the ovary of fertile F1 female hybrids produced by crossing maternal X. laevis 
with paternal X. muelleri (Malone and Michalak, 2008). The hybrids showed a differential 
pattern of gene expression with 839 of genes upregulated in the hybrids relative to X. laevis 
and 777 genes upregulated in X. leavis relative to the hybrids. Similarly, a total of 2930 
genes were upregulated in the hybrids relative to X. muelleri and 4349 genes upregulated in 
X. muelleri relative to hybrids. In a related study of sterile F1 hybrid males of X. laevis and 
X. muelleri, a pattern of differential gene expression was also observed and it was found 
that approximately 1.2% of genes inherited from X. laevis were misexpressed in the hybrids 
whereas approximately 35% genes inherited from X. muelleri were misexpressed (Malone 
et al., 2007). It was suggested, therefore, that the X. muelleri component of the hybrid 
genome was preferentially silenced. 
Three novel peptides (magainin-LM1, PGLa-LM1 and CPF-LM1) were identified in 
the secretions of the hybrids. Their origins are a matter for speculation. As shown in Fig. 4, 
magainin-LM1 shows only one amino acid substitution (Gly13  Ala) compared with 
magainin-2 from X. laevis. Magainin-1 and magainin-2 are encoded by the same gene in 
X. laevis (Zasloff, 1987) but the deduced precursor sequence contains five copies of the 
magainin-2 sequence and one copy of the magainin-1 sequence (Terry et al., 1988). Both 
peptides are present in secretions of the hybrid and X. laevis with magainin-2 in higher 
concentration as expected (Figs. 1 and 2). It is probable, therefore, that magainin-LM1 
arises from the expression of a duplicate magainin gene derived from X. laevis that has been 
subject to mutation in the domain encoding magainin-2. Magainin-M1, but not magainin-
M2, was detected in secretions of the hybrid.  Magainin-M2 is present in much lower 
concentration (approximately 9-fold) than magainin-M1 in X. muelleri secretions 
(Mechkarska et al., 2011a) so that it is possible that its presence in the secretions of the 
hybrid was missed. 
PGLa was not detected in skin secretions of X. muelleri (Mechkarska et al., 2011a). 
However, if the gene is present but expressed at a very low level, PGLa-LM1in the hybrid 
may have arisen from upregulation of the PGLa-M1 gene inherited from X. muelleri. 
However, PGLa was detected along with PGLa-LM1 in the hybrid secretions so that the 
alternative explanation that PGLa-LM1 results from the expression of a mutated duplicated 
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PGLa gene inherited from X. laevis is another possibility. The origin of CPF-LM1 is 
unclear. The peptide shows a greater structural similarity to the CPF peptides identified in 
the X. laevis secretions compared with CPF-M1 and CPF-M2 from X. muelleri (Fig. 4). 
However, the degree of sequence identity is low (12 amino acid substitutions and one 
amino acid deletion compared with CPF-5, the peptide from X. laevis with the closest 
resemblance). All six CPF peptides present in the X. laevis secretions (CPF-1, -3, -4, -5, -6, 
and -7) are found in the secretions of the hybrids suggesting that CPF-LM1 may have arisen 
from the expression of a mutated duplicate CPF gene inherited from X. laevis. The amino 
acid sequence of CPF-2 is predicted from the nucleotide sequence of a cDNA 
(Wakabayashi et al., 1985; Richter et al., 1986) but the peptide was not detected in 
secretions from either X. laevis or the hybrids. The proposed origin of the host-defense 
peptides in the hybrid secretions is represented schematically in Fig. 5. 
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♀ X. laevis 
11 peptides 
♀ F1 Hybrid 
X. laevis x X. muelleri 
18 peptides 
♂ X. muelleri 
6 peptides 
Magainin-1 
Magainin-2 
Magainin-1 
Magainin-2 
 ? Magainin-M1 
X 
Magainin-LM1 
Magainin-M1 
Magainin-M2 
PGLa 
? 
PGLa 
    PGLa-LM1    ?  
CPF-1 
CPF-3 
CPF-4 
CPF-1 
CPF-3 
CPF-4 
CPF-5 CPF-5
CPF-6 CPF-6
CPF-7 
? 
CPF-7 
CPF-M1 
X 
CPF-LM1 
CPF-M1 
  CPF-M2 
?
XPF-1  
XPF-2 
XPF 1 
XPF-2 
XPF-M1 XPF-M1 
Tigerinin-M1 Tigerinin-M1 
Fig. 5. Proposed origin of the host-defense peptides present in skin secretions of female F1 X. laevis x 
X. muelleri hybrids. Magainin-M2 and CPF-M2 from X. muelleri were not detected in the hybrids as 
indicated by X. Three novel peptides (magainin-LM1, PGLa-LM1, and CPF-LM1), indicated by bold 
type, are found in the hybrid skin secretions only. The dashed line indicates that it is unclear whether 
the gene encoding the peptide is inherited from X. laevis or X. muelleri. 
X
X
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It should be pointed out that the X. muelleri male parents of the hybrids originated from 
the Nkambeni area of Swaziland whereas the X. muelleri individuals studied by 
Mechkarska et al. (2011a) were from South Malawi. It is possible that the two populations 
are synthesizing different molecular variants so that the three novel peptides identified in 
the secretions of the hybrids could be derived from the male parent. This is unlikely, 
however, as it has been shown that skin secretion from populations of X. laevis from widely 
separated regions of Africa contain antimicrobial peptides with the same primary structures 
(M. Mechkarska and J.M. Conlon, unpublished data). 
The study permits a comparison of the effects on expression of antimicrobial peptide 
genes of inter-species hybridization in the laboratory with ancient allopolyploidization 
events in the lineage. Previous investigations analysing the multiplicity of antimicrobial 
peptides in the skin secretions of tetraploid and octoploid Xenopus species (Mechkarska et 
al., 2011b; King et al., 2012) have shown that the numbers of paralogs from the octoploid 
frogs were not significantly greater than the corresponding numbers from the tetraploid 
frogs. It was concluded, therefore, that nonfunctionalization (gene silencing) (Lynch and 
Katju, 2004) has been the most common fate of duplicated antimicrobial peptide genes 
following the putative allopolyploidization events in the Xenopus lineage (Conlon et al., 
2012). In contrast, the full complement of antimicrobial peptide genes from X. laevis are 
expressed in the F1 hybrids as well as four out of six antimicrobial peptide genes from 
X. muelleri. These hybrids, like the parent species, are tetraploid (2n = 36) (Koroma et al., 
2011). Additionally, hybridization has resulted in expression of three novel genes encoding 
peptides not detected in skin secretions of the parent species. One such peptide, CPF-LM1 
shows potent, broad spectrum antimicrobial activity. One may speculate, therefore, that the 
hybrid, with a greater complement of host-defense peptides, is better protected against 
invasion by pathogenic microorganisms in the environment than the parent species but firm 
evidence to support this claim is required. 
During the process of interspecies hybridization, even without polyploidization, 
epigenetic changes that control gene expression often take place in addition to genome 
reconfigurations. There is an increasing body of evidence coming from studies ranging 
across biological systems from yeast and plants to humans that demonstrate that epigenetic 
changes induced by hybridization or environmental stress may be inherited by future 
generations and therefore may contribute to adaptation to novel environments [reviewed in 
(Whitelaw and Whitelaw, 2006)]. All of the inheritable epigenetic effects, such as DNA 
methylation, histone modification, microRNA, small interfering RNA and spatial location 
of DNA, have been shown to trigger changes in gene expression and ultimately phenotype 
in the next generation, without variation in genotype (Finnegan, 2002; Jablonka and Raz, 
2009). Cytosine methylation is one of the most important epigenetic mechanisms operating 
in plant and vertebrate genomes and analysis of methylated fragments of X. laevis x  
X. muelleri F1 hybrids (Koroma et al., 2011) revealed four distinct methylation patterns 
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clusters with the two parental species X. laevis and X. muelleri separate from hybrid males 
and females. The hybrids were characterized by a significantly higher proportion (70.6%) 
of methylated fragments compared with the parental species (64.5%), and this difference is 
consistent with previously observed disruptions of hybrid transcriptomes. Hybrid-specific 
methylated fragments (20.9% of the markers analyzed) were identified indicative of novel 
methylation states due to interspecies hybridization. It remains to be determined whether 
the novel peptides identified in the hybrids in this study arise from stably inherited 
epigenetic effects. Since the female hybrids are fertile, it is important to ascertain whether 
the offspring from the mating of the hybrids with either of the parental species will inherit 
the increased complement of host-defense peptides. 
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Chapter 8 
General discussion 
Milena Mechkarska  
Part of the discussion is published in the review: Host-defense peptides in skin secretions of 
African clawed frogs (Xenopodinae, Pipidae). J.M. Conlon, M. Mechkarska, J.D. King. 
Gen Comp Endocrinol (2012a) 176:513-518. 
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The aim of the work described in this thesis is the isolation of AMPs with therapeutic 
potential against multidrug-resistant pathogens from skin secretions of frogs belonging to 
the Pipidae family. At the beginning of 2010 only three species belonging to the subfamily 
Xenopodinae had been analyzed for the presence of AMPs - the diploid frog 
S. tropicalis (Ali et al., 2001), the tetraploid frog X. laevis (Zasloff, 1987; Giovannini et 
al., 1987) and the octoploid X. amieti (Conlon et al., 2010a). During the course of this 
research more than 50 AMPs were purified from the skin secretions of an additional 
seven members of the family Pipidae: X. borealis (Chapter 2), X. clivii (Chapter 3), 
X. andrei in parallel with “S. new tetraploid 1” (Chapter 4), X. muelleri together with the 
incompletely characterized X. muelleri West (Chapter 5), and H. boettgeri (Chapter 6). 
In addition, an attempt was made to understand the mode of inheritance of AMP genes 
by studying the AMP profile of F1 hybrid frogs X. laevis x X. muelleri and comparing it to 
those of the parents (Chapter 7). 
The importance of the AMPs isolated from Pipidae frogs is discussed from the 
following viewpoints: 
 Development of novel therapeutically active compounds against multidrug-
resistant pathogens.
 Clarification of taxonomic relationships between frog species and study of their
evolutionary history.
 Analysis of the effect of polyploidization and interspecies hybridization on the fate
and mode of inheritance of duplicated AMP genes.
Therapeutic potential of AMPs from frogs of the Pipidae family 
In common with the vast majority of frog skin AMPs, all the newly identified AMPs 
from skin secretions of frogs of the Pipidae family (Chapters 2-6) belong to the class of 
cationic α-helical peptides (Chapter 1). 
Seven peptides have been identified that show therapeutic potential for development 
into anti-infective agents: CPF-B1, CPF-C1, CPF-MW1 and CPF-SP1 (from Xenopodinae) 
and the hymenochirins-1B, -2B and -3B (from Pipinae). Their primary structures are shown 
in Table 1 and their antimicrobial and hemolytic activities are compared in Table 2. 
The CPF peptides are potent against the clinically relevant microorganisms E. coli,  
S. aureus, C. albicans, K. pneumonia and P. aeruginosa with minimum inhibitory 
concentration (MIC) ≤ 25 μM but are only moderately cytotoxic against human 
erythrocytes. In addition, the CPF peptides are very active against MRSA and MDRAB 
with MIC ≤ 12.5 μM (Chapters 1, 2 and 4). Although the hymenochirins display only 
moderate antimicrobial and antifungal activity, they have the advantage of very low 
hemolytic activity - mean concentration of peptide producing 50% hemolysis 
(HC50) ≥ 225 μM.
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Table 1. Naturally-occuring AMPs from skin secretions of Pipidae frogs with potential for 
development into potent non-toxic, anti-infective agents for use against drug resistant 
microorganisms.  
Frog species AMP Primary structure 
“S. new tetraploid 1” CPF-SP1 GFLGPLLKLGLKGVAKVLPHLIPSRQQ 
X. borealis CPF-B1 GLGSLLGKAFKIGLKTVGKMMGGAPREQ
X. clivii CPF-C1 GFGSLLGKALRLGANVL.NH2 
X. muelleri West CPF-MW1 GLGSLLGKAFKFGLKTVGKMMGGAPREQ 
H. boettgeri Hymenochirin-1B 
Hymenochirin-2B 
Hymenochirin-3B 
IKLSPETKDNLKKVLKGAIKGAIAVAKMV.NH2 
LKIPGFVKDTLKKVAKGIFSAVAGAMTPS 
IKIPAVVKDTLKKVAKGVLSAVAGALTQ 
Table 2. MIC against microorganisms and hemolytic activity against human erythrocytes 
(HC50) of the peptides isolated from skin secretions of Pipidae frogs. 
E. coli S.aureus C. albicans K. pneumoniae P. aeruginosa HC50 
CPF-SP1 25 6 25 25 6 >100
CPF-B1 5 5 25 - - >200
CPF-C1 6 6 - 25 25  140
CPF-MW1 3 6 25 - -  70
Hymenochirin-1B 20 10 80 20 40 225 
Hymenochirin-2B 20 40 80 20 20 >300 
Hymenochirin-3B 20 40 80 40 40 >300 
Data are expressed in µM. 
Because the potency of the AMPs is determined by four different parameters that are 
strongly interrelated (Chapter 1) (Powers and Hancock, 2003), it is difficult to predict the 
antimicrobial activity, selectivity, and mode of action of a given peptide from its amino 
acid sequence or physicochemical properties. Comparison of the primary sequences of the 
CPFs and the hymenochirins reveals that there is no conserved amino acid sequence 
associated with antimicrobial activity (Table 1). In addition, there is no obvious common 
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set of physicochemical parameters which determine the activity of a given peptide 
(Table 3). 
Table 3. Physicochemical properties of the CPFs and the hymenochirins, isolated from skin 
secretions of Pipidae frogs. 
Peptide Hydrophobicity Charge at 
pH 7 
pI Alpha-helical
domain 
CPF-SP1 +10.5 +4 11.73 5-11
CPF-B1 -1.1 +4 10.98 2-12, 14-17
CPF-C1 +15.3 +2 11.49 5-14
CPF-MW1 -0.6 +4 10.98 2-12, 14-17
Hymenochirin-1B +4.9 +6 10.65 5-27 
Hymenochirin-2B +13.5 +4 10.71 8-16 
Hymenochirin-3B +19.5 +4 10.71 9-16 
There is no simple correlation between peptide charge and membrane activity. Thus, 
the activity of CPF-C1 with a +2 charge is similar to that exerted by peptides with a charge 
of +4. Similarly, the activity of hymenochirin-1B with a charge of +6 is similar to that 
observed for hymenochirin-2B and -3B with a charge of +4. Another strong driving force 
for the binding of peptides to membranes is the formation of α-helical structures (Wieprecht 
et al., 1999). This feature is essential for the activity against neutral (eukaryotic) 
membranes, but seems less important for the action towards negatively charged 
(prokaryotic) ones. In terms of effect on microorganisms, helicity is an absolute 
requirement for the antimicrobial activity towards Gram-positive bacteria, while the 
situation regarding the Gram-negative bacteria is less stringent (Dathe et al., 1997; 
Giangaspero et al., 2001). Analysis of the secondary structure of the peptides included in 
Table 3 using the AGADIR program (Munoz and Serrano, 1994) indicate that all can adopt 
an α-helical conformation over at least part of their structures. A Schiffer-Edmundson 
wheel representation (Schiffer and Edmundson, 1967) of the structures illustrates the 
amphipathic character of the helices (Fig. 1). 
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Fig. 1. Schiffer-Edmundson wheel representation of the most active CPFs and hymenochirins 
demonstrating the amphipathic nature of the predicted α-helical conformation. The polar Lys, Glu, 
Asp and Arg segregate on one face of the helix with the hydrophobic Leu, Ile, Pro and Val residues 
on the opposite face. The basic residues in the peptides, essential for potent antimicrobial activity, are 
shown in bold type. 
CPF-B1 CPF-C1 
CPF-MW1 CPF-SP1 
Hymenochirin 
2B 
Hymenochirin 
3B 
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The wheel representation of the amphipathic structure of hymenochirin-1B is shown in 
Chapter 6. Therefore, it is difficult to explain why the hymenochirins have reduced activity 
towards S. aureus or are less hemolytic when compared to the CPF peptides. 
Hydrophobicity correlates with the higher affinity of peptides for zwitterionic lipids 
(Wieprecht et al., 1997a) but plays a secondary role in their interaction with negatively 
charged membranes (Kiyota et al., 1996; Wieprecht et al., 1997b; Kwon et al., 1998). An 
increase in hydrophobicity is often followed by an increase of the hemolytic potency 
(Javadpour et al., 1996; Skerlavaj et al., 1996; Dathe et al., 1997). The findings presented in 
this thesis are not fully consistent with this rule. For example, the hymenochirins are the 
most hydrophobic but are the least hemolytic of the peptides in Tables 2 and 3. 
Possible clinical applications of α-helical AMPs isolated from skin secretions of 
different frog species have been recently reviewed (Conlon and Sonnevend, 2011). The 
following peptides, by exerting activity against multidrug-resistant Gram-positive and 
Gram-negative bacteria, as well as the opportunistic yeast pathogen C. albicans, show 
therapeutic potential as anti-infective agents: alyteserin-1c (from Alytes obstetricans); 
ascaphin-8 (Aschapus truei); brevinin-1BYa (Rana boylii); brevinin-2PRa (Rana pirica); 
brevinin-2-related peptide (B2RP) (Lithobates septentrionalis); B2RP-ERa (Hylarana 
erythraea); kassinatuerin-1 (Kassina senegalensis); pseudin-2 (Pseudis paradoxa); and 
temporin-DRa (Rana draytonii). 
Further support for the CPF peptides as candidates for development into therapeutic 
agents comes from other work carried out in the laboratory on AMPs from X. amieti 
(Conlon et al., 2010a), X. pygmaeus, X. petersii and X. lenduensis (King et al., 2012), and  
S. epitropicalis (Conlon et al., 2012b). Thus, CPF-AM1 shows broad spectrum bactericidal 
activity with MIC values ≤ 25 μM against reference strains of E. coli and S. aureus and 
against multiple clinical isolates of antibiotic-resistant A. baumannii, including strains that 
are resistant to colistin (Conlon et al., 2012c), and Stenotrophomonas maltophilia 
(unpublished data). Two peptides - CPF-SE2 and CPF-SE3 - from S. epitropicalis show 
potent growth-inhibitory activity (MIC = 2.5 - 5µM) against a range of clinical isolates of 
MRSA but are hemolytic (Conlon et al., 2012b). Similarly, a synthetic replicate of 
CPF-PG1 from X. pygmaeus has relatively high potency against the Gram-positive 
bacterium S. aureus (MIC = 6 µM) and shows moderate hemolytic activity 
(HC50 = 145 µM) (King et al., 2012). More members of the CPF family are described in 
this thesis: CPF-B2, CPF-B3 and CPF-B4 (from X. borealis), CPF-AN1 (from X. andrei) 
and CPF-MW3 (from X. muelleri West). However, their antimicrobial potential was not 
investigated as these peptides were isolated from skin secretions in very low yields. 
The use of peptide-based anti-infective agents is limited by their toxicities to host cells 
such as erythrocytes. If the therapeutic index (ratio of MIC against microorganisms to HC50 
for hemolysis of human erythrocytes) of the promising peptides is found to be too low for 
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systemic use, alternative routes of application may still be feasible. For example, skin 
infections in otherwise healthy young individuals are a common clinical manifestation of 
community-acquired MRSA infections (Skov et al., 2012). MRSA is a serious problem in 
infections of the superficial epidermis, such as impetigo in infants and children (Geria and 
Schwartz, 2010) and in colonization of surface lesions such as the foot ulcers of diabetic 
patients (Bowling et al., 2009). Consequently, the peptides may find application as topical 
treatment options in combating skin infections and in therapeutic regimes to promote 
wound healing. 
AMPs have attracted interest as therapeutic agents for treatment of acne vulgaris (Melo 
et al., 2006; Popovic et al., 2012). Acne vulgaris is a disease affecting the pilosebaceous 
unit (PSU), with both bacterial and inflammatory components (Bhambri et al., 2009; 
Grange et al., 2010). A major role in the development of an acne lesion is proliferation by 
Propionibacterium acnes within the PSU (Bojar and Holland, 2004; Kurokawa et al., 
2009). The inflammatory immune response of the host to P. acnes is important in the 
pathogenesis of acne and contributes to the complications during the course of the disease 
(Mouser et al., 2003; Sugisaki et al., 2009). Frog skin peptides show potential for 
development into a topical agent because they possess the desired dual action: directly 
inhibit growth of P. acnes and suppress the inflammatory immune response (Popovic et al., 
2012). 
Natural resistance to AMPs has been demonstrated in vitro (Banemann et al., 1998; 
Bishop and Finlay, 2006). Development of induced resistance will also occur (Groisman et 
al., 1992; Nikaido, 1996; Otto, 2006; Llobet et al., 2008) but at rates that are orders of 
magnitude lower than those observed for conventional antibiotics (Ge et al., 1999; Perron et 
al., 2006). However, sub-toxic AMP concentrations which do not damage the cell 
membranes can stimulate bacterial populations to switch to a metabolically dormant state 
associated with biofilm formation (Berditsch et al., 2012). This mechanism can lead to 
bacterial persistence responsible for chronic diseases (Lewis, 2010; Berditsch et al., 2012). 
Moreover, Habets and Brockhurst (2012) reported that evolved resistance to pexiganan 
generated experimentally provides S. aureus with cross-resistance to human-neutrophil-
defensin-1 which plays a key role in the innate immune response to infections. 
Taxonomy and evolutionary history of Pipidae frogs 
Back in the 19th and early 20th centuries, the recognition of taxa, such as genera, species 
and subspecies and establishing the phylogeny of animal species was based entirely upon 
morphological characteristics and the fossil record (Gould, 1977; Hennig, 1979). In the 
1950s the definition of taxa was facilitated by including behavioural characteristics such as 
advertisement calls and other attributes. Following the development of biochemical and 
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molecular biology techniques, the study of animal evolution has increasingly relied upon 
comparison of molecular features (Guttman, 1973; Graur and Li, 2000; Carroll et al., 2001). 
There is an increasing body of evidence that AMPs present in frog skin secretions 
possess the necessary features to be considered as a reliable marker for anuran taxonomy 
and for study of evolutionary history of the different frog families. AMPs are genetically 
encoded and evolve rapidly via positive selection, explaining the extraordinary diversity of 
the peptide families (Duda et al., 2002; Tennessen, 2005). On the basis of limited 
similarities in their amino acid sequences, frog skin AMPs may be grouped together in 
families that share a common evolutionary origin (Goraya et al., 2000; Duda et al., 2002). 
Skin secretions from a single species frequently contain several members of a particular 
peptide family (Tennessen and Blouin, 2007). Since there is virtually no overlap in the 
sequences of individual peptides from one species to another (Conlon et al., 2004), the 
dermal peptides of frogs are valuable in taxonomic evaluations of closely related genera 
and species (Conlon et al., 2004; Apponyi et al., 2004; Zheng et al., 2005). 
On the basis of morphological characters alone, it was concluded that Silurana is more 
closely related to the genera Hymenochirus, Pipa, and Pseudhymenochirus than to Xenopus 
(Cannatella and Trueb, 1988). However, subsequent analyses based upon comparisons of 
the nucleotide sequence of mitochondrial genes provided support for divergence of the 
Xenopodinae (Silurana + Xenopus) from the Pipinae (Hymenochirus + Pipa + 
Pseudhymenochirus) before the divergence of the Pipinae subfamily (de Sa and Hillis, 
1990; Evans et al., 2004; Evans, 2008).  Collectively, the amino acid sequences of AMPs 
isolated from Xenopodinae and Pipinae provide support for the latter view. The AMPs 
isolated to-date from skin secretions of species belonging to Xenopodinae (Chapters 2-5; 
Conlon et al., 2010a; Conlon et al, 2012b; King et al., 2012) are grouped in the same four 
peptide families - magainin, PGLa, CPF, and XPF - initially identified in skin secretions 
from X. laevis (Figs. 2-4). This finding is not unexpected as the genomic DNA sequences of 
S. tropicalis and X. laevis are 90% identical within coding regions and roughly half of the 
duplicated genes are maintained in X. laevis after the putative tetraploidization took place 
(Yanai et al., 2011). The hymenochirins isolated from skin secretions of H. boettgeri show 
very low structural similarity to the peptides from Xenopodinae consistent with an earlier 
divergence of the Pipinae from the Xenopodinae (Chapter 6). 
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Magainin-related peptides 
S. tropicalis ST1 GLKEVAHSAKKFAKGFISGLTGS 
S. epitropicalis SE1 GLKEVLHSTKKFAKGFITGLTGQ 
X. laevis 1 GIGKFLHSAGKFGKAFVGEIMKS
X. laevis 2 GIGKFLHSAKKFGKAFVGEIMNS
X. petersii P1 GIGKFLHSAGKFGKAFVGEIMKS
X. petersii P2 GIGQFLHSAKKFGKAFVGEIMKS
X. borealis B1 G**KFLHSAGKFGKAFLGEVMIG
X. borealis B2 GIGKFLHSAGKFGKAFLGEVMKS
X. muelleri M1 GIGKFLHSAGKFGKAFIGEIMKS
X. muelleri M2 GFKQFVHSLGKFGKAFVGEMIKPK
X. muelleri West MW1 GIGKFLHSAGKFGKAFLGEVMKS 
X. laevis x X. muelleri LM1 GIGKFLHSAKKFAKAFVGEIMNS 
X. clivii C1 GVGKFLHSAKKFGQALASEIMKS
X. clivii C2 GVGKFLHSAKKFGQALVSEIMKS
X. pygmaeus PG1 GVGKFLHAAGKFGKALMGEMMKS 
X. pygmaeus PG2 GVSQFLHSASKFGKALMGEIMKS 
X. lenduensis L1 GIGKFLHSAKKFGKAFVGEVMKS 
X. lenduensis L2 GISQFLHSAKKFGKAFAGEIMKS 
X. amieti AM1 GIKEFAHSLGKFGKAFVGGILNQ
X. amieti AM2 GVSKILHSAGKFGKAFLGEIMKS
X. andrei AN1 GIKEFAHSLGKFGKAFVGGILNQ
X. andrei AN2 GVSKILHSAGKFGKAFLGEIMKS
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PGLa-related peptides 
S. tropicalis ST1 GMATKAGTALGKVAKAVIGAALa 
“S. new tetraploid 1” SP1 GMATKAGTALGKVAKAVIGAALa 
S. epitropicalis SE1 GMATKAGTALGKVAKAVIGAALa
S. epitropicalis SE2 GMATAAGTTLGKLAKFVI*GAVa 
X. laevis 1 GMASKAGAIAGKIAKVALK*ALa 
X. petersii P1 GMASTAGSIAGKIAKVALK*ALa
X. borealis B1 GMASKAGTIAGKIAKTAIKLALa 
X. borealis B2 GMASKAGSIVGKIAKIAL*GALa
X. muelleri West MW1 GMASKAGSVLGKITKIAL*GALa 
X. muelleri West MW2 GMASKAGAIAGKIAKTAIKLALa
X. laevis x X. muelleri LM1 GMASKAGSVAGKIAKFAL*GALa 
X. pygmaeus PG1 GMASKAGTIVGKIAKVAL*NALa 
X. lenduensis L1 GMASTAGSIFGKLAKTAL*GALa
X. lenduensis L2 GMASTAGSVLGKLAKVAIKAALa
X. lenduensis L3 GMASTAGSVLGKLAKVAL*GALa
X. lenduensis L4 GMASTVGSIFGKLAKTAL*GALa
X. amieti AM1 GMASKAGSVLGKVAKVALKAALa 
X. amieti AM2 GMASTAGSVLGKLAKAVAIGALa 
X. andrei AN1 GMASKAGSVLGKVAKVALKAALa 
X. andrei AN2 GMASKAGSVLGKLAKVAI*GALa
Fig. 2. A comparison of the primary structures of magainin and PGLa-related peptides from species 
belonging to the taxon Xenopodinae. Amino acid residue deletions denoted by * have been 
introduced in to some sequences to maximize structural similarity. a denotes C-terminal α-amidation. 
Conservation of amino acid residues is emphasized by the shading. 
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CPF-related peptides 
S. tropicalis ST1  GFLGPLLKLAAKGVAKVIPHLI**PSRQQ 
“S. new tetraploid 1” SP1 GFLGPLLKLGLKGVAKVLPHLI**PSRQQ 
“S. new tetraploid 1” SP2 GFLGPLLKLGLKGAAKLLPQLL**PSRQQ 
S. epitropicalis SE1 GFLGPLLKLGLKGVAKVIPHLI**PSRQQ 
S. epitropicalis SE2 GFLGPLLKLGLKGAAKLLPQLL**PSRQQ 
X. laevis 1 GLASFLGKALKAGL*KIGAHLLGGAP*QQ
X. laevis 2 GFASFLGKALKAAL*KIGANMLGGTP*QQ
X. laevis 3 GFGSFLGKALKAAL*KIGANALGGSP*QQ
X. laevis 4 GLASLLGKALKAGL*KIGTHFLGGAP*QQ
X. laevis 5 GFGSFLGKALKTAL*KIGANALGGSP*QQ
X. laevis 6 GFASFLGKALKAAL*KIGANMLGGAP*QQ
X. laevis 7 GFGSFLGKALKAAL*KIGANALGGAP*QQ
X. petersii P1 GFGSFLGKALKAAL*KIGANALGGAP*QQ
X. petersii P2 GLASFLGKALKAGL*KIGSHLLGGAP*QQ
X. petersii P3 GFGSFLGKALKAAL*KIGANVLGGAP*QQ
X. petersii P4 GFGSFLGKALKAAL*KIGANVLGGAP*EQ
X. petersii P5 GFGSFLGKALKAAL*KIGADVLGGAP*QQ
X. borealis B1 GLGSLLGKAFKIGL*KTVGKMMGGAPREQ
X. borealis B2 GLGSLLGSLFKFIP*K****LL**PSIQQ
X. muelleri M1 GLGSLLGKAFKFGL*KTVGKMMAGAPREQ
X. muelleri M2 GLGSLLGKAFKFGL*KTVGKMMAGAPREE
X. muelleri West MW1 GLGSLLGKAFKFGL*KTVGKMMGGAPREQ 
X. muelleri West MW2 GLGSLLGKAFKFGL*KTVGKMMGGAPREE 
X. laevis x X. muelleri LM1 GFGSFLGSLFKTGL*KIIPKLL**PSIQQ 
X. clivii C2 GLGSLLGKALKFGL*KAAGKFMGGEP*QQ
X. pygmaeus PG2 GFGSFLGKALKAGL*KLGANLLGGAP*QQ
X. pygmaeus PG3 GFGSLLGKALKAGL*KLGANLLGGAP*QQ
S. tropicalis ST2  GFLGSLLKTGLKV****GSNLLa 
S. tropicalis ST3  GLLGPLLKIAAKV****GSNLLa 
“S. new tetraploid 1” SP3 GFLGSLLKTGLKV****GSNLLa 
S. epitropicalis SE3 GFLGSLLKTGLKV****GSNLLa
X. clivii C1 GFGSLLGK*ALRL****GANVLa
X. lenduensis L1 GIGSLLAK*AAKL****GANLLa 
X. lenduensis L2 GIGSALAK*AAKL****VAGIVa 
X. lenduensis L3 GLGTFLGN*ALKTGLKIGANLLa 
X. amieti AM1 GLGSVLGK*ALKI****GANLLa 
X. amieti AM2 GIGSALAK*AAKL****VAGIVa 
X. amieti AM4 GLGSLVGN*ALRI****GAKLLa 
X. andrei AN1 GFASVLGK*ALKL****GANLLa 
Fig. 3. A comparison of the primary structures of CPF-related peptides from species belonging to the 
taxon Xenopodinae. Amino acid residue deletions denoted by * have been introduced in to some 
sequences to maximize structural similarity. a denotes C-terminal α-amidation. Conservation of amino 
acid residues is emphasized by the shading. 
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XPF-related peptides 
S. tropicalis ST1  GLASTLGSFLGKFAKGGAQAFLQPK 
“S. new tetraploid 1” SP1 GFWSSALEGLKKFAKGGLEALTNPK 
“S. new tetraploid 1” SP2 GLASTIGSLLGKFAKGGAQAFLQPK 
S. tropicalis ST2  GVWSTVLGGLKKFAKGGLEAIVNPK 
S. tropicalis ST3  GVFLDA***LKKFAKGGMNAVLNPK 
S. epitropicalis SE2 GLASTIGSLLGKFAKGGAQAFLQPK 
S. epitropicalis SE3 GFWTTAAEGLKKFAKAGLASILNPK 
S. epitropicalis SE4 GVWTTILGGLKKFAKGGLEALTNPK 
S. epitropicalis SE1 GLFLDT***LKKFAKAGMEAVINPK 
X. laevis 1 GWASKIGQTLGKIAKVGLQGLMQPK
X. laevis 2 GWASKIGQTLGKIAKVGLKELIQPK
X. borealis B1 GFKQFVHSM*GKFGKAFVGEIINPK
X. borealis B2 GWASKIGTQLGKMAKVGLKEFVQS*
X. muelleri M1 GWASKIGQTLGKMAKVGLKDLIQA*
X. muelleri West MW1 GWASKIGQTLGKLAKVGLKEFAQS* 
X. clivii C1 GWASKIGQALGKVAKVGLQQFIQPK
X. amieti AM1 GWASKIAQTLGKMAKVGLQELIQPK
X. andrei AN1 GWASKIGQTLGKMAKVGLQELIQPK
X. andrei AN2 GWVSKIGQTLGKMAKVGLQELIQPK
Fig. 4. A comparison of the primary structures of XPF-related peptides from species belonging to the 
taxon Xenopodinae. Amino acid residue deletions denoted by * have been introduced in to some 
sequences to maximize structural similarity. a denotes C-terminal α-amidation. Conservation of amino 
acid residues is emphasized by the shading. 
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Evolutionary pressure to conserve the primary structures of the antimicrobial peptides 
from Xenopodinae has not been uniform (Figs. 2-4). Peptides belonging to the PGLa family 
are most strongly conserved (7 out of 22 amino acids invariant) followed by the magainin 
family (4 out of 23 amino acids invariant). The amino acid sequences of the XPF family 
peptides have been poorly conserved (only 3 out of 25 amino acids invariant). 
A comparison of the primary structures of the CPF-peptides suggests that they divide 
naturally into two groups with and without a C-terminally α-amidated amino acid residue 
(Fig. 3). Even after deletions have been introduced into some sequences in order to 
maximize structural similarity, only the 3 amino acids are invariant in the first group and 
only the N-terminal glycine residue is invariant in the group of the amidated CPFs. 
Nevertheless, in both the XPF and CPF peptides, amino acid substitutions are generally 
conservative and secondary structure predictions indicate that the amphipathic α-helical 
character of all the peptides has been maintained (Chapters 2-5; King et al., 2012; Conlon et 
al., 2012a). 
During the last 4 years, the genus Xenopus has been expanded to include two new 
entries with a status of fully recognized octoploid species – X. itombwensis (Evans et al., 
2008) and X. lenduensis (Evans et al., 2011). At the same time, there are several 
incompletely characterized members of the Xenopodinae for which further confirmation is 
needed in order to gain recognized species status (Evans et al., 2004; Evans et al., 2005; 
Evans, 2007). Two such members have been addressed in this thesis with the aim of 
providing evidence to confirm their putative species designation. 
The first example is the tetraploid Silurana analysed in Chapter 4. There are several 
studies involving this frog first described as “Xenopus species nova VII” (Graf and 
Fishberg, 1986; Tymowska, 1991) and subsequently as “Silurana new tetraploid 1” (Evans 
et al., 2004). In the publication arising from the work in Chapter 4 (Mechkarska et al., 
2011), it was referred as S. paratropicalis according to the terminology of Flajnik et al. 
(1993). However, as it is not recognized as a separate species, it was pointed out that the 
term S. paratropicalis is a nomen nudum and therefore invalid (Blackburn and Beier, 2011). 
Consequently, the name “Silurana new tetraploid 1” is used instead of S. paratropicalis in 
the Discussion (Chapter 8). 
In the genus Silurana, analysis of mitochondrial DNA suggests that tetraploidization 
occurred by allopolyploidization. Hence another diploid (2n=20) ancestral species is 
predicted to have existed in addition to the ancestor of the diploid species S. tropicalis 
(Evans et al., 2005; Evans, 2007). All AMP families - PGLa, XPF and CPF - found in 
S. tropicalis skin secretions (Ali et al., 2001) were detected in skin secretions from 
“Silurana new tetraploid 1” (Figs. 2-4). The magainins were not detected in either species 
and so it was speculated that the gene encoding the magainins arose in the Xenopus lineage 
after its divergence from Silurana. However, a peptide belonging to the magainin family 
  C
ha
pt
er
  8
 
182
was recently purified from the tetraploid S. epitropicalis (Conlon et al., 2012b). A BLAST 
search of the S. tropicalis genome database (Hellsten et al., 2010) reveals the presence of a 
gene encoding a magainin-related peptide (referred to as magainin-ST1) that would bear, if 
expressed, three amino acid differences from the S. epitropicalis ortholog (magainin-SE1). 
However, the reported antimicrobial activity of magainin-SE1 is very weak (Conlon et al., 
2012b) so that it is possible that the presence of magainin peptide(s) in S. tropicalis and in 
“S. new tetraploid 1” secretions may have been missed. An alternative explanation may be 
that the polyploidization event in the Silurana lineage gave rise to species with differential 
expression of the tetraploid genomes so that more AMP genes have been silenced in 
“S. new tetraploid 1” - including the gene for the magainin - than in S. epitropicalis. 
The second example of an incompletely characterized species is the frog which is 
given the working name X. muelleri West (Measey et al., 2004) that is analysed in 
Chapter 5. Two discontinuous (allopatric) populations X. muelleri occupy ranges in east 
and west Africa (Rodel, 2000; Harper et al., 2010; Frost, 2011). It has been proposed that 
the western population represents a separate species (Measey et al., 2011). In previous 
reports involving  molecular genetics studies and analysis of the evolution of  advertisement 
calls, this population is referred to as X. new tetraploid 1 (Evans et al., 2004; Tobias et al., 
2011). Comparison of the AMP profiles of the two frog populations suggests that they are 
not conspecific because (a) no orthologous peptide has the same amino acid sequence, and 
(b) two PGLa members are detected in X. muelleri West secretions while PGLa is lacking 
in the X. muelleri secretions. On the basis of the AMP sequences, X. muelleri West is more 
closely related to X. borealis than to X. muelleri. Therefore, the data provide strong support 
for the separate species designation of X. muelleri West. 
Previous investigations of ranid frogs have used the same methodology described in 
this thesis to demonstrate that Rana tagoi tagoi and Rana tagoi okiensis are probably not 
conspecific (Conlon et al., 2010b) and that the relict leopard frog Lithobates onca and the 
lowland leopard frog Lithobates yavapaiensis, although closely related phylogenetically, 
are separate species (Conlon et al., 2010c). On the other hand, the presence of identical 
peptides in skin secretions from specimens of the Chiricahua leopard frog Lithobates 
chiricahuensis occupying regions in southern Arizona and from morphologically distinct 
specimens occupying the Mogollon Rim of central Arizona suggest that the two 
populations probably do not represent separate species (Conlon et al., 2011). The skin 
peptide profiles of Australian hylid frogs from the genera Crinia, Litoria, and Uperoleia 
have been used, together with morphological and cognate methods, to differentiate between 
sub-species and even different population clusters of the same species (Jackway et al., 
2011). 
The eight octoploid species have complex taxonomic relationships and can be divided 
into two subgroups (Chapter 1, Fig.11). According to this proposed evolutionary scenario, 
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X. amieti and X. andrei share a common octoploid ancestor that differs from the octoploid 
ancestor of the “vestitus-wittei” subgroup. More detailed analysis of the mitochondrial 
DNA and gene sequences of RAG1 and RAG2 of the newly identified octoploids 
X. lenduensis and X. itombwensis suggest that there have been at least three independent 
allooctopolyploidization events in Xenopus (Evans et al., 2008; Evans et al., 2011). The 
results from our work on AMPs in skin secretions confirm the particularly close 
phylogenetic relationship between X. andrei (Chapter 4) and X. amieti (Conlon et al., 
2010a). The observed differences in primary structures between AMPs from X. lenduensis 
(King et al., 2012) and orthologs from the sister-pair species X. amieti and X. andrei are 
consistent with the fact that X. lenduensis (which belongs to the “vestitus-wittei” subgroup) 
originated from a different octoploid ancestor. However, further analysis is necessary to 
clarify the relations between the different octoploid species. 
Effect of polyploidization and hybridization in Xenopodinae 
All extant vertebrates carry large numbers of duplicated genes suggesting evolutionary 
conservation of genes that arise through local, regional or global DNA duplication events 
(Lynch and Conery, 2000). The 2R hypothesis – influenced initially by studies on the Hox 
gene clusters - postulates that two rounds of whole genome duplications (WGD) occurred 
in relatively rapid succession, perhaps within 10 million years, sometime very early in 
vertebrate evolution but after divergence of amphioxus approximately 550-600 MYA 
(Escriva et al., 2002; Furlong and Holland, 2002; Lundin et al., 2003). A further round of 
WGD in the main branch of the vertebrate lineage that produced all the teleost fishes 
(approximately 320-350 MYA) (Robinson-Rechavi et al., 2001). In addition to the WGD 
postulated in the 2R hypothesis, there have been duplication events involving multiple 
duplications and translocations of individual genes, segmental duplications of large 
stretches of DNA and perhaps whole chromosomes (Hughes, 1999; Martin, 2001; 
Robinson-Rechavi et al., 2001). 
Gene or genome duplications per se will not lead to an increase in the complexity of 
life forms but they are an important evolutionary strategy by which organisms acquire 
phenotypic diversity (Ohno, 1970). A priori three evolutionary fates for a duplicated gene 
are proposed (Lynch and Katju, 2004): (a) nonfunctionalization which involves deletion of 
the daughter gene or its degeneration into a psuedogene; (b) subfunctionalization in which 
the mother and daughter genes are retained and share the same biological role, and (c) 
neofunctionalization in which the mother and daughter genes are retained but the daughter 
gene evolves to adopt a new biological role. Usually, WGD events are followed by massive 
gene loss (Gu et al., 2002). However, the mechanisms that lead to retention, followed by 
adoption of new function, versus loss of duplicated genes have broader implications at both 
a genetic and an evolutionary level. 
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The duplication of the genome in the ancestor of the Xenopodinae is significantly more 
recent than the teleost-specific duplication and the ancient vertebrate specific 
2R duplication. At the same time, it is older than the typical lifetime of duplicated genes in 
a diploid background (several million years) (Lynch and Conery, 2000). Only in the Pipidae 
family do polyploids comprise the majority of the species (Duellman and Trueb, 1994; 
Martino and Sinsch, 2002) and ploidy reaches one of its highest levels - dodecaploidy 
(Tymowska, 1991). X. laevis has retained ~50% of the duplicated gene loci when compared 
to its unduplicated relative S. tropicalis. Because the taxon is so well defined, the 
Xenopodinae constitutes an excellent system in which to study the evolutionary trajectory 
of duplicated genes following one or more polyploidization events. 
The distribution of AMPs in skin secretions from all species from Xenopodinae studied 
to date are compared in Table 4 (Chapters 2-5; Conlon et al., 2010a; King et al., 2012; 
Conlon et al., 2012b). The multiplicity of the peptides belonging to the PGLa, CPF, and 
XPF families is no greater in the tetraploids S. epitropicalis and “S. new tetraploid 1” than 
in the diploid S. tropicalis. Similarly, the multiplicity of the magainin, PGLa, CPF, and 
XPF families is not significantly greater in the octoploid Xenopus species than in the 
tetraploid Xenopus species. The data suggest, therefore, that nonfunctionalization is the 
most common fate of duplicated AMP genes following polyploidization events.  
A similar high level of gene deletion and/or gene silencing in octoploid and 
dodecaploid Xenopus species is seen among major histocompatibility complex (MHC) 
genes (Sammut et al., 2002; Du Pasquier et al., 2009) and also in the case of genes 
encoding RAG1 and RAG2 proteins crucial to the process of somatic rearrangement of 
DNA in adaptive immunity. In the latter example, degeneration of RAG1/RAG2 paralogs 
occurs via incorporation of premature stop codons and frameshift mutations (Evans, 2007; 
Evans et al., 2005). 
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Table 4. Multiplicity of the AMPs present in skin secretions of diploid, tetraploid, and 
octoploid frogs of the Xenopodinae. 
Ploidy 
level (2n) 
Magainin PGLa CPF XPF Total 
S. tropicalis 20 0 1 3 3 7
“S. new tetraploid 1” 40 0 1 3 2 6
S. epitropicalis 40 1 2 3 4 10
X. laevis 36 2 1 6 2 11
X. petersii 36 2 1 5 0 8
X. pygmaeus 36 2 1 3 0 6
X. borealis 36 2 2 4 2 9
X. muelleri 36 2 0 2 1 5
X. mulleri West 36 1 2 3 1 7 
X. clivii 36 2 0 2 1 5
X. amieti 72 2 2 4 1 9
X. andrei 72 2 2 1 2 7
X. lenduensis 72 2 4 3 0 9
Peptidomic analysis does not allow discrimination between deletion of the duplicated 
gene from the frog genome and silencing at the level of transcription or translation. 
Similarly, it is not claimed that the AMPs isolated from skin secretions in these studies 
necessarily represent the full complement of expressed AMP gene products as components 
present in very low abundance and/or with very weak growth-inhibitory activity may have 
been missed. 
The Xenopodinae provide examples of subfunctionalization among the AMPs. As 
shown in Table 5, the two CPF peptides (CPF-AM1 and CPF-AM4) from X. amieti 
(Conlon et al., 2010a), the two CPF peptides (CPF-SP1 and CPF-SP3) from 
“S. new tetraploid 1” (Chapter 4), and the two PGLa peptides (PGLa-B1 and PGLa-B2) 
from X. borealis (Chapter 2) have moderately well conserved primary structures and show 
comparable potencies against the Gram-positive bacterium S. aureus and the 
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Gram-negative bacterium E. coli. They appear to be sharing the responsibility of protecting 
the organism against environmental pathogens. 
Table 5. Examples of subfunctionalization and possible neofunctionalization among AMPs 
from Xenopodinae. 
Peptide Amino acid sequence MIC 
E. coli 
MIC 
S. aureus 
CPF-AM1 GLGSVLGKALKIGANLL.NH2 12.5 6
CPF-AM4 GLGSLVGNALRIGAKLL.NH2 25 12.5
CPF-SP1 GFLGPLLKLGLKGVAKVLPHLIPSRQQ  25 6
CPF-SP3 GFLGSLLKTGLKVGSNLL.NH2 50 25
PGLa-B1 GMASKAGTIAGKIAKTAIKLAL.NH2 12.5 25
PGLa-B2 GMASKAGSIVGKIAKIALGAL.NH2 25 50
PGLa-AM1 GMASKAGSVLGKVAKVALKAAL.NH2 12.5 25
PGLa-AM2 GMASTAGSVLGKLAKAVAIGAL.NH2 >200          >200 
The basic residues in the peptides, essential for potent antimicrobial activity, are shown in bold type. 
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In order to appreciate the possibility of neofunctionalization among the AMP genes in 
subfamily Xenopodinae, it is necessary to discuss structure-activity relationships among the 
gene products. The potency of an AMP (Chapter 1) is determined by complex interactions 
among four parameters: cationicity (net positive charge), hydrophobicity, stability of the 
α-helix, and degree of amphipathicity (Conlon et al., 2007a; Powers and Hancock, 2003). 
Increasing cationicity while maintaining amphipathicity promotes interaction between the 
peptide and the more negatively charged cell membrane of prokaryotes, and so generally 
increases antimicrobial potency (Conlon et al., 2007a). However, in the case of the PGLa 
peptides from X. amieti, the amino acid substitutions Lys5 → Thr and Lys19 → Ile have 
resulted in a selective decrease in cationicity which in turn has resulted in complete 
disappearance of antimicrobial activity (Table 5). This suggests the possibility of 
neofunctionalization with PGLa-AM2 having adopted a new biological role but the nature 
of this new function is currently unknown. 
Interspecies hybridization and AMP multiplicity 
Polyploidization in clawed frogs occurs mainly through allopolyploidization – genome 
duplication associated with hybridization between species (reviewed in Evans, 2008). Skin 
secretion AMPs profile from hybrid X. laevis x X. muelleri female frogs (Chapter 7) was 
compared to that of X. laevis and X. muelleri (Chapter 5) to study the mode of inheritance 
of AMPs. It is possible that the interspecies hybrids generated in the laboratory represent a 
model of ancient allopolyploidization events in the lineage (Chapter 1) without increasing 
the total amount of genetic information as these hybrids, like the parent species, are 
tetraploid (2n = 36) (Koroma et al., 2011). It was confirmed that the full complement of 
AMPs from X. laevis as well as four out of six AMPs from X. muelleri were present in 
secretions of the hybrid (Chapter 7). In addition, three novel AMPs, not detected in skin 
secretions of the parent species, were present in the hybrids and are presumed to have 
arisen as a result of hybridization. Therefore, comparing the total number of AMPs in the 
hybrids, with those from the tetraploid Xenopus species (Table 3) suggests the conclusion 
that interspecies hybridization leads to increased multiplicity of AMPs in the skin 
secretions. 
The origin of the Pipidae dates back at least to the Mesozoic (Late Jurassic around 
150 MYA) (Roelants and Bossuyt, 2005; Roelants et al., 2007; San Mauro, 2010; San 
Mauro et al., 2005). The extensive fossil record that spans about 90 million years (from the 
Cretaceous) (Trueb, et al., 2005) indicates that large scale population movements of Pipidae 
species have probably occurred in the Central African highlands during different periods of 
time. Sympatry observed amongst representatives of Xenopus may have been an important 
factor in the evolution of these frogs. Thus, X. wittei and X. vestitus are interpreted as 
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allopolyploids, the products of interspecies hybridization (Tinsley and Jackson, 1998) but 
conclusive evidence is lacking. 
Many present day representatives of Xenopus and Silurana live in sympatry. However, 
there have been relatively few reports of naturally occurring hybrids in the genus Xenopus 
in the wild, mainly amongst members of the laevis and the muelleri group (Picker, 1985; 
Yager, 1996; Fischer et al., 2000). In contrast, many Xenopus species can be hybridized in 
the laboratory and gametic incompatibilities are generally found to be absent (Kobel et al., 
1996). As Xenopus females are heterogametic and males are homogametic, it has been 
pointed out that this genus represents an exception to Haldane’s rule that the heterogametic 
sex typically suffers the greater dysfunctional effects of hybridization (Malone et al., 2007). 
In interspecies crosses the males are consistently found to be sterile and the females are 
fully or partially fertile. The fertile female hybrids may play an important role in the 
evolution of the Xenopus frogs. 
Future perspectives 
More than 150 years have passed since Mark Twain penned the words: “I don’t see no 
p’ints about that frog that’s any better’n any other frog” in The Celebrated Jumping Frog of 
Calaveras County (1867). Now we actually do know why some frogs are better than others. 
The new insights gained from the work on AMPs from skin secretions of polyploid 
frogs from Pipidae family suggest the following directions for future research: 
Design of analogues of the CPFs and the hymenochirins with potential for 
development into therapeutic agents 
Development of frog AMP-based anti-infectives as a platform for next-generation 
therapeutics will help address the growing threat of multidrug-resistant infections. Despite 
displaying potent activity against strains of antibiotic resistant bacteria and against certain 
pathogenic fungi, no anti-infective peptide based upon their structures has been adopted in 
clinical practice. Consequently, the therapeutic potential of frog skin AMPs has yet to be 
realized. 
The CPF-B1, CPF-C1, CPF-MW1, CPF-SP1 peptides, as well as hymenochirin-1B, 
-2B and -3B that are highlighted in the Discussion (Table 1) exert broad spectrum 
antimicrobial activity and so represent good templates for targeted drug design. They will 
be the subject of extensive structure-activity relationships studies aimed at generating 
analogues with improved antimicrobial potency against MDR pathogens that are non-
hemolytic. A successful strategy for structural modification of promising naturally 
occurring AMPs has been established in the laboratory (Conlon et al., 2007a). It involves 
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selective increase in cationicity concominant with decrease in helicity and hydrophobicity 
in the transformation of the naturally occurring AMPs into non-toxic therapeutic agents. 
Subsequently, the efficacy and pharmacokinetic properties of the best analogues of the 
naturally occurring peptides will be investigated both in vitro and using in vivo models of 
diseases caused by MDR pathogens. 
A major obstacle to the development of effective peptide-based anti-infective drugs is 
their short half-lives in the circulation which severely limits their usefulness for systemic 
applications. Peptides lacking stable secondary structures are susceptible to proteolysis by a 
range of microbial proteases (Schmidtchen et al., 2002). Several approaches have been 
developed to increase the stability of peptide analogues towards proteolytic enzymes which 
involve coupling of the peptides to fatty acids and substitutions of L-amino acids by 
D-amino acids or unnatural amino acids (Chen et al., 2006; Conlon et al., 2007b; Tossi et 
al., 2012). 
The conjugation of a fatty acid moiety at the N-terminus of peptide scaffolds has been 
demonstrated to improve significantly antimicrobial activity (Shalev et al., 2006; Jerala, 
2007) and is known also to compensate for a loss of hydrophobicity within the peptidic 
chain based on amino acid residue substitutions (Malina and Shai, 2005). As only natural 
L-amino acid residues are targets of the proteases, substitutions by D-amino acids at 
susceptible sites would render the peptide partially or totally resistant to proteolysis without 
loss of antimicrobial activity (Chen et al., 2006; Conlon and Sonnevend, 2011; Conlon, et 
al., 2012d). D-stereoisomers, by decreasing α-helicity, also tend to be less hemolytic than 
their L-counterparts (Papo et al., 2002). An alternative strategy is to select unnatural amino 
acids, such as α-aminoisobutyric acid (Aib) (Conlon et al., 2007b) and ornithine (Strom et 
al., 2003). Aib is a non-chiral, α,α-dimethylated amino acid and its incorporation into a 
peptide introduces conformational constraints. As a result, Aib substitution leads to 
stabilization of an existing helical conformation and provides stability against proteases. 
Another worthwhile avenue for future exploitation is the evaluation of CPF peptides 
and the hymenochirins, as well as their analogues, for antitumour and insulin-releasing 
potential. Since cancer and diabetes are conditions associated with increased susceptibility 
to infections due to a compromised immune system and/or impaired wound healing, the 
combined antimicrobial and antitumor or insulin-releasing activity of these peptides may 
prove particularly helpful in the development of new therapies to counter the increasing 
health burden of the diseases. 
Cancer chemotherapy faces challenges posed by tumours becoming unresponsive to 
commonly used anti-cancer agents (Chen and Tiwari, 2011). There is an urgent need for 
new types of drugs with appropriate pharmacokinetic and toxicological profiles that exert 
preferential cytotoxicity towards tumour cells compared with non-neoplastic cells. Anti-
cancer activity of AMPs has been studied in much less detail but it has been shown that 
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alyteserin-2a, isolated from skin secretions from A. obstetricans (Conlon et al., 2009a), 
represent a good template to design more potent analogues that selectively target tumour 
cells (Conlon et al., 2012e). 
Similarly, many frog skin peptides have been shown to stimulate insulin-release from 
BRIN-BD11 clonal β-cells at low concentrations that are not toxic to the cells (Ojo et al., 
2013). Consequently, these compounds show potential for treatment of patients with Type 2 
diabetes The CPF peptides from skin secretions of X. laevis and S. epitropicalis show 
particularly high potency, producing a significant increase in the rate of insulin release at 
concentrations as low as 3 x 10-11 M (Srinivasan et al., 2013). CPF peptides from 
X. borealis, X. clivii, X. muelleri West and “S. new tetraploid 1”, described in Chapters 2-5, 
may show increased potency and therefore greater therapeutic potential. 
Further studies to elucidate taxonomic relationships among frogs from the Pipidae 
Based on advertisement calls and/or molecular characters, X. fraseri forms a 
monophyletic group with tetraploid X. pygmaeus, the octoploids X. amieti, X. andrei and 
X. boumbaensis, and the dodecaploid X. ruwenzoriensis (Kobel, 1996). However, more 
detailed comparative studies of the evolution of globin expression of the tetraploids in 
genus Xenopus suggest that X. fraseri, despite sharing the same chromosome number with 
the rest of the species, may have evolved as a result of an independent genome duplication 
(Burki and Fischberg, 1985). X. fraseri may occupy an anomalous position in the evolution 
of Xenopodinae being more closely related to Silurana than the other tetraploids. Both 
X. fraseri and S. tropicalis are morphologically similar, e.g. possess equal number of claws, 
and display similar electrophoretic patterns for their albumins (Burki and Fischberg, 1985). 
Two other tetraploids similar to X. fraseri have been identified and referred as X. cf. fraseri 
1 and 2 (Evans et al., 2004). Characterization of their species status is still incomplete. The 
AMP secretory profile of X. fraseri will provide insight into the taxonomic relations of this 
species with the other members of the Xenopodinae. 
The taxonomic relationship between the octoploids X. vestitus and X. wittei is complex. 
Based on molecular analysis of the mtDNA, at least three independent allooctoploidization 
events are suggested (Evans et al., 2011). According to the scenario, X. vestitus forms a 
sister group with X. lenduensis which shares common ancestry of half of their genome with 
X. itombwensis and X. wittei, and the other half with X. amieti and X. andrei. Comparison 
of the electrophoretic patterns of the albumins reveals that more globin genes have been 
silenced in X. vestitus than in X. wittei (Burki and Fischberg, 1985). By applying the same 
approach used in Chapters 2-5, the full complement of AMPs in skin secretions of these 
species will be determined. Once their primary structures are known, they will be compared 
with those of the previously characterized orthologous peptides from X. andrei, X. amieti, 
and X. lenduensis (Chapter 4; Conlon et al., 2010a; King et al., 2012). An expected 
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outcome of this research will be a better understanding of the evolutionary history of these 
frogs and may permit differentiation between the alternative hypotheses. 
Relationships between different taxa in the subfamily Pipinae have been much less 
studied than those in the Xenopodinae. It is proposed to analyze the skin secretions from 
the single species P. merlini belonging to the genus Pseudhymenochirus. Since this genus is 
taxonomically closely related to Hymenochirus (Evans et al., 2004; Bewick et al., 2012), it 
is expected that the skin secretions of P. merlini will contain AMPs. A comparison of the 
structures of these putative peptides with the hymenochirins will provide insight into the 
taxonomic relationship between Pseudhymenochirus and Hymenochirus. Moreover, the 
only representative of genus Pipa studied to-date is P. pipa and, unexpectedly, AMPs are 
absent from skin secretions (Conlon et al., 2009b). In order to answer the question whether 
the lack of AMPs is species-specific or is common to all the members of the genus, other 
species will be analyzed. It is tempting to speculate that the AMP genes have evolved after 
the divergence of Pipa and the other genera in Pipidae family. An alternative explanation is 
nonfunctionalization of the AMP genes necessitated by the unusual reproductive behavior 
of Pipa. This includes female dorsal skin brooding and AMPs may be toxic to the eggs. 
Investigations of the link between polyploidization and multiplicity of AMPs 
The evolutionary scenario described in Chapter 1 outlines the importance of 
allopolyploidization for the speciation of Xenopodinae. Both X. ruwenzoriensis and 
X. longipes evolved independently and are considered to be products of such 
allopolyploidization events between different octoploid and tetraploid ancestors (Evans et 
al., 2004). Further investigations are required to address ambiguities regarding the origin of 
these species. Since X. ruwenzoriensis and X. longipes are dodecaploid (the highest level of 
ploidy observed in Xenopus), they represent a good model to extend the study on effect of 
gene dosage on AMPs multiplicity in skin secretions. In light of the findings presented in 
Chapter 4, it is expected that the number of the AMPs will not be substantially different 
from the number in tetraploids and octoploids, as many AMP genes will have been 
silenced. However, the dodecaploids are considered as a model of interspecies 
hybridization between parents with different chromosome sets. Consequently, an alternative 
(although less likely) outcome is a possibility: an increased number of AMPs which include 
peptides common with both parents together with novel components. 
Insight into the mode of inheritance of AMP genes in interspecies hybrids 
Interspecies hybridization between female X. laevis and male X. muelleri increases the 
multiplicity of the AMPs and leads to expression of novel peptides in the skin secretions of 
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female F1 frogs (Chapter 7). It is proposed to extend this research by studying other species 
hybrids such as female X. laevis x X. borealis. Both X. borealis and X. muelleri belong to 
the muelleri lineage and are thought to be evolutionary equidistant from X. laevis (Evans et 
al., 2004; Evans et al., 2005; Evans, 2007). Using both directions of interspecies cross, in 
which the mother is either X. laevis or X. borealis, would provide more information relating 
to: 1) multiplicity of the AMPs in skin secretions of hybrid frogs; 2) influence of the 
maternal and paternal genomes on the mode of inheritance of the AMP genes; and 3) origin 
of the novel peptides. An increase in AMP multiplicity is expected but the possibility that 
this finding might be species-specific is not excluded. 
Dramatic genetic and epigenetic reconfigurations are known to occur in the hybrid 
Xenopus background such as: mis-expression and novel gene expression pattern, or changes 
in the cytosine methylation pattern and histone modifications (Chain et al., 2008; Malone 
and Michalak, 2008; Koroma, et al., 2011). As many AMP genes in a species are silenced 
after genome duplications take place (Chapter 4), it seems reasonable to speculate that their 
expression will be re-activated due to the presence of transcription factors from the other 
parent present in the hybrid environment. This mechanism may explain the presence of 
novel peptides in the skin secretions. The hypothesis that a hybrid with a greater 
complement of AMPs, including novel active peptides, will be better protected against 
invasion by pathogenic microorganisms in the environment than the parent species also 
needs further investigation. 
The issue of whether epigenetic changes will play a role in the inheritance of the full 
complement of AMPs including the novel peptides needs to be addressed. Since the female 
hybrids are fertile, analysis of the AMPs in the offspring from mating the X. laevis x 
X. muelleri and X. laevis x X. borealis hybrids with either of their parental species 
(F2 generation) will be undertaken. The main question to be answered is whether the novel 
complement of AMPs is stably transferred into the next generation. 
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The emergence of pathogenic bacteria and fungi resistant to commonly used antibiotics 
poses a serious threat to public health and necessitates novel treatment approaches in order 
to control infections. Antimicrobial peptides (AMPs) are one of the central components of 
the system of innate immunity and due to their non-specific and highly destructive 
mechanism of killing, pathogens will develop resistance at lower rates than conventional 
antibiotics. Skin secretions of frogs from the family Pipidae are a rich source of AMPs 
which show potential for development into therapeutic agents. 
Until recently, the only representatives of the Pipidae family frogs from which dermal 
AMPs had been identified were the diploid frog Silurana tropicalis, the tetraploid frog 
Xenopus laevis and the octoploid frog Xenopus amieti. Therefore, this program of research 
was undertaken with the aim to isolate, purify and characterize AMPs with therapeutic 
potential from skin secretions of other polyploid species of African clawed frogs of the 
Pipidae family. Emphasis is given to the application of the AMPs as markers to elucidate 
the taxonomic relationships and evolutionary history of the frogs. The study also 
investigates the effects which polyploidization and interspecies hybridization have had on 
the multiplicity of AMPs in frog skin secretions. 
Chapter 2 and Chapter 3 present data from the peptidomic analysis of norepinephrine-
stimulated skin secretions of two well-characterized and closely related tetraploid Xenopus 
species – X. borealis and X. clivii. Multiple peptides with varying degrees of antimicrobial 
activity were isolated. Structural characterization demonstrated that they were orthologous 
to magainins, peptide glycine-leucine-amide (PGLa), caerulein-precursor fragments (CPFs) 
and xenopsin-precursor fragments (XPFs), previously isolated from S. tropicalis, X. laevis 
and X. amieti. CPF-B1 and CPF-C1 were the most abundant AMPs in the skin secretions of 
X. borealis and X. clivii respectively. CPF-B1 (GLGSLLGKAFKIGLKTV  
GKMMGGAPREQ) was active against clinical isolates of the hospital-associated 
pathogens, methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant 
Acinetobacter baumannii (MDRAB) with MIC = 5 µM and showed low hemolytic activity 
against human erythrocytes (HC50 >200 µM). CPF-C1 (GFGSLLGKALRLGANVL.NH2) 
also showed potent activity against a range of Gram-negative bacteria. CPF peptides, 
therefore, represent promising candidates for development into therapeutic agents for use 
against these emerging antibiotic-resistant pathogens. 
The genera Silurana and Xenopus are united in the subfamily Xenopodinae and have a 
complex evolutionary history. Chapter 4 includes data from the peptidomic analysis of skin 
secretions from an incompletely characterized tetraploid species termed “S. new tetraploid 1” 
with chromosome number 2n=40 and the octoploid species X. andrei (2n=72). The species 
represent model systems in which to study of the fate of duplicated AMP genes following 
putative allopolyploidization events. Multiple peptides belonging to the PGLa, XPF, and 
CPF familes were identified. The primary structures of the AMPs from X. andrei indicate a 
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close phylogenetic relationship between this species and the previously studied X. amieti. 
Three CPF peptides from “S. new tetraploid 1” showed potent, broad-spectrum 
antimicrobial activity and are present in high abundance. In contrast, only a single CPF 
peptide was isolated in low yield from the X. andrei secretions. There is no increase in the 
multiplicity of the AMPs in skin secretions of “S. new tetraploid 1” and the octoploid 
X. andrei when compared to the diploid S. tropicalis (2n=20) and the tetraploid X. laevis 
(2n=36). It is concluded that nonfunctionalization (gene silencing) has been the most 
common fate of duplicated AMP genes following polyploidization in the Silurana and 
Xenopus lineages. 
AMPs constitute a characteristic ‘‘fingerprint’’ of a particular frog species that may be 
used for an unequivocal taxonomic classification. Two populations of the tetraploid 
X. muelleri, occupying separate non-contiguous ranges in east and west Africa, are studied 
in Chapter 5. Their taxonomic relationship is unclear and it has been proposed that the 
western population represents a separate species referred to as X. muelleri West while the 
eastern population retains the original name X. muelleri. A comparison of the primary 
sequences of AMPs in skin secretions reveals that no orthologous peptide from the two 
populations of X. muelleri has the same amino acid sequence. Additionally, the X. muelleri 
secretions, like those from X. clivii, did not contain a PGLa peptide whereas the 
X. muelleri West secretions contained two members of this family. The data indicate that 
X. muelleri West is more closely related to X. borealis than to X. muelleri and so provide 
strong support for the proposal that X. muelleri and X. muelleri West should be described as 
separate species. 
In contrast to species in the subfamily Xenopodinae, frogs from the subfamily Pipinae 
have not been investigated as a source of AMPs. The AMP profile in skin secretions from 
Hymenochirus boettgeri as a representative of genus Hymenochirus (subfamily Pipinae) is 
described in Chapter 6. A novel family of five structurally-related peptides, designated as 
hymenochirins, was identified. Hymenochirin-1B (IKLSPETKDNLKKVLKGAIKGAIAV 
AKMV.NH2) is C-terminally α-amidated whereas hymenochirins-2B - 5B have the general 
structure XKIPX2VKDTLKKVAKG X2SX2 AGAX3.COOH. The most abundant peptide in 
the secretions was hymenochirin-3B (IKIPAVVKDTLKKVAKGVLSAVAGALTQ). 
Synthetic replicates of hymenochirin-1B - 4B possess broad-spectrum antimicrobial 
activity and relatively weak hemolytic activity and so represent potential candidates for 
development into therapeutically valuable agents against drug-resistant pathogens. The 
hymenochirins show very low structural similarity with the antimicrobial peptides isolated 
from skin secretions of S. tropicalis and X. laevis consistent with the proposed ancient 
divergence of the Pipinae and Xenopodinae. 
The F1 hybrid frogs X. laevis x X. muelleri represent a model of interspecies 
hybridization in the Pipidae family that does not result in an increase in ploidy. They are 
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studied in Chapter 7 and the data obtained provide an insight into the mode of inheritance 
of AMPs. A total of 18 different AMPs were isolated from skin secretions of the female 
hybrids. In addition to the complement of AMPs from the parent species, three previously 
undescribed peptides (magainin-LM1, PGLa-LM1, and CPF-LM1) were purified from the 
secretions of the hybrid frogs that were not detected in secretions from either X. laevis or 
X. muelleri. Magainin-LM1 differs from magainin 2 from X. laevis by a single amino acid 
substitution (Gly13  Ala) but PGLa-LM1 and CPF-LM1 differ appreciably in structure 
from orthologs in the parent species. CPF-LM1 shows potent, broad-spectrum 
antimicrobial activity and is hemolytic. The data indicate that hybridization increases the 
multiplicity of host-defense peptides in skin secretions. As the female F1 hybrids are fertile, 
hybridization may represent an adaptive strategy among Xenopus species to increase 
protection against pathogenic microorganisms in the environment. 
The thesis is completed by a general discussion in Chapter 8 of the results and 
conclusions in Chapters 2-7. The potential of AMPs from skin secretions of frogs 
belonging to the Pipidae family is reviewed from three different aspects: promising 
candidates for development into therapeutic valuable anti-infective agents; reliable 
taxonomic and phylogenetic markers; and tools to study the fate of duplicated genes in 
Xenopus and Silurana. The interspecies Xenopus hybrids are proposed as a suitable model 
to perform future studies on the mode of inheritance of skin AMPs. 

Samenvatting 
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De opkomst van pathogene bacteriën en schimmels, die resistent zijn tegen 
conventionele antibiotica vormen een serieus gevaar voor de volksgezondheid en vereist 
een nieuwe aanpak om infecties in bedwang te houden. Antimicrobiële peptiden (AMPs) 
vormen een van de centrale componenten in het aangeboren immuun system en door hun 
niet specifieke en hoogst vernietigende mechanismen, zullen pathogenen langzamer 
resistentie opbouwen dan bij gebruik van conventionele antibiotica. De huidsecreties van 
kikkers van de Pipidae familie vormen een rijke bron van AMPs die het ontwikkelen van 
therapeutische middelen mogelijk zou kunnen maken. 
Tot voor kort waren alleen AMPs- geïdentificeerd van de kikkerhuid van de diploid 
kikker Silurana tropicalis, van de tetraploide kikker Xenopus laevis en van de octoploide 
kikker Xenopus amieti, die allen behoren tot de Pipidae familie. Om die reden werd dit 
onderzoeksprogramma uitgevoerd met het doel om AMPs met therapeutisch potentiaal te 
isoleren, te zuiveren en te karakteriseren ten opzichte van de  huidsecreties van andere 
polyploide soorten van de Afrikaanse klauwkikker van de Pipidae familie. De nadruk ligt 
op het gebruik van AMPs als markers om de taxonomische relaties en de evolutionaire 
geschiedenis van de kikkers in kaart te brengen. Deze studie onderzoekt de effecten die 
polyploidizatie en interspecies hybridisatie gehad hebben op het multipliceren van AMPs in 
de huidsecretie van deze kikkers. 
Hoofdstukken 2 en 3 presenteren de data van de peptidomische analyse van 
norepinephrine-gestimuleerde huidsecreties van twee goed gekarakteriseerde en nauw 
verwante tetraploide Xenopus soorten – X. borealis en X. clivii. Meerdere peptiden met 
verscheidene antimicrobiële activiteiten werden geïsoleerd. Structuurkarakterisatie toonde 
aan dat deze ortholoog waren tot magainins, peptide-leucine-amide (PGLa), caerulein-
precursor fragmenten (CPFs) en xenopsin-precursor fragmenten (XPFs), die al eerder 
waren geïsoleerd van S. tropicalis, X. laevis en X. amieti. CPF-B1 en CPF-C1 waren de 
meest voorkomende AMPs in de huidsecreties van respectievelijk X. borealis en X. clivii. 
CPF-B1 (GLGSLLGKAFKIGLKTVGKMMGGAPREQ) was actief bij de klinische 
isolatie van de ziekenhuis-gerelateerde pathogene, methicillin-resistente Staphylococcus 
aureus (MRSA) en de meervoudig-resistente Acinetobacter baumannii (MDRAB) met een 
MIC = 5 µM en een lage hemolytische activiteit tegen menselijke erythrocyten 
(HC50 > 200 µM). CPF-C1 (GFGSLLGKALRLGANVL.NH2) was ook sterk actief tegen 
verschillenden Gram-negatieve bacteriën. CPF peptiden representeren daarom een groep 
van veelbelovende kandidaten voor de ontwikkeling van therapeutische middelen tegen het 
verschijnen van antibiotica resistente pathogenen. 
De genera Silurana en Xenopus zijn verenigd in de subfamilie Xenopodinae en hebben 
een complexe evolutionaire geschiedenis. Hoofdstuk 4 bevat data van de peptidomische 
analyse van huidsecretie van een onvolledig gekarakteriseerde tetraploide species genaamd 
“S. new tetraploid 1” met chromosoom nummer 2n=40 en de octoploid species X. andrei 
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(2n=72). Deze soorten vertegenwoordigen een model waarin het van gedupliceerde AMP 
genen bestudeerd kunnen worden, na een putatieve allopolyploidizatie gebeurtenis. 
Verscheidene peptiden behorende tot de PGLa, de XPF, en de CPF families werden 
geïdentificeerd. De primaire structuren van de AMPs van X. andrei wijzen op een nauwe 
phylogenetische verwantschap tussen deze species en de eerder bestudeerde X. amieti. Drie 
CPF peptiden van de “S. new tetraploid 1” vertoonden een sterke, breed-spectrum 
antimicrobiële activiteit en zijn in overmaat aanwezig. Daarentegen werd slechts een enkel 
CPF peptide en in lage kwantiteit geïsoleerd uit de secreties van de X. andrei. Er is geen 
toename in de multipliciteit van de AMPs in huidsecreties van de “S. new tetraploid 1” en 
de octoploid  X. andrei ten opzichte van de diploid S. tropicalis (2n=20) en de tetraploid 
X. laevis (2n=36). De conclusie is dat de meest voorkomende uitkomst van gedupliceerde 
polyploidisatie in de Silurana en Xenopus geslacht is niet-functionalisatie (gene silencing). 
AMPs vormen een karakteristieke “vingerafdruk” van een specifiek kikkersoort die 
gebruikt zou kunnen worden voor een eenduidige taxonomische classificatie. Twee 
populaties van de tetraploid X. muelleri, die apart voorkomen in twee afzonderlijke en niet 
aan elkaar verbonden gebieden in oost en west Afrika zijn bestudeerd in hoofdstuk 5. Hun 
taxonomische relatie is niet duidelijk en er is voorgesteld dat de westerse populatie een 
aparte soorten vertegenwoordigt, genaamd X. muelleri West, terwijl de oostelijke populatie 
zijn oorspronkelijke naam X. muelleri behoudt. Een vergelijking van de primaire sequenties 
van de AMPs in de huidsecreties maakt duidelijk dat geen orthologe peptide van de twee 
X. muelleri populaties dezelfde serie aminozuren vertoont. Bovendien, bevatten de 
huidsecreties van X. muelleri, net als die van de X. clivii, niet een PGLa peptide terwijl de 
X. muelleri West secreties twee leden van deze familie bevatten. De resultaten tonen aan 
dat X. muelleri West meer gelieerd is aan X. borealis dan aan X. muelleri. Dit het voorstel 
ondersteunt dat X. muelleri en X. muelleri West het best als twee verschillende soorten 
kunen beschreven worden. 
In tegenstelling tot de species in de subfamilie Xenopodinae, zijn de kikkers van de 
subfamilie Pipinae nog niet onderzocht als een potentiele bron van AMPs. Het AMP profiel 
in de huidsecreties van Hymenochirus boettgeri als vertegenwoordiger van de genus 
Hymenochirus (subfamily Pipinae) is beschreven in hoofdstuk 6. Een nieuwe familie van 
vijf structuur-gerelateerde peptiden, hymenochirins genoemd, is geïdentificeerd. 
Hymenochirin-1B (IKLSPETKDNLKKVLKGAIKGAIAVAKMV.NH2) is C-terminally 
α-amidated terwijl hymenochirins-2B - 5B de algemene structuur XKIPX2VKDTLKKV 
AKGX2SX2 AGAX3.COOH hebben. De meest voorkomende peptide in de secreties was 
hymenochirin-3B (IKIPAVVKDTLKKVAKGVLSAVAGALTQ). Synthetische kopieën 
van hymenochirin-1B - 4B bevatten breed-spectum antimicrobiële activiteit en een relatief 
zwakke hemolytische activiteit en vertegenwoordigen dus potentiele kandidaten voor de 
ontwikkeling van therapeutisch waardevolle middelen tegen medicijnen-resistente 
pathogene. De hymenochirins vertonen een zeer geringe structurele gelijkenis met de 
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antimicrobiële peptiden die geïsoleerd waren van huidsecreties van S. tropicalis en X. laevis 
wat weer consistent is met de voorgestelde oude afscheiding van de Pipinae en de 
Xenopodinae. 
De F1 hybride kikkers X. laevis x X. muelleri vormen een interspecies hybridizatie 
model in de Pipidae familie die geen toename in ploidy initieert. Deze zijn bestudeerd in 
hoofdstuk 7 en de verkregen resultaten geven een inzicht in de overerving van AMPs. In 
totaal werden 18 AMPs geïsoleerd van de huidsecretie van de vrouwelijke hybriden. Naast 
het aantal AMPs, afkomstig van de ouderlijke soorten, werden drie niet eerder beschreven 
peptiden (magainin-LM1, PGLa-LM1, en CPF-LM1) gezuiverd uit de secreties van de 
hybride kikkers die niet ontdekt waren in secreties afkomstig van of X. laevis of van 
X. muelleri. Magainin-LM1 verschilt van magainin 2 van de X. laevis met een enkele 
aminozuur substitutie (Gly13  Ala), maar PGLa-LM1 en CPF-LM1 verschillen aanzienlijk 
in structuur vergeleken met hun orthologen in de ouderlijke speciën. CPF-LM1 vertoont 
een sterke breedspectrum antimicrobiële activiteit en is hemolytisch. De data suggereren 
dat hybridisatie de multipliciteit van gastheer-verdedigende peptiden in huidsecreties doet 
toenemen. Aangezien de vrouwelijke F1 hybriden vruchtbaar zijn, zou hybridisatie een 
aanpassingsstrategie voor de Xenopus soorten kunnen zijn om zich beter te verdedigen 
tegen pathogene micro-organismen in de hun omgeving. 
Het proefschrift wordt in hoofdstuk 8 afgesloten met een algemene discussie over de 
resultaten en de conclusies uit hoofdstukken 2-7. Het potentieel van AMPs afkomstig van 
huidsecreties van de Pipidae kikkerfamilie wordt beschreven vanuit drie verschillende 
aspecten: als potentiele kandidaten voor de ontwikkeling van therapeutisch interessante 
anti-infectie middelen; als betrouwbare taxonomische en phylogenetische markers; en als 
gereedschap om het lot van gedupliceerde genen te bestuderen in Xenopus en Silurana. De 
interspecies Xenopus hybride wordt voorgesteld als een geschikt model voor verdere studie 
in de soort van vererving van dermaal afkomstige AMPs. 
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